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Patients with compromised respiratory host defences,
particularly associated with cystic fibrosis (CF), are susceptible
to respiratory tract colonization by Pseudomonas aeruginosa.
Isolates of P. aeruginosa from the sputum of patients suffering from
chronic, obstructive pulmonary disease express one or more unusual
characteristics. These include a mucoid colonial morphology (due to
alginate synthesis), antibiotic hypersensitivity, loss of the
specific O-antigen, polyagglutinability and serum sensitivity.
Problems associated with the epidemiological typing of these
atypical strains were overcome by the development of a technically
improved spotting method of pyocin typing, based on the method of
Gillies & Govan (1966). The spotting method provides greater
discrimination through the recognition of S-pyocin production, and
confirmed that in most cases, the phenotypic heterogeneity of
P. aeruginosa isoiates from CF patients emerged in vivo.
The genetic basis of aiginate synthesis and antibiotic
hypersensitivity in P. aeruginosa were investigated using two
different approaches. In the case of alginate synthesis, mucoid
derivatives of P. aeruginosa strain PAO were isolated and at least
two loci (muc) associated with the "switching on" of alginate
synthesis were mapped on the chromosome by means of FP2-mediated
conjugation and F116L-mediated transduction. Evidence for the
regulatory nature of one of these muc loci was obtained following
the construction of R'muc and R'muc+ plasmids from R68.45. The
R'muc+ plasmid, pJF4, "switched off" alginate synthesis in four out
(i)
of five clinical mucoid P. aeruginosa isolates, suggesting that the
muc locus characterized in PAO is responsible for "switching on"
alginate synthesis in some clinical strains.
The genetic basis of clinically associated antibiotic
hypersensitivity was investigated using P. aeruginosa isolates 492a
and 492c. These strains were from the same sputum specimen and of
the same pyocin type, but expressed different antibiograms. 492c
was hypersensitive (10-100 times more sensitive than 492a) to
carbenicillin, methicillin, flucloxacillin, mecillinam, cefuroxime
and naladixic acid, and showed enhanced sensitivity (4-8 times more
sensitive than 492a) to chloramphenicol, trimethoprim and
novobiocin. Two genetic determinants associated with antibiotic
hypersensitivity (blsAl and tpsAl) were mapped in the 30 min region
of the chromosome by means of R68.45-mediated plate matings between
a Leu- mutant of 492c and PAO recipients, followed by transductional
analysis using F116L. b1sA1 was closely linked to na 1B and was
responsible for the difference in antibiograms between 492a and
492c, whereas tpsAl, which mapped between ser-3 and hisV could also
be transferred to PAO from 492a. The genetic basis of antibiotic
hypersensitivity in the unrelated clinical isolates 519c and 2358
was similar to that demonstrated for 492c. A b1sA mutant was
isolated from PA0969 following mutagenesis and screening.
Using a similar approach, two genetic determinants associated
with antibiotic hypersensitivity (blsB3 and blsC4) were identified
in the mutant strain 799/61. blsB3 was cotransducible with pro-82
and coded for hypersensitivity to ^-lactams, trimethoprim, naladixic
(ii)
acid, novobiocin, rifampicin and chloramphenicol. blsC4 was closely
linked, but distinct from blsA and gave rise to a similar phenotype
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PSEUDOMONAS AERUGINOSA: THE ORGANISM AND ITS HABITAT
Members of the genus Pseudomonas are widespread microbial
inhabitants of soil and water (Douderoff & Palleroni, 1974). They
are Gram negative straight or curved rods with dimensions 0.5 to ljum
by 1.5 to 4;um, and are motile by means of single or multiple polar
flagella (Palleroni, 1975). They are strict aerobes, except for
those species which can use denitrification as a means of anaerobic
respiration, and are amongst the most catabolical ly versatile
microbes known.
The genus can be subdivided into five groups on the basis of
rRNA homology (Palleroni, 1975). rRNA Homology Group I contains the
fluorescent species of which Pseudomonas aeruginosa is the type
species. Strains of P. aeruginosa are generally pigmented due to
the production of pyocyanin and various fluorescent pigments, and
grow well at 37°C (a characteristic which distinguishes them from
other fluorescent pseudomonads) with an upper limit in growth
temperature of 44°C (Palleroni, 1975). P. aeruginosa is a
nutritionally versatile species and most strains are capable of
utilizing 70 to 80 organic compounds as growth substances (Douderoff
& Palleroni, 1974). According to Rhame (1980) "P. aeruginosa is a
strong contender for the microorganism capable of thriving in the
greatest number of seemingly dissimilar ecological niches."
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P. aeruginosa is generally a saprophyte and appears to be a
natural inhabitant of agricultural soil. Green et a 1 (1974)
recovered P. aeruginosa from 34% of 58 soil samples taken from
different Californian locations where there was no history of the
use of organic fertilizers, no pasturing of animals and no
P. aeruginosa isolated from the irrigation water. Soil in which
tomatoes were grown yielded the most frequent isolations (46% of 24
samples). In another study, Schroth et a 1 (1977) demonstrated that
P. aeruginosa could frequently be isolated from soil used in pots
for ornamental plants (84% of 49 soil samples).
The plants themselves are only rarely colonized in the field
(Green et al, 1974), although under conditions of moderately high
temperatures and humidity, P. aeruginosa will survive and multiply
within plant tissue, causing rotting of the leaves. This is a
particular problem in greenhouses (Schroth et al, 1977), and in the
tropics where P. aeruginosa is the cause of an economically
important disease of tobacco (Elrod & Braun, 1942). Once harvested,
salad plants in particular are rapidly colonized with P. aeruginosa
(Shooter et al, 1969; Kominos et al, 1972), probably due to the
humid conditions usually inherent in transport and storage.
Perhaps the most important habitat for P. aeruginosa is surface
water, particularly where there has been human or animal activity.
This is partly due to the fact that a small proportion of normal
human beings (8% according to Stoodley & Thoma, 1970) and domestic
animals (3% according to Ringen & Drake, 1952) carry P. aeruginosa
as part of their normal gut flora. Consequently, P. aeruginosa is
frequently isolated from sewage and polluted streams (Hoadley,
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1977). In warm climates, the species also thrives in organically
rich unpolluted stream water (Hoadley, 1977). Swimming pool water
is frequently contaminated with P. aeruginosa, particularly in the
absence of adequate chlorination (Nemedi & Lanyi, 1971), likewise
jacuzzis or health spas (Vogt et al, 1982).
As if to emphasize its aquatic predilection and versatility,
P. aeruginosa can frequently be isolated from distilled water where
populations of up to 10? cells ml-* can be maintained for up to 42
days (Favero et al, 1971).
Although P. aeruginosa can be isolated from seawater,
particularly near sewage outfalls, it is probably not naturally a
marine organism (Hoadley, 1977).
As well as its nutritional versatility, P. aeruginosa is
reknowned for its intrinsic resistance to a wide range of anti¬
microbial agents and this characteristic extends its natural habitat
considerably. The organism is able to survive and often multiply in
aqueous quaternary ammonium disinfectants (Neu, 1983) as well as
soaps, handcreams, ophthalmological solutions and infusion fluids.
Consequently, the hospital environment provides an ideal habitat for
P. aeruginosa due to the constant provision of moisture, warmth and
a source of nutrients generally unsuitable for most other organisms.
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CHAPTER II
HOST FACTORS ASSOCIATED WITH P. AERUGINOSA COLONIZATION
AND INFECTION
As previously mentioned, up to 8% of the normal human
population may carry P. aeruginosa as a gut commensal, but, in
general, healthy individuals are not colonized by this organism
either in the gastrointestinal tract or any other site. However,
hospitalized patients, particularly those being treated in an
intensive care unit, rapidly become colonized by P. aeruginosa, and
the frequency of intestinal carriage in such patients can be as high
as 75% (Neu, 1983). Likewise, oropharyngeal colonization by
P. aeruginosa and other Gram negatives, normally a rare occurence
(Rosenthal & Tager, 1975), seems to increase with severity of
illness (Johanson et al, 1972).
To a normal, healthy individual P. aeruginosa is not a
particularly invasive organism, but to a compromised individual, the
species is an opportunitist pathogen par excellence, and like a
microbial hyena will lurk in the background waiting to attack those
less able to defend themselves.
No single factor is of paramount importance in host defence
against P. aeruginosa, as an effective system is dependent on the
integrated functions of both local and systemic components (Peterson,
1980). Breakdown of the local defences at any epithelial surface
can lead to colonization by P. aeruginosa, and the consequences of
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such colonization are dependent on the state of the remaining,
systemic defence mechanisms, and the virulence of the particular
bacterial strain.
The increased susceptibility of hospitalized patients to
P. aeruginosa colonization and infection follows the breakdown of
various components of the normal host defences through injury, prior
illness, therapy or surgical procedures. However, healthy
individuals can increase their susceptibility to P. aeruginosa
colonization and infection through a variety of occupational or
recreational pursuits, e.g. deep-sea diving under saturation
conditions (Alcock, 1977) and prolonged submersion in a jacuzzi
(Sausker et al, 1978; Vogt et al, 1982).
The range of infections attributed to P. aeruginosa is
extensive and has been reviewed elsewhere (Cross et al, 1983;
Geddes, 1980; Neu, 1983; Sherertz & Sarubbi, 1983). The purpose of
this chapter is to consider the factors associated with
P. aeruginosa colonization and infection in one particular site -
the respiratory tract.
P. aeruginosa is associated with two major forms of respiratory
tract infection. The first of these is acute pneumonia, which is
the most common of the nosocomial infections caused by this organism
(Sherertz & Sarubbi, 1983), and usually affects the elderly (Rose
et al, 1973), the immunocompromised patient (Reynolds & Fick, 1980),
or the patient requiring prolonged treatment in an intensive care
unit (Johanson et al, 1972). In some instances, pneumonia due to
P. aeruginosa can be acquired outside hospital, particularly by
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individuals with chronic lung or heart disease (Tillotson & Lerner,
1968). Many cases of P. aeruginosa pneumonia develop as a further
complication of bacteraemia, particularly in leukaemic patients
(Neu, 1983).
The second type of respiratory tract infection involving
P. aeruginosa is a chronic pulmonary infection usually associated
with cystic fibrosis (CF) patients (Doggett & Harrison, 1969), and
occasionally causing exacerbations in chronic bronchitics (Rivera &
Nicotra, 1982). Unlike acute pneumonia which is often associated
with bacterial invasion and dissemination, pulmonary infection
in CF patients is a localized bronchiolitis and the mechanism of
tissue damage appears to be different (H0iby, 1984^.
Prior colonization is an important predisposing factor in the
acquisition of both these kinds of respiratory infection. In the
case of nosocomial pneumonia, Johanson et al (1972) observed that
23% of patients colonized with Gram negative bacteria, later
developed pneumonia, compared with 3% of the non-colonized patients.
Prior colonization with the causative organism was demonstrated in
91% of patients who developed nosocomial pneumonia. The percentage
of CF patients colonized with P. aeruginosa varies from one centre
to another, and estimates range from 50% (Htfiby, 1982; Kulczycki
et al, 1978) to 90% (Elston & Hoffman, 1967). The transition from
asymptomatic P. aeruginosa colonization to chronic and progressive
pulmonary infection in these patients is difficult to define and may
vary from one patient to another, however, it is likely that both
host and bacterial factors are involved (HeSiby, 1974).
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The remainder of this chapter will discuss the host factors
associated with P. aeruginosa colonization and infection in the
respiratory tract. The bacterial factors associated with the
pathogenesis of P. aeruginosa pneumonia and chronic pulmonary
infection will be the subject of the next chapter.
P. aeruginosa colonization of the respiratory tract
Figure 1 illustrates the human respiratory tract indicating the
anatomy and major components of normal respiratory defence
mechanisms. These mechanisms can be divided into four categories
(Reynolds, 1983).
(1) Mechanical; e.g. the cough reflex, which in normal
subjects is a very effective means of expelling foreign bodies and
secretions (Newhouse et al, 1976); and the mucociliary clearance
mechanism which is important between the posterior two-thirds of the
nasal cavity and nasopharynx, and the larynx to the terminal
bronchioles (Newhouse et al, 1976).
(2) Anatomical, e.g. the nose, epiglottis, larynx and
respiratory branch which are responsible for directing the air-flow.
(3) Non-specific antimicrobial and antitoxic factors present
in tracheobronchial secretions and on the alveolar surfaces, e.g.
^-antitrypsin, which is inhibitory to bacterial proteases, iron-
binding proteins (lactoferrin and transferrin), and surfactants
(Reynolds & Fick, 1980).
(4) Immunological mechanisms, e.g. immunoglobulins, complement
components and alveolar macrophages (Reynolds, 1983).
8
Figure 1. The normal host defences of the respiratory tract (Based
on Mims, 1982).
These mechanisms combine to provide surveillance of the
respiratory tract under normal circumstances. However, in times of
crisis, the responsiveness of the system can be enhanced by the
recruitment of various components of the systemic defences, i.e.
mobilization of polymorphonuclear granulocytes (PMN) to the lung
tissue, providing a secondary supply of phagocytes. In addition,
alteration of the permeability of the alveolar surfaces as a result
of inflammation allows the entry of intravascular proteins, further
complement components, antibodies and other immune constituents
(Reynolds & Fick, 1980).
Onl y 2% of normal indiv idual s carry P. aeruginosa as part of
their normal pharyngeal flora (Rosenthal & Tager, 1975), however,
the upper respiratory tract is extremely susceptible to
P. aeruginosa colonization in severely ill patients (Johanson et al,
1972). The reasons for this colonization are not entirely clear,
but the nutritional status of the patient is probably important
(Reynolds, 1983). It has been suggested that the normal resistance
of upper respiratory tract epithelial cells to Gram negative
colonization is associated with the presence of a particular cell-
surface glycoprotein, fibronectin (Woods et al, 1983). Fibronectin
is thought to mask Gram negative bacterial receptor sites on the
epithelial cell surface, and factors associated with severe or
chronic illness reduce the level of fibronectin, thus increasing the
availability of these receptor sites, and facilitating colonization
by P. aeruginosa or other Gram negatives (Johanson et al, 1979).
Fibronectin also acts as a binding site for Gram positive organisms
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whose presence normally prevent colonization by Gram negatives
(Sprunt & Redman, 1968).
It is apparent that conditions impairing lung clearance promote
bacterial colonization (Johanson et al, 1972). Clearance of
particulate material from the airways is the raison d'etre of the
mucociliary escalator, the normal functioning of which requires
normal beating cilia, a periciliary fluid layer in which the cilia
beat and the presence of a material with special rheological
properties to act as a mechanical coupler, i.e. airway mucus (Lopez-
Vidriero, 1981). The mucus is a complex secretion from secretory
cells of the submucosal layer and surface epithelium, substances
locally produced and tissue fluid transudate (Lopez-Vidriero, 1981).
It is 95% water with the glycoprotein, mucin, as the main macro-
molecular component. Other components include lipids, immuno¬
globulins, lysozyme, lactoferrin, proteolytic enzymes and protease
inhibitors. The rheological properties of the mucus are determined
by the special characteristics of the mucin molecule and the degree
of cross-linking between mucin molecules , the protein components
also contribute (Lopez-Vidriero, 1981). Mucus is released on to the
surface of the ciliated epithelium as droplets and these are drawn
out into strands by the action of the cilia which beat in the
periciliary zone of fluid of low viscosity (Sleigh, 1981). If this
periciliary layer is too shallow or too deep, the propulsion of
mucus will be severely restricted or may cease altogether (Sleigh,
1981). In general, both the rate of ciliary beat and proportion of
ciliated cells in the epithelium increase from smaller to larger
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airways so that the role and efficiency of mucus propulsion
increases as it ascends the mucociliary escalator (Sleigh, 1981).
Individuals suffering from the "imraotile cilia syndrome", a
congenital defect in the structure and function of respiratory and
other cilia, are prone to chronic respiratory infections (Eliasson
et al, 1977) presumably following bacterial colonization.
It has recently been shown, using an in vitro system, that
P. aeruginosa binds extremely well to human tracheobronchial mucin
(Vishwanath & Ramphal, 1984), suggesting that airway mucus may be an
important colonization site for P. aeruginosa in individuals with
defective mucociliary clearance, e.g. patients with CF, who will be
discussed in the following section.
The role of the immunological components of the respiratory
host defences in prevention of bacterial colonization has not been
well documented. However, in one study, Brownstein (1978) showed
the immunosuppression of mice rapidly led to upper respiratory tract
colonization by P. aeruginosa followed by pneumonia.
Tracheostomy or introduction of an endotracheal tube can lead
to bacterial colonization of the tracheobronchial tree in the same
way that catheterization can lead to colonization of the urinary
tract. Particularly if ventilatory equipment is attached which may
itself be contaminated, and as a result, forcefully aerosolize the
bacteria into the airways (Reynolds & Fick, 1980). This factor is
particularly relevant in the case of P. aeruginosa, considering the
organism's ability to colonize hospital equipment and to contaminate
instruments and prostheses. Alternatively, the bacterial source may
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be the patient's own pharyngeal or gastric secretions (Sanderson,
1983).
P. aeruginosa colonization of the respiratory tract in CF patients
Cystic fibrosis is the most frequent lethal genetic syndrome
among Caucasian children (Wood et al, 1976), and is inherited as an
autosomal recessive trait (Danks et al, 1965). The incidence of CF
varies between populations, ranging from 1 in 620 live births in
South West African Afrikaners of Dutch descent (Super, 1975) to 1
in 15,000 amongst the Italians (Antonelli & Donfrancesco, 1970). In
middle and western Europe, the incidence is approximately 1 in 2,000
(Wood et al, 1976). CF has been detected in non-white populations,
though the incidence is very low, e.g. amongst blacks in Washington
D.C., the frequency is 1 in 17,000 live births (Kulczychi & Schauf,
1974).
No known biochemical or structural defect accounts for all the
pathophysiologic phenomena associated with CF, thus its definition
rests on the clinical findings. Generally, there are four criteria
for diagnosis: (i) A positive sweat test (sweat chloride >60mEql
^), (ii) Chronic obstructive pulmonary disease, (iii) Exocrine
pancreatic insufficiency (in 80 to 90% of patients), (iv) Family
history can be helpful if confirmed cases are known (Wood et a 1,
1976).
Obstruction of exocrine gland ducts occurs in all (or nearly
all) patients due to the inspissation of secretions, and one of the
earliest possible problems arising from this is a gastrointestinal
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blockage known as meconium ileus, which originally lead to death in
up to 25% of babies born with CF (Oppenheimer & Esterly, 1962).
However, the clinical features associated with CF are extremely
variable in their expression and severity, and it has been estimated
that 40-50% of sufferers remain undiagnosed (Fick, 1981). For those
patients who are diagnosed, the average life expectancy has
increased dramatically over the last 30 years. In 1950 patients
invariably died in infancy but by 1976 the average life expectancy
had increased to 19 years (Chartrand & Marks, 1983). Better manage¬
ment of gastrointestinal complications is largely responsible for
this improvement, and consequently the fate of the majority of
patients nowadays is determined by the progressive pulmonary disease
which accounts for >95% of deaths other than those due to meconium
ileus (Wood et al, 1976).
There is no simple explanation for the natural history and
pathogenesis of the CF pulmonary disease, but it is generally agreed
that bacterial infection is important and responsible for the
irreversible lung damage (Reynolds & Fick, 1980). The lungs are
apparently normal at birth (Wood et al, 1976), and it has been
suggested that circulating pancreatic proteases initiate early
inflammatory changes in the small airways, which subsequently become
colonized by bacterial and/or viral pathogens (Kuzemko, 1983).
The bacterial species most frequently isolated from the
respiratory tracts of CF patients are Staphylococcus aureus,
Haemophilus influenzae and P. aeruginosa (Doggett & Harrison, 1969;
Kulczycki et al, 1978; Mearns et al, 1972; Iacocca et al, 1963).
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The relative significance of these organisms in the patho¬
genesis of lung disease has been the subject of considerable
controversy. One theory is that S. aureus is always the initial
pathogen, and colonisation by P. aeruginosa takes place only
following lung damage (Burns & May, 1968; Lawson, 1969; Kilbourn,
1978). However, Mearns et al (1972) noted a significant decrease in
the frequency of isolation of S. aureus from CF patients between
1950 and 1971, probably as a result of improved anti-staphylococcal
therapy, while over the same period, P. aeruginosa isolations
increased.
This raises the question of the role of antimicrobial therapy
(particularly directed against S. aureus) in predisposing to
P. aeruginosa colonization. Several studies have concluded that
this is indeed a major contributing factor (Huang et al, 1961; Burns
& May, 1968; Iacocca et al, 1963; Kulczycki et al, 1978). However,
prior antimicrobial therapy is unlikely to provide the whole answer,
as one of the earliest bacteriological studies of 14 CF patients ,
published before the era of routine broad spectrum antibiotic
therapy (Di Sant'Agnese & Anderson, 1946) reported a single patient
colonized by Bacillus pyocyaneus (P. aeruginosa). Similarly,
Iacocca et al (1963) reported that prior antibiotic therapy merely
increased the frequency of P. aeruginosa isolations from 18% to 43%.
An alternative explanation for the increased frequency of
P. aeruginosa isolations noted by Mearns and colleagues (1972), is
the change in patient population as a result of increased life
expectancy.
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Prior lung damage may, as Lawson suggests (Lawson, 1969), be a
key predisposing factor to P. aeruginosa colonization, however, in a
more recent survey, Htfiby (1982) noted that 50% of the CF patients
attending his clinic in Denmark were colonized with P. aeruginosa,
and that some, but not all of those had impaired lung function at
the time when P. aeruginosa was first isolated.
The role of P. aeruginosa in the pathogenesis of lung disease
in CF patients is not the subject of the present section and will be
discussed later. Here, I am primarily concerned with those aspects
of the CF respiratory tract which are associated with increased
susceptibility to colonization by P. aeruginosa, assuming that prior
antibiotic therapy and lung damage do not provide the whole answer.
In order to tackle this problem we need to ask (i) what part of
the respiratory tract is initially colonized by P. aeruginosa?, and
(ii) consider how the normal host defences are compromised in the CF
patient.
Iacocca et al (1963) cultured specimens from the nasopharynx
and throat, and compared them with sputum samples taken on the same
occasion from 29 CF patients. P. aeruginosa was isolated from 62%
of the sputum samples, 55% of the throat specimens, but only 31% of
the nasopharyngeal specimens. Laraya-Cuasay et al (1976) noted that
86.6% of their patients carried P. aeruginosa in the throat, but
isolates from the nose were extremely rare (as were skin isolates).
Shapiro et al (1982) performed quantitative bacteriology on sinus
aspirations from 20 CF patients and found that 13 yielded
P. aeruginosa in numbers >10^ bacteria ml~l. However, they found no
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association between the bacteria isolated in the sinuses and those
in the nasopharynx, throat or sputum. Woods e t a 1 (1980)
demonstrated a correlation between in vitro adherence of
P. aeruginosa to buccal cells and respiratory tract colonization
with the organism. In this study, the P. aeruginosa adherence
in vitro varied directly with the loss of fibronectin from the
buccal cell surface, as well as increased levels of salivary
proteases.
According to Kulczycki and colleagues (1978), P. aeruginosa
flourishes in the bronchial secretions of CF patients, and this has
been confirmed in vitro by Ohman & Chakrabarty (1982).
It is generally accepted that the tracheobronchial secretions
of a CF patient differ from those of a normal individual, and from
patients with other respiratory conditions. However, it is not
always clear whether this is the cause or result of bacterial
colonization and infection. Fick & Reynolds (1983) obtained lung
lavage fluid and sputum from a group of CF patients and compared
them with similar secretions from non-CF individuals (smokers and
non-smokers). The CF secretions were found to contain more
phagocytic cells, immunoglobulins, complement components, ^-anti¬
trypsin and proteases, but less transferrin than the non-CF
secretions. These differences could all be explained on the basis
of inflammation. However, Frates et al (1983) cultured explants of
airway tissue from CF patients and patients suffering from other
chronic pulmonary disease. This method overcame the complications
of infection, and they were able to show that the secretion rate of
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mucus glycoproteins was 3-6 fold higher in CF patients than non-CF,
and the CF glycoproteins were more highly sulphated and more acidic
than those from non-CF tissue explants. According to Roussel
(1984), CF glycoproteins have longer carbohydrate chains, and he has
suggested that "an inborn alteration of bronchial mucin carbohydrate
chains, inducing a specificity in bacterial adhesion, and an
alteration of the mucociliary clearance represents a tempting
hypothesis to explain the increased risk of infection".
The tracheobronchial secretions from CF patients have a lower
water content than normal (Wood et al, 1976). This could be
explained by the recent finding that epithelial cells in the
respiratory tract and sweat glands have an abnormally low
permeability to Cl~ (Quinton, 1983; Knowles et al , 1983).
Consequently, in the case of respiratory epithelium, the balance of
transepithelial liquid flow would be shifted away from the lumen,
thus concentrating the mucus on the airway surfaces (Knowles et al,
1983).
The electrolyte content of CF tracheobronchial secretions
appears to differ significantly from normal, e.g. Na+ and CI- levels
are lower and K+ is raised (Matthews et al, 1963). There is some
controversy concerning the levels of Ca^+ in CF secretions. There
appears to be an alteration in the cellular handling of Ca^+ which
may lead to enhanced accumulation of Ca^+ by the CF cell (Case,
1984), and certainly the Ca2+ concentration of CF saliva is raised
(Martinez, 1982). In addition, the increased anionic character of
the mucous glycoproteins may promote increased sequestration and
release of Ca^"*" (Wood et al, 1976).
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On the basis of the altered physical properties of CF tracheo¬
bronchial secretions, in particular the reduced water content, it
would be reasonable to presume that mucociliary transport would be
impaired. However, there is some controversy relating to this
point. According to Wood et al (1976), mucociliary transport is
impaired 5 to 10 fold in CF patients. Wanner (1981) also reported a
reduced tracheal mucus transport rate in 14 adult CF patients, but
found no correlation between transport rate and clinical status.
Yeates et al (1976) observed abnormal mucociliary transport in some,
but not all CF patients.
There have been few reports on the structure and function of
the ciliated epithelium in CF patients, although epithelial meta¬
plasia with loss of cilia has been noted in young CF infants who
died from non-respiratory complications (Bedrossian et al, 1976).
On the other hand, there have been numerous reports (reviewed by
Wood et al, 1976) of "ciliary dyskinesis factors" in the sera of CF
patients and their parents. In the hands of certain workers, these
factors disrupt the ciliary beat pattern of rabbit tracheal explants
and oyster gill cilia. However, a similar effect on human ciliated
epithelium has not been proven.
Regardless of the status of the mucociliary transport mechanism
in CF patients, a direct consequence of excessive secretion of
abnormal respiratory mucus, of which there is no doubt, is the
plugging of peripheral airways - one of the earliest pulmonary
lesions found almost universally among CF patients of all ages
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(Bedrossian et al, 1976). These mucus plugs may well provide an
ideal colonization site for P. aeruginosa.
There appears to be no particular immunological defect in CF
patients which would predipose to P. aeruginosa colonization of the
respiratory tract. The alveolar macrophages appear to be morpho¬
logically and functionally normal (Thomassen et al, 1980), phago¬
cytosis by peripheral leucocytes is normal (Biggar et al, 1971),
immunoglobulin levels appear to be normal (including secretory IgA)
and no consistent complement abnormality has been reported (Wood
et al, 1976).
However, once colonization has been established, various
abnormalities may be associated with chronic pulmonary infection and
these will be discussed in a later section.
Invasive P. aeruginosa respiratory tract infection
Colonization of the upper respiratory tract of a severely ill
patient can give rise to large numbers of bacteria (10^ organisms
ml~l) in oropharyngeal secretions, and impaired consciousness
increases the chances of aspirating those secretions (Woods, 1983).
Alternatively, the bacterial reservoir may be a colonized trachea,
which is often the case in ventilated patients (Sanderson, 1983).
In order to determine which components of the normal host defences
are important in the control of P. aeruginosa invasion of the
respiratory tract, it is necessary to determine which patients are
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particularly susceptible to P. aeruginosa infection and consider the
nature of the defect(s) in these patients.
In a study of 36 cases of P. aeruginosa pneumonia, Pennington
et al (1973) concluded that cancer was the most common predisposing
condition, followed by chronic lung or heart disease. These workers
also observed that susceptibility to P. aeruginosa pneumonia was
frequently associated with treatment directed towards the primary
disease, e.g. cancer chemotherapy. Rose et al (1973) noted that
elderly men recovering from major surgery were particularly at risk
and many of these were receiving multiple or broad spectrum
antimicrobial drugs prior to the onset of P. aeruginosa pneumonia.
A significant number of these patients (42%) developed bacteraemia
and this was invariably fatal. The major predisposing factor in the
acquisition of non-bacteraemic P. aeruginosa pneumonia appears to be
chronic lung or heart disease (Tillotson & Lerner, 1968) and the
mortality rate, even in the absence of bacterial dissemination to
the bloodstream, was 80% in this study. Crane & Lerner (1983) have
quoted a 72% overall mortality rate of P. aeruginosa pneumonia.
Various experimental models have set out to determine the role
of specific host defence components in the control of acute
P. aeruginosa pneumonia. Pennington & Emrie (1978) showed that
immunosuppressed guinea pigs invariably died from bilateral
haemorrhagic pneumonia following intratracheal instillation of
P. aeruginosa, and that mortality was correlated with a diminished
PMN inflammatory response. Kazmierowski et al (1977) demonstrated
that short term survival of experimental P. aeruginosa pneumonia
could be enhanced in leucopoenic dogs, by treatment of the animals
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with type-specific anti-pseudomonas IgG. However, granulocyte
transfusion and antimicrobial chemotherapy were necessary for long
term survival. Granulocyte transfusions have been shown to improve
the chances of survival of severely granulocytopoenic human patients
with established P. aeruginosa infection (Alavi et al, 1977).
From these, and other studies involving P. aeruginosa
bacteraemia (Brownstein, 1978; Peterson, 1980), it appears that the
granulocyte plays a significant role in controlling P. aeruginosa
invasion and dissemination. The normal role of this cell type is
the phagocytosis and intracellular killing of opsonized bacteria,
where opsonization involves complement components and/or specific
antibodies (Young & Armstrong, 1972). Non-opsonic phagocytosis in
vitro has also been reported for certain P. aeruginosa strains
(Speert et al, 1984).
Conditions leading to quantitative and or qualitative granulo¬
cyte abnormalities include acute leukaemia (Aduan & Reynolds, 1979)
and burns (McEuen et al, 1976). Patients undergoing immuno¬
suppressive therapy following transplants, are usually severely
granulocytopoenic (Peterson, 1980). Such patients have increased
susceptibility to P. aeruginosa pneumonia and bacteraemia.
The other major components of the systemic host defences which
play a role in controlling P. aeruginosa invasion are the humoral
immune system, the complement system and the cell-mediated immune
system (CMI). Humoral immunity and CMI both involve complex
interactions between macrophages and lymphocytes. The ultimate
humoral immune response is antibody production by plasma cells
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derived from B-1ymphocytes, whereas CMI involves activation and
transformation of T-lymphocytes in response to antigen (Peterson,
1980). The transformed T-cells secrete soluble mediators of immune
reactivity (lymphokines), which in turn stimulate the activity of
macrophages (Peterson, 1980).
The principle functional antibodies against P. aeruginosa
appear to be opsonins of the IgG and IgM immunoglobulin classes
(Young, 1974). Ninety percent of normal humans over the age of two
years have IgM antibodies in their sera directed against
P. aeruginosa (Gaines & Landy, 1955). IgM opsonizing antibody has
an obligatory requirement for complement, as phagocytes do not have
IgM receptors (Young, 1974), whereas IgG opsonization is potentiated
by complement but can proceed without it (Young, 1974). Opsonizing
antibodies are generally directed against the lipopolysaccharide
(LPS) component of the P. aeruginosa outer membrane, which is
responsible for the resistance of this organism to phagocytosis in
the absence of opsonization (Young, 1972).
The other principle effector mechanism of humoral immunity is
complement-dependent bacteriolysis (H0iby, 1979). However, since
91% of invasive P. aeruginosa strains are serum resistant (Young &
Armstrong, 1972; Young, 1974), this mechanism is probably of little
significance in controlling acute P. aeruginosa infections.
It is difficult to assess the role of antibodies in
susceptibility to P. aeruginosa pneumonia due to the interrelated
roles of the phagocyte, antibody and complement systems. However,
McCall et al. (1973) reported three patients with IgM deficiency who
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had defective opsonic activity against P., aeruginosa resulting in
severe pulmonary infection. Complement-mediated and PMN function
was normal in these patients.
The diagnostic and prognostic significance of antibodies to
P. aeruginosa in acute infections is that patients with high
antibody titres have a better prognosis than patients without such
antibodies (Htfiby, 1979), e.g. in the case of the leucopoenic dog
model of experimental pneumonia (Kazmierowski et al, 1977).
Antibody production is also important for the neutralization of the
extracellular bacterial products which appear to be primarily
responsible for the tissue damaging capabilities of P. aeruginosa
(Peterson, 1980).
The importance of CMI in the control of P. aeruginosa invasion
has not been extensively studied (Aduan & Reynolds, 1979). In fact,
the incidence of P. aeruginosa infection is low in patients with
Hodgkin's disease, which is associated with defective T-lymphocyte
function (Aduan & Reynolds, 1979). However, Porwoll et al. (1983)
demonstrated that T-1ymphocytes from normal adults proliferate
in vitro in the presence of P. aeruginosa suggesting that such a
response may be important in controlling against infection.
Chronic pulmonary infection in CF patients
Although the characteristics of the P. aeruginosa strains
associated with chronic pulmonary infections in CF patients will be
discussed in detail in the next chapter, two of these
characteristics are worth mentioning in this context because of
their relevance to studies of the host defence mechanisms involved
in this particular infection. Firstly, P. aeruginosa isolates from
the sputa of CF patients are frequently mucoid (Doggett et al, 1964;
Doggett e t al, 1966; Doggett, 1969; H<6iby, 1975). Mucoid
P. aeruginosa were first reported in 1927 (Sonnenschein, 1927) but
until the 1960s were considered a rarity. Indeed, isolation rates
for mucoid strains from sources other than CF patients range from
0.8% (Cetin et al, 1965) to 3% (Hoiby, 1975), whereas 70-80% of
P. aeruginosa isolates from CF patients are mucoid (Doggett, 1969;
Htfiby, 1975). Patients suffering from chronic lung disease with
bronchiectasis, but not CF, are sometimes colonized with
P. aeruginosa, and in one study, mucoid strains accounted for 10% of
isolates associated with this condition (Rivera & Nicotra, 1982).
The origin of these mucoid strains will be discussed in the
following chapter, however it is generally believed that the
presence of mucoid P. aeruginosa in the respiratory tract of a CF
patient is associated with chronic infection and a poor prognosis,
whereas non-mucoid isolates merely reflect harmless colonization.
Htfiby (1974) has shown that the presence of mucoid P. aeruginosa in
the sputum is associated with a significantly greater number of
precipitating antibodies in the serum, directed against
P. aeruginosa cellular components, than when non-mucoid strains only
are present. More recently, Henry et al. (1982) reported that CF
patients harbouring mucoid P. aeruginosa have significantly lower
Schwachman scores (indicating a poorer clinical condition) than
patients carrying non-mucoids, and they concluded from this that
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mucoid P. aeruginosa are true pathogens, whereas non-mucoids are of
little significance.
The second unusual characteristic associated with P. aeruginosa
isolates from CF patients is serum sensitivity. As previously
mentioned, Young (1974) noted that only 9% of invasive P. aeruginosa
isolates were sensitive to the bactericidal action of normal human
serum, and likewise, 21% of "colonizing" strains, i.e. isolated from
patients but not associated with infection. However, Thomassen &
Demko (1981) observed that 46% of P. aeruginosa strains from CF
patients were sensitive to normal human serum, and Penketh et al.
(1983a) reported 53% serum sensitivity amongst their CF
P. aeruginosa isolates.
Apart from the increased incidence of respiratory tract
infections, CF patients are no more susceptible to infections than
normal children of comparable age (Schiotz, 1981). Consequently,
there appears to be no generalized immunodeficiency in these
patients (Htfiby et al, 1975). Unlike the acute invasive lung
infections seen in immunocompromised individuals, systemic spread of
P. aeruginosa is rarely encountered in CF patients (Huang & Doggett,
1979), suggesting that granulocyte function is normal. Studies
relating to the humoral immune response in CF patients indicate that
immunoglobulin levels in serum and sputum are normal or
appropriately increased (Wallwork et al, 1974; Schiritz et al,
1979a). Numbers of T and B lymphocytes are also normal (H/iby &
Mathiesen, 1974). However, there is some evidence that IgG from CF
patients may have reduced opsonic antibody function because of a
molecular change in the Fc portion (Fick & Reynolds, 1983). There
may also be a structural abnormality in secretory IgA (Wallwork
et al, 1974).
There are a number of reports in the literature of "blocking
factors" in CF serum and sputum which protect serum sensitive
strains from the bactericidal activity of normal serum. Thomassen &
Demko (1981) reported that 5/12 patients in poor clinical condition
harboured P. aeruginosa strains which were sensitive to normal
serum but resistant to their own, indicating the presence of a
"blocking factor" which was specific for their own strain. The
authors considered that this factor may be IgG. Penketh et a 1.
(1983a) identified a titratable "blocking factor" in the serum of
6/61 CF patients. This component was indeed present in the IgG
fraction, interfered with the bactericidal activity of normal serum
on the autologous P. aeruginosa strain but could not be absorbed out
by that strain. Hence, it was suggested that this "blocking factor"
may be directed against naturally occurring IgM. In this study
there was no correlation between "blocking factor" and clinical
condition or duration of P. aeruginosa colonization. Schiller &
Millard (1983) demonstrated the presence of "protective activity" in
18/19 CF sputa, which was effective for both autologous or hetero¬
logous P. aeruginosa strains. This activity could be absorbed out,
was not related to clinical condition, and considered to be IgA. A
second, non-adsorbable "protective/blocking factor" was identified
in this study and this was thought to be a bacterial product.
A specific IgG "blocking factor" has also been identified in
the sera of two non-CF patients suffering from chronic P. aeruginosa
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infections - one a respiratory tract infection and the other a
urinary tract infection (Guttman & Waisbren, 1975). These authors
proposed that some patients with chronic infection develop a
population of antibody which inhibits and/or replaces the normal
bactericidal IgM population. They further pointed out that IgG only
manifests itself as a blocking antibody when the structure of the
infecting organism is unfavourable for IgG-mediated complement
activation, and that the density and distribution of antigen
receptor sites on the bacterial surface may influence the effect of
antibacterial IgG. However, the authors also indicated that it was
not possible to determine whether the presence of blocking
antibodies was the cause or effect of the chronic infection.
The possibility that CMI may be defective in CF patients has
received some attention. Sorensen and colleagues (Sorensen et al,
1977; Sorensen e t a 1 , 1978; Sorensen e t a 1 , 1979) noted a
significant specific incapacity of lymphocytes from severely
affected patients to respond to P. aeruginosa and certain other Gram
negatives. There was some indication that both cellular and plasma
factors are involved in this dysfunction and in two patients, the
capacity to respond recovered after vigorous antibiotic therapy.
In another study, Gibbons et al. (1976) demonstrated that
severely ill CF patients had greatest impairment of CMI, but this
could be reversed by steroid treatment.
Numerous studies have implicated a central role for the
systemic host defences in the pathogenesis of chronic pulmonary
infection in CF patients. Immune complexes have been demonstrated
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in the sera and sputa of such patients (Schitftz et alt 1978; Moss &
Lewison 1980; Heiiby & Schitftz, 1982) and the role of these immune
complexes in complement activation leading to tissue damage is well
documented (Schitftz et al, 1979a; Skov, 1980; H0iby & Schitftz,
1982). It has also been noted that P. aeruginosa is capable of
evoking an IgE response in some CF patients which could result in an
allergic reaction (Pitcher-Wilmott et al, 1982).
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CHAPTER III
BACTERIAL FACTORS ASSOCIATED WITH THE PATHOGENESIS
OF P. AERUGINOSA RESPIRATORY TRACT INFECTIONS
Pathogenicity is the capacity of a microorganism to produce
disease in a susceptible host. In order to do so, the pathogen must
be able to enter the host, multiply and damage host tissue, and
either resist, or not stimulate the host defences (Smith, 1977).
The microbial factors responsible for these processes are the
determinants of pathogenicity or the degree of pathogenicity
(virulence), and may be cell-associated or extracellular.
There are several potential problems associated with the study
of microbial pathogenicity. Firstly, virulence is only manifested
in vivo, and bacteria grown in vitro may not express all their
virulence determinants (Smith, 1977), hence meaningful studies on
the role of particular virulence determinants in pathogenesis
require experimental models which mimic as closely as possible the
susceptible host and disease in question. The second problem is
that the virulence determinants relevent to one disease are not
always important in another - an important factor when considering
the pathogenicity of P. aeruginosa which is capable of causing many
different kinds of infections at many different sites. Thirdly, the
fact that P. aeruginosa is an opportunist pathogen poses the problem
of deciding which aspects of the disease are the result of host
factors and which are mediated by the organism.
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In certain cases, microbial products may not directly cause
tissue damage, however, the mere presence of the bacteria, e.g. on
the surface of a mucous membrane, may be sufficient to stimulate
host-mediated tissue damage. Therefore, the microbial
characteristics associated with colonization may have a pathogenic
role.
There are a number of cellular and extracellular factors which
have been linked with the pathogenicity of P. aeruginosa and these
are summarized in Table 1. The main purpose of this chapter is to
examine the role of these virulence determinants in acute and
chronic respiratory infections, and also to consider the pathogenic
significance of certain unusual characteristics which have been
identified in P. aeruginosa isolates from chronic respiratory
infections, particularly in CF patients.
Unusual characteristics associated with P. aeruginosa from chronic
pulmonary infections
As mentioned previously, P. aeruginosa isolates from CF
patients and patients with bronchiectasis are frequently mucoid,
whereas isolates from other clinical sources, and from the environ¬
ment, rarely have this characteristic (Doggett, 1969; H0iby, 1975;
Rivera & Nicotra, 1982). Early biochemical studies on the exopoly-
saccharide produced by a mucoid P. aeruginosa isolate from the
sputum of a CF patient, revealed that the substance was a
polyuronide with properties similar to alginic acid (Linker & Jones,
1964). Subsequently, it was shown that mucoid strains from CF and
non-CF sources produced an acetylated copolymer of Jj-D-mannuronic
TABLE 1 Cellular and extracellular products of P. aeruginosa
thought to be associated with pathogenicity.
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acid and its C-5 epiraer <*-L-gul uronic acid with structure and
properties remarkably similar to algal alginate (Carlson & Matthews,
1966; Linker & Jones, 1966). Apart from mutants of the closely
related Pseudomonas species P. putida, P. fluorescens and
P. mendocina (Govan et al, 1981), the only other bacterial source of
this kind of exopolysaccharide is Azotobacter vinelandii (Gorin &
Spencer, 1966).
It is important at this point to make a distinction between the
alginate-like exopolysaccharide produced by mucoid P. aeruginosa
strains, and slime, which is a loosely defined material with
variable composition depending upon the strain, cultural conditions
and method of analysis. The term 'mucoid' is restricted to those
strains producing the characteristic colonial type 5 of Phillips
(Phillips, 1969) within 24h on agar media, whereas many classic non-
mucoid strains (Phillips colonial types 1 to 4) produce viscid,
slimy colonies and broth cultures, particularly when incubation is
prolonged, and in media with a high carbon content (Haynes, 1951).
Evidence for the emergence and establishment of mucoid
P. aeruginosa strains in CF patients was first provided by Doggett
et al (1966) who observed that in individual CF patients, initial
colonization was by a non-mucoid strain, but during the course of
infection, mucoid isolates gradually emerged and eventually came to
predominate. However, this idea was not universally accepted as
Zierdt & Williams (1975) believed that "the mucoid P. aeruginosa
strain is probably spread from patient to patient, rather than
acquiring its mucoid characteristic de novo in the CF patient.
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The second unusual characteristic associated with P. aeruginosa
isolates from chronic pulmonary infections is antibiotic
hypersensitivity. Whereas the minimal inhibitory concentration
(MIC) of carbenicil 1 in for P. aeruginosa is generally 25-5Qug ml-*
(Knudsen et al, 1967), May & Ingold (1972) reported that 35% of
strains isolated from sputum (from CF patients, chronic bronchitics
or patients with bronchiectasis), were sensitive to 6<ug ml *
carbenicillin, and some had MIC's as low as 0.7;ug ml~l .
In a later study, Berche et al (1979) compared 47 mucoid with
71 non-mucoid clinical isolates on the basis of sensitivities to 18
antibiotics and concluded that both groups could be divided into two
distinct classes on this basis. Class A contained strains
significantly more resistant to antibiotics such as the amino¬
glycosides and tetracycline than those strains allocated to Class B.
These workers did not distinguish the strains on the basis of their
origin as they were attempting to show a significant difference
between the mucoid and non-mucoid isolates. This they failed to do.
Another group of workers (Seale et al, 1979), in an examination
of serotypes and antibiotic susceptibilities of P. aeruginosa
isolates from single CF sputum specimens, found that 20% of sputa
contained isolates heterogeneous in their susceptibilities to the
antibiotics carbenicillin, chloramphenicol, gentamicin, cotrimoxa-
zole, streptomycin and tetracycline. Sensitivities were assessed
using antibiotic disks and again there was no association between
antibiogram and expression of the mucoid character.
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The percentage of patients harbouring multiple P. aeruginosa
strains onthe basis of antibiotic sensitivities as determined by
MIC's was 51% according to a similar survey by Thomassen et al
(1979). Despite this finding, only one serotype was generally
present in a single patient and fromthis it was concluded that a
patient with CF may be infected with one strain of P. aeruginosa
that is capable of expressing many variant characteristics.
The surveys of Seale et al (1979) and Thomassen et al (1979)
did not specifically report P. aeruginosa isolates which were
unusually susceptible to antibiotics, however a study carried out in
our own laboratory (Irvin et al, 1981) reported a number of
P. aeruginosa isolates from CF patients that were unusually
sensitive (hypersensitive) to a range of antibiotics including the
^B-lactams carbenicil 1 in, azlocillin and methicillin, and to the
unrelated antibiotic, trimethoprim. The carbenicil1 in MIC's of
these strains were <ljug ml~l, and thus comparable with those
reported by May & Ingold (1972). In addition, we reported the
isolation of a "normal" and hypersensitive strain (492a and 492c)
from the same sputum specimen. These two strains were of the same
pyocin type, suggesting that the hypersensitive strain may have
emerged in vivo.
Various workers have reported that a significant proportion of
P. aeruginosa isolates from CF patients are sensitive to normal
human serum (Thomassen & Demko, 1981; Penketh £t_al, 1983b). In a
survey of 109 CF isolates, 87 sputum isolates from non-CF patients
and 118 isolates from other clinical sources, Penketh et al (1983a)
confirmed that 53.2% of the CF isolates were serum sensitive,
compared with 13.8% of non-CF sputum isolates arid 11.1% of isolates
from other clinical sources. In addition, they observed that 64% of
the CF strains could not be serotyped due to the loss of the O-type
reaction, and 50.5% were agglutinated by more than one of the typing
sera, i.e. were polyagglutinable (PA). Amongst the non-CF sputum
isolates they noted 17% were PA, whereas only 10.2% of the non¬
respiratory isolates expressed this characteristic. Although there
was a close correlation between loss of the O-type reaction, PA and
serum sensitivity, some "intermediate" strains were identified with
some, but not all of these features.
Schiller & Hatch (1983) carried out a survey of P. aeruginosa
isolates from various clinical sites to determine whether there was
any relationship between certain microbial characteristics,
including serum sensitivity and serotype, and the source of the
particular strain. These workers confirmed that CF isolates were
more likely to be serum sensitive than non-CF isolates (26/30 CF
isolates were serum sensitive compared with 4/22 sputum isolates
from non-CF patients and 3/41 from wounds, blood, urine and burns).
They also observed that nine of the CF isolates which were serotyped
were PA (it is not clear whether all 30 CF strains were in fact
serotyped).
The structural basis of serum sensitivity and PA in clinical
P. aeruginosa isolates from CF patients has been examined by Hancock
et al (1983). Results of this study suggested that PA strains were
agglutinated by antibody in the typing serum directed at non-
serotype determinants, rather than expressing multiple immunotype
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antigens. All the PA strains were serum sensitive, however, not all
the typable strains were serum resistant. Hancock et al suggested
that the structural basis for PA and serum sensitivity in
P. aeruginosa isolates from CF patients, is a deficiency in the
smooth O-antigen-containing LPS, although a number of the typable
serum resistant strains were also apparently deficient in this
component of the outer membrane in this study.
Meadow et al (1984), using PA mutants of P. aeruginosa strain
PAC1R, have confirmed that changes in the LPS composition of such
mutants, expose other outer membrane components, e.g. outer membrane
proteins, and rough core components, which are responsible for the
cross-reactivity with heterologous O-antisera. The nature of the
LPS changes identified in their mutants ranged from complete lack of
O-antigenic components to altered mobility of the high molecular
weight LPS fraction on Sephadex G75.
Bacterial attachment and initial colonization of the respiratory
tract
An important event in the establishment of both acute and
chronic respiratory tract infections is the initial bacterial
colonization of the upper respiratory tract. Although host factors
are largely responsible for allowing P. aeruginosa "a foot in the
door", it is important to discover which bacterial factors are
important in the initiation of colonization, especially if this step
is to be prevented.
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Adherence of P. aeruginosa to human buccal epithelial cells has
been shown to be mediated by pili, on the experimental basis that
purified pili, when preincubated with buccal cells, decrease the
adherence of intact organisms (Woods et al, 1983). However, it is
not clear whether attachment to buccal cells in vivo is an important
step in P. aeruginosa colonization of the respiratory tract. The
ability to adhere to ciliated epithelium may be more relevant, and
in one study, Niederman et al (1983) compared bacterial adherence to
human buccal cells and ciliated epithelial cells from the nose and
trachea. The results of this study indicated that P. aeruginosa
adheres better to ciliated epithelium than squamous epithelium
in vitro, and that the mechanisms involved in such adherence are
probably different for the two sites. In addition, in normal
subjects, bacterial adherence at one site did not correlate with
adherence at another.
Two different groups have developed experimental models for
examining the adherence of P. aeruginosa to tracheal epithelium
Ramphal and coworkers exposed mouse tracheas to 0.1N HC1 for 15
mins, after which they were cut into sections and placed in petri
dishes for adherence studies. Ramphal & Pyle (1983a) showed that
adherence to acid injured tracheal cells was a phenomenon limited to
P. aeruginosa (both mucoid and non-mucoid strains), and did not
occur with Escherichia coli or Klebsiella pneumoniae. They also
showed that mucoid P. aeruginosa adhered to mucin strands of
uninjured control tracheas. In another study (Ramphal & Pyle,
1983b) these workers showed that mucin and sialic acid inhibited the
adherence of mucoid and non-mucoid strains of P. aeruginosa to acid
injured tracheal cells. The affinity of P. aeruginosa (both mucoid
and non-mucoid) for tracheobronchial mucin has recently been
confirmed using an in vitro assay (Vishwanath & Ramphal, 1984).
The role of pili in the adherence of P. aeruginosa to acid
injured tracheal epithelium has also been examined by Ramphal et al
(1984) in the absence of mucin. In this study, pili incubated with
tracheal cells inhibited the adherence of a non-mucoid strain in a
dose-dependent manner. However, pili did not appear to be the final
mediators of adherence of mucoid strains, suggesting that there are
differences in the receptors and mechanisms of adhesion for mucoid
and non-mucoid strains in this model.
Baker & Tao (1982) have reported an alternative tracheal
culture model using hamster tracheal sections incubated under tissue
culture conditions whereby ciliary activity is maintained for up to
two days. Using this model, Baker & Marcus (1982) compared the
adherence of mucoid and non-mucoid clinical P. aeruginosa isolates
to the tracheal epithelium. The mucoid organisms were seen adhering
to the cilia in clusters, embedded in an extracellular matrix,
whereas the non-mucoid organisms generally adhered singly. In
addition, the mucoid isolates adhered more rapidly than the non-
mucoid isolates, indicating a more efficient mechanism of
attachment.
Long-term bacterial survival in the respiratory tract
Initial colonization is an important step in the establishment
of both acute and chronic respiratory tract infections, and probably
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involves similar mechanisms in both cases. However, the factors
necessary for bacterial survival and multiplication thereafter are
largely dependent on the state of the host defences. As discussed
in the previous chapter, individuals who succumb to acute
P. aeruginosa pneumonia are usually neutropoenic and thus incapable
of resisting bacterial invasion. The breakdown of host tissue
releases nutrient for bacterial growth(Cicmanec & Holder, 1979),
hence the bacterial factors responsible for multiplication in host
tissue and causing tissue damage are probably similar.
In contrast, CF patients and other individuals susceptible to
chronic P. aeruginosa infections are not as severely compromised and
as a result, a host-parasite relationship develops between bacterium
and host. In CF patients, the relationship between host and
opportunist is very finely balanced.
Most patients tolerate heavy P. aeruginosa colonization for
long periods of time without morbidity or decline in lung function,
however, small changes in bacterial numbers may be sufficient to tip
the scales, as one of the features of chronic infection in these
patients is the intermittent development of acute exacerbations,
i.e. malaise, weight loss and symptoms of acute bronchitis
associated with increased bacterial counts in sputum (Geddes, 1982).
Experimental evidence suggests that bacterial alginate may be
important for long term survival of mucoid P. aeruginosa in the
lower respiratory tract, as in addition to its adhesive properties,
alginate has been shown to inhibit bacterial opsonization by rabbit
antiserum in vitro (Baltimore & Mitchell, 1980), and to inhibit
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phagocytosis by alveolar macrophages cultured from rats and guinea
pigs (Ruhen et al, 1980). Alginate may also present a physical and
ionic barrier to the penetration of aminoglycoside antibiotics
(Slack & Nichols, 1981). Costerton's group have reported that
mucoid P. aeruginosa could be seen as encapsulated microcolonies in
the alveoli of post-mortem lung tissue from a CF patient (Lam et al,
1980). This is understandable when one considers the physical
properties of P. aeruginosa alginate, in particular the capacity to
form a gel in 3mM Ca^+ - a level which one would expect to find in
pulmonary secretions (Govan et al, 1983). Surprisingly perhaps,
Blackwood & Pennington (1981) could show no difference between
mucoid and non-mucoid strains in terms of pulmonary clearance by
guinea pigs. However, these workers used washed bacterial cells and
it should also be remembered that the mucociliary clearance
mechanism in a normal guinea pig could not be compared with that of
a CF patient (or bronchiectic). The use of unwashed cells in a
similar experimental model (but using rats instead of guinea pigs),
demonstrated that a mucoid strain was cleared less efficiently than
an isogenic non-mucoid strain (Govan et al, 1983).
The role of other surface components in the survival of
P. aeruginosa in the lung has not been systematically studied. It
is well established that CF patients chronically infected with
P. aeruginosa have high titres of antibodies directed against 0-
antigens in both serum and sputum (Htfiby, 1979). Thus bacteria
lacking the 0-antigen may be resistant to opsonization by these
antibodies, in other words, a defective LPS would provide a
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selective advantage in this situation and could be considered a
virulence determinant.
While the structural basis of antibiotic hypersensitivity in
clinical P. aeruginosa isolates has not yet been determined,
antibiotic hypersensitive strains of Neisseria gonorrhoeae are
frequently isolated from cases of gonorrhoea (Eisenstein & Sparling,
1978). The outer membranes of these strains have increased perme¬
ability, and this is thought to aid colonization of the mucosal
surfaces (Lysko & Morse, 1981).
Various extracellular virulence determinants may be important
for the long-term survival of P. aeruginosa in the lung. Antibodies
directed against alkaline protease, elastase and exotoxin A have
been detected in the serum of CF patients (Klinger et al, 1978;
Doring, et al, 1983; Doring & Htfiby, 1983; Cukor et al, 1983)
indicating that these enzymes are produced in vivo by the
colonizing/infecting strains. Proteases may potentiate bacterial
survival in vivo through the inactivation of complement factors
(Schultz & Miller, 1974) and cleavage of IgG (Fick et al, 1982).
Jagger et al (1983) have reported that 65% of 380 P. aeruginosa
isolates from CF patients had elastase activity and 64% had alkaline
protease activity. They also noted that strains from colonized
patients were more proteolytic than those from chronically infected
patients, suggesting that protease activity may be selected against
in this situation.
Cash et al (1979) have developed a rat model of chronic
respiratory infection with P. aeruginosa, where bacteria
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encapsulated in agar beads are instilled into the lungs
intratracheally. The lesions associated with this experimental
infection are similar to those described in patients with non-
bacteraemic P. aeruginosa pneumonia (Renner et al, 1972; Tillotson &
Lerner, 1968) and CF patients chronically infected with
P. aeruginosa (Bedrossian e t al, 1976), i.e. goblet cell
hyperplasia, focal areas of necrosis, and acute and chronic
inflammatory infiltrate.
One research group has attempted to develop an animal model of
CF by treating rats with reserpine on a daily basis for 14 days
(Thompson et al, 1976; Wood & Martinez, 1977; Perlmutter & Martinez,
1978). The pulmonary secretions of chronically reserpinized rats
showed some of the alterations associated with CF, however, the
treatment gave rise to so many diverse side effects that the model
is no longer considered to mimic CF. To my knowledge, there are no
published reports of bacteriological studies using this model.
Various groups have used the Cash model of chronic respiratory
infection to examine the role of particular P. aeruginosa virulence
determinants on bacterial survival and ability to cause pathological
lesions in the lung (Woods et al, 1982; Sokol & Woods, 1984; Cash
et al, 1983). It is generally agreed that neither exotoxin A nor
elastase contribute significantly to bacterial survival in the rat
lung.
According to Al-Dujaili (1976), the P. aeruginosa haemolysins
may contribute to bacterial survival in the lung due to its toxic
activity against alveolar macrophages.
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Lung damage in acute and chronic infections
Fetzer et al (1967) examined post-mortem lung tissue from seven
patients who had died from bacteraemic P. aeruginosa pneumonia and
noted two types of gross lesions:- (i) poorly defined, haemor-
rhagic, nodular, indurated areas, occasionally with a small central
necrotic locus, (ii) firm, yellow-brown, necrotic nodules with
slightly raised, well-demarcated, lobulated borders. These workers
commented that the second type of lesion was quite unlike that seen
in other forms of bronchopneumonia. They also noted that bacteria
were almost invariably found adjacent to capillaries and not in the
walls of arteries and veins suggesting that colonization of the
capillaries may provide a route for bacterial dissemination.
Gray & Kreger (1979) have reported that lesions very similar to
those described above can be elicited in the lungs of rabbits by the
experimental administration of P. aeruginosa proteases. Using a
guinea pig model of acute P. aeruginosa pneumonia, Blackwood et al
(1983) evaluated the roles of exotoxin A and elastase as virulence
factors in this kind of infection. They concluded that elastase,
but not exotoxin A had a significant pathogenic role.
P. aeruginosa has been shown to be the cause of epidemics of
haemorrhagic pneumonia in mink (Shimizu et al, 1974), and using this
infection as an experimental model, Homma et al (1983) have
evaluated a multicomponent vaccine, consisting of the common
protective P. aeruginosa antigen (OEP) and toxoids of protease and
elastase, for its ability to prevent an epidemic of haemorrhagic
pneumonia in a mink population. These workers showed that the
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raulticomponent vaccine was significantly more effective in this
respect than a single component vaccine (containing OEP only),
suggesting that protease and elastase contribute to the virulence of
the P. aeruginosa strain in this infection, whether in terms of
bacterial invasion or survival in the lung.
Using the rat model of chronic respiratory infection, Cash
et al (1983) have reported that histopathological changes were noted
when exotoxin A and protease, alone or in combination, were
instilled. Similar conclusions have been drawn by Woods et al
(1972) and Sokol & Woods (1984). In addition, Cash et al (1983)
noted that the continued presence of P. aeruginosa and its products
served to maintain a chronic inflammatory response. These workers
postulated that the accumulation of PMN's at the site of the lesion
is induced and maintained by LPS due to its chemoattractant
properties.
In the hamster tracheal organ culture model, Baker (1982) has
shown the exotoxin A and elastase, but not alkaline protease,
contribute to the destruction of ciliated epithelium.
It has been postulated that haemolysins produced during
P. aeruginosa lung infections may degrade surfactants leading to
atelectasis and other pathological alterations (Liu, 1979).
It would be reasonable to conclude, from this review of the
literature, that the pathogenicity of P. aeruginosa in the lung
involves the expression and interaction of various different
factors, the relative importance of which vary according to the type
45
of infection or experimental model used to study them. Whereas the
factors likely to cause tissue damage in acute infection are
characteristic of the majority of clinical isolates of
P. aeruginosa, the unusual characteristics associated with long-term
colonization and chronic infection of the lung are a reflection of
the adaptability of this complex microbe.
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CHAPTER IV
GENETICS AND P. AERUGINOSA PATHOGENICITY
The role of genetics in the study of P. aeruginosa pathogenicity
In recent years, the role of genetics in the study of microbial
pathogenicity has become increasingly important, due to the rapid
developments in technology for the genetic manipulation of micro¬
organisms. In the case of P. aeruginosa, classical genetic
techniques (e.g. the isolation of particular mutants), in
combination with animal models, have been used to assess the role of
exotoxin A, elastase and alkaline protease in corneal infections
(Ohman et al, 1980; Howe & Iglewski, 1984), the role of proteases in
burn infections (Pavlovskis & Wretlind, 1979), and the role of
exotoxin A and elastase in chronic lung infections (Wood set a 1,
1982; Sokol & Woods, 1984) and acute lung infections (Blackwood
et al, 1983). In addition, the isolation of a P. aeruginosa mutant
producing a non-toxic, immunologically cross-reactive exotoxin A
protein (Cryz et al, 1980) has recently led to the development of a
toxoid of exotoxin A with potential as a vaccine component (Cryz &
Iglewski, 1983).
The genetic basis, and particularly the regulation, of
P. aeruginosa virulence determinants, e.g. exotoxin A, phospholipase
C and elastase, has been the subject of considerable interest and
research. The majority of the published reports have described the
use of classical genetic techniques, particularly R68.45 mediated
conjugation for the mapping of genetic loci associated with these
extracellular products. Recently, workers such as Coleman et al
(1983) and Vasil et al (1982) have examined the expression of a gene
encoding phospholipase C through the use of recombinant DNA
technology (cloning).
Because of the important and varied role of genetics in the
analysis of P. aeruginosa pathogenicity, I will briefly outline the
history of P. aeruginosa genetics, including the development of
techniques for the genetic manipulation and analysis of the organism
and then give examples of their use in the study of virulence.
The genetics of P. aeruginosa
The isolation of auxotrophic mutants in P. aeruginosa was first
described in 1955 by Loutit (Loutit, 1955) and in the same year, a
system of genetic recombination, using conjugation, was described by
Holloway (Holloway, 1955). The ready availability of P. aeruginosa
bacteriophages from sewage and from clinical isolates of
P. aeruginosa, led to the development of a transductional system
(Hoi loway et al, 1960), and genetic mapping studies ensued. The
P. aeruginosa strain chosen for detailed genetic analysis,
originally designated Strain 1 (Holloway, 1955), and now known as
strain PAO, was isolated from an infected wound in an Australian
hospitalized patient. A second strain, designated PAT (isolated
fromroutine clinical material in South Africa by Don & van den Ende,
1950) and the source of the "original" P. aeruginosa sex factor,
FP2, has also been subjected to genetic analysis (Watson & Holloway,
1978), but not on the same scale as strain PAO.
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For over 20 years detailed mapping of the PAO chromosome was
hampered by the inability to demonstrate genetic circularity. The
reason for this was that FF2 and various other sex factors such as
FP5 (Matsumoto & Tazaki, 1973) and FP39 (Pemberton & Holloway,
1973) apparently transferred the chromosome unidirectionally from a
single origin. Consequently, the mapping of markers located beyond
40 mins from the origin of transfer was extremely inaccurate, due to
the low recovery of recombinants. The chromosome was estimated to
be 80-110 mins in length on the basis of a molecular mass of 2.1 x
109 dal tons (Pemberton, 1974). Subsequently, another sex factor,
FP110, has been shown to transfer the chromosome from an origin at
about 27 mins (Royle & Holloway, 1980), but this has not been used
in routine mapping studies due to the development of the alternative
systems to be described.
In 1976, the isolation of a new sex factor, R68.45 (Haas &
Holloway, 1976) represented a major advance in Pseudomonas genetics.
R68.45 is a variant of the broad host range lnc P-l plasmid R68
(Holloway & Richmond, 1973) which has chromosome mobilizing ability
(Cma) in P. aeruginosa and various other Gram-negative organisms
including P. putida (Martinez & Clarke, 1975)^ Escherichia coli and
several species of Rhizobium (Beringer et al, 1978; Kondorosi et al,
1977; Megias et al, 1982). The molecular basis for Cma in R68.45
appears to be the duplication of a DNA segment occurring as a single
copy in R68, thus giving rise to a transposable genetic element
which is designated 1S21 (Willetts et al, 1981). R68.45 possesses
several interesting properties which make it an extremely useful
genetic tool, (i) Chromosome mobilization occurs from multiple
origins and is non-polarized, hence chromosomal recombinants for
most markers are formed at acceptable frequencies - about 10"^ per
donor cell on solid media (Haas & Holloway, 197 6; Haas & Holloway,
1978). (ii) In R68.45-mediated plate matings, most recombinants
inherit short chromosome fragments (up to about 10 mins long) and
the plasmid is lost from these recombinants during purification,
hence R68.45 can be used like a "large" generalized transducing
phage for the construction of strains (Haas & Holloway, 1978);
(iii) It is possible to isolate derivatives of R68.45 which carry
segments of chromosomal DNA (Holloway, 1978). Such plasraids, known
as R primes (R')» are useful tools for the study of gene expression,
as they allow the construction of partial diploid strains, and
provide an intermediate step in the transfer of particular genes to
a cloning vector.
Genetic circularity of the PAO chromosome was finally
demonstrated in 1981 (Royle et al, 1981), and it was also shown that
FP2-mediated chromsome transfer did not take place from a single
origin as previously believed. Early mapping studies by Loutit
(1969) had indicated that two FP2 linkage groups existed; a major
one containing most markers mapped at that time, and a minor one
containing four loci which were essentially unlinked to markers of
the major linkage group. It is now clear that the minor linkage
group is the consequence of chromosome transfer from one or several
origins close to the major one, and in the opposite direction to
that found for the major origin (Soldati et al, 1984).
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In recent years, the discovery and subsequent utilization of
transposons has revolutionized microbial genetics. Transposons are
normal constituents of most bacterial genomes which may have evolved
as nature's tools for genetic engineering because of their ability
to rearrange other DNA sequences (Kleckner, 1981).
In P. aeruginosa, a strategy of transposon-faci 1 itated
recombination was described by Krishnapillai et al (1981), whereby
several Tn 1 insertions in the late chromsome region of PAO were
obtained, from which the R plasmids R18 and R91-5 could mobilize the
chromosome in a polarized fashion by virtue of Tnl homology between
chromosome and plasmid. Transposon insertion into the chromosome
also provides a useful method for obtaining mutants, without the
problem of multiple lesions, so often associated with chemical
mutagenesis, particularly using nitrosoguanidine (NG) (Haas et al,
1984; Stapleton et al, 1984).
Another major development in the technology of P. aeruginosa
genetics is the establishment of specialized host:vector systems for
gene cloning (Wood et al, 1981; Bagdasarian, 1981; Bagdasarian &
Timmis, 1981; Sakaguchi, 1982; Haas et al, 1984). Cloning provides
a means of isolating and characterizing particular gene products as
well as studying their expression.
The genetic basis of P. aeruginosa virulence determinants
Figure 2 is a diagram of the current P. aeruginosa chromosome
map showing the locationsof markers relevent to this thesis.






























































Figure 2. Chromosome map of P. aeruginosa PAO indicating the
location of markers relevent to this thesis, based on the
following references:- Holloway & Crockett (1982),
Soldati et al (1984), Friih et al (1983), Rella & Haas
(1982), Hanne et al (1983), Howe et al (1983), Tsuda
et al (1981), Okii et al (1983),Gray & Vasil (1981a),
Roehl et al (1983), Wretlind & Pavlovskis (1984), Darzins
& Chakrabarty (1984). Markers with asterisks were mapped
during the course of this thesis. The following marker
designations have been used: alg, instability of
alginate production; ami, amidase; aph, aminoglycoside 3-
phosphotransferase II; arg, arginine requirement; bla, B-
lactamase production; bis, ^-lactam hypersensitivity;
cys, cysteine requirement; eda, 2-keto 3-deoxy 6-phospho-
gluconate aldolase; edd, 6-phosphogluconate dehydratase;
ese, phage E79 resistance; fla, flagella; his, histidine
requirement; i 1 v , isoleucine, valine requirement; las,
elastase production; leu, leucine requirement; 1ys,
lysine requirement; met, methionine requirement; muc,
mucoid colonial type (alginate production); nal,
resistance to nalidixic acid; oru, ornithine utilization;
pic, phospholipase C; pro, proline requirement; pru,
proline utilization; pur, purine requirement; pyr,
pyrimidine requirement; rec, recombination ability; ser,
serine requirement; som, somatic antigen; str, resistance
to streptomycin; thr, threonine requirement; tox,
exotoxin A production; tps, sensitivity to trimethoprim;
trp, tryptophan requirement; xcp, extracellular protease
production; zwf, glucose 6-phosphate dehydrogenase.
determinants, all of which are naturally expressed in PAO. The
structural gene for exotoxin A (toxA) was identified following the
isolation of a PAO mutant which produced an enzymatically inactive
and non-toxic exotoxin protein, and the mapping of this locus was
performed using R68.45 mediated plate matings (Hanne et al, 1983).
Two additional loci tox-1 and tox-2 are associated with toxin
production (Gray & Vasil, 1981a). Whereas tox-2 mutants are
specifically deficient in exotoxin A, suggesting that this locus is
involved in the regulation of synthesis, tox-1 mutants were also
altered in the secretion or synthesis of other extracellular
proteins (Gray & Vasil, 1981a). Several other loci associated with
the regulation and release of extracellular proteins (including
protease, elastase, staphylolytic enzyme and lipase) have also been
mapped in PAO using R68.45 mediated conjugation (Wretlind &
Pavlovskis, 1984). These loci, designated xcp appear to be
distributed around the chromosome in small clusters. An xcp locus
(xcp-7) in strain PAKS, thought to encode a proelastase activating
enzyme, which also influences the release and/or activity of other
extracellular proteins, has been transferred into PAO using R68.45
and mapped at 55' like xcp-5 and xcp-53 (Wretlind & Pavlovskis,
1983).
The structural gene for elastase (lasA) has been mapped at 75
mins, using both R68.45 mediated conjugation and Tnl facilitiated
recombination (Howe et al, 1983) following the isolation of a mutant
specifically deficient in elastase production (Oilman et al, 1980).
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Further studies on the regulation of extracellular virulence
determinants in PAO have revealed that exotoxin A, alkaline protease
and elastase yield are subject to independent iron regulation (Sokol
et al, 1982). According to Bjorn et al (1979), growth of strains
in vitro, in medium containing a high iron concentration 5.0;ug ml"*)
causes an 85% decrease in exotoxin A yield as compared with strains
grown in low iron (0.05;ug ml-1). In constrast, synthesis of
phospholipase C and alkaline phosphatase in P. aeruginosa is subject
to phosphate repression, and two closely linked chromosomal loci
(plcA,B) associated with the coregulationof these enzymes have been
identified and mapped (Berka et al, 1981; Gray & Vasil, 1981b; Gray
et al, 1981; Gray et al, 1982). The structural gene for phospho¬
lipase C has not actually been mapped, but its expression has been
examined through the use of cloning techniques. Vasil et al (1982)
cloned the phospholipase C gene along with the structural genes of
five other phosphate-repressible proteins, indicating the existence
of a phosphate regulon. Coleman et al (1983) also cloned the
structural gene for P. aeruginosa phospholipase C and noted that the
gene product was a polypeptide of MW 78,000. Both of these studies
succeeded in obtaining expression of the phospholipase C gene in
E. coli where haemolytic activity was cell associated rather than
extracellular, which is the case in P. aeruginosa.
Despite the fact that the regulation and synthesis of alkaline
phosphatase and phospholipase C is different from exotoxin A and
elastase they all seem to share a common release mechanism, whereas
alkaline protease apparently has a a separate mechanism for
regulation and release (Wretlind & Pavlovskis, 1984).
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The other potential virulence determinants normally expressed
in strain PAO are cellular components, i.e. pili, flagella and LPS.
In an elegant study using R'fla derivatives of R68.45 for complemen¬
tation analysis, Tsuda and colleagues (Tsuda et al, 1981) have
identified two linked clusters of genes on the PAO chromosome (at
approximately 85') associated with flagella synthesis and function.
It was once thought that in general, genes controlling related
functions in P. aeruginosa were non-clustered (Holloway, 1975).
However, several other examples of gene clustering have now been
demonstrated, particularly involving catabolic genes (Roehl et al,
1983). Evidence for a chromosomal location of the genetic
determinants for polar pili has been reported (Bradley, 1980),
however, the loci have not actually been mapped.
A systematic genetic study of LPS synthesis in P. aeruginosa
has yet to be undertaken, however, several markers, potentially
associated with this important outer membrane component have been
mapped. The loci eseA and eseB are associated with resistance to
the virulent phage E79 (Hoi loway et al, 1971). The receptor site
for this phage in strain PAO has been shown to reside in the LPS
(Jarrell & Kropinski, 1977), hence a mutation to phage resistance
could mean loss or alteration of that receptor. Indeed, Jarrell &
Kropinski (1977) confirmed that the LPS of E79r PAO mutant lacked
certain of the major constituents found in wild type LPS, and Meadow
& Wells (1978) have since shown that in strain PAC, the E79 receptor
is associated with the core fraction of the LPS. Matsumoto & Tazaki
(1975) have mapped two loci (somA and somB) associated with heat-
stable somatic antigens, by means of interstrain crosses. Although
biochemical analysis was not performed on the antigens in question,
they were almost certainly LPS-associated, based on the work of
Chester et al (1973) and Koval & Meadow (1975).
The genetic basis of characteristics not normally expressed in PAO
Certain characteristics expressed by clinical P. aeruginosa
isolates are not normally expressed by strain PAO. There are
several possible reasons for this, (i) PAO does not carry the
necessary genetic information, whether chromosomal or plasmid-
mediated, for the expression of the characteristic. In this case,
to obtain a derivative of PAO capable of expressing the charac¬
teristic in question, one would first have to transfer the gene(s)
responsible from an appropriate clinical strain into PAO. It would
not be possible to isolate a PAO mutant with the desired properties,
(ii) PAO carries the genetic information, but appropriate growth
conditions are necessary for expression, i.e. the normal lack of
expression is phenotypic rather than genotypic. (iii) PAO carries
the necessary genetic information but this is normally repressed
(genotypical 1 y). In this case, it would be possible to isolate
mutants which expressed the characteristic.
Strain PAO does not normally express any of the unusual
characteristics associated with isolates from chronic respiratory
tract infections, i.e. alginate synthesis, antibiotic
hypersensitivity, serum sensitivity and PA. Hence, the genetic
analysis of these characteristics is not as straight-forward as, for
example, elastase and exotoxin A production.
55
a) Alginate synthesis.
Despite some controversy, evidence suggested that mucoid
P. aeruginosa strains arise in vivo from classic, non-mucoid strains
(Doggett et al, 1966), as when the two forms are found together in
the same specimen, they generally belong to the same serotype (Diaz
et al, 1970) and pyocin type (Willams & Govan, 1973). However, in
contrast to their emergence in vivo, when cultured in vitro, mucoid
strains of P. aeruginosa tend to revert to the non-mucoid form
(Zierdt & Schmidt, 1964). 1
Markowitz et al (1978) examined the possibility that alginate
production by clinical mucoid P. aeruginosa isolates might be
plasmid associated. Eighteen such strains were evaluated with
respect to plasmid content and ability to maintain well
characterized plasmids. Not surprisingly, no such association was
observed.
The first report of in vitro isolation of mucoid variants was
by Williamson (1956) who claimed that "mucoid colonies could be
obtained in pure form by repeated transfer of the smooth state cells
through 'eugon' broth enriched with 4% potassium gluconate, and the
selective transfer of isolates possessing mucoid characteristics to
a solid modification of Hayne's media". However, there was no
indication whether such mucoid strains were alginate producers or
merely copious producers of slime.
Martin (1973), during the course of phage typing, noted rings
of mucoid growth around areas of phage lysis while the background
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lawn remained non-mucoid. Subculture from these areas resulted in
pure cultures of mucoid colonies which looked and behaved like
clinical isolates. Martin believed that mucoid variants derived in
this manner required the presence of phage in the lytic cycle for
the continued expression of the mucoid character and used the term
"pseudolysogeny" to describe this phenomenon.
An investigation of the influence of various substances on the
stability of mucoid P. aeruginosa in vitro (Govan, 1975) showed that
clinical and phage derived strains maintained their mucoid colonial
form when serially subcultured on desoxycholate citrate agar (DCA),
or in sodium deoxycholate broth.
In 1978, we published an alternative method for isolating
mucoid variants in vitro without the use of phage (Govan & Fyfe,
1978), based on the observation that certain mucoid strains were
slightly more resistant to some antibiotics than related non-mucod
forms (Govan, 1976). In retrospect, this observation was somewhat
fortuitious as the increased antibiotic resistance of mucoid strains
became a subject of controversy (Markowitz et al, 1980; Irvin et al,
1981). The selective agent of choice in the isolation method was
carbenicil1in, though other ^B-lactams and tobramycin have also been
used successfully.
The frequency of isolation of mucoid variants from strain PAO
using this procedure was approximately 1 in 10^ cells and this
frequency could be increased following mutagenesis with
ethylmethanesulphonate (EMS). Mucoid strains so derived do not
require the continued presence of the antibiotic for expression of
57
the characteristic, and infra-red spectroscopy of the exopoly-
saccharide confirmed it to be an acetylated polymer of mannuronic
and guluronic acids.
A modified version of the isolation procedure has since
provided a means of isolating alginate-producing variants of
P. putida, P. fluorescens and P. mendocina (Govan et al, 1981).
Alginate biosynthesis in these species had not previously been
reported.
From these results, we concluded that (i) P. aeruginosa strain
PAO, and probably most other P. aeruginosa strains, have the
necessary genetic information for the synthesis of alginate, but
this is normally repressed, and (ii) expression of the genes
involved in the alginate biosynthetic pathway occurs following a
mutation, probably in a regulatory gene. Similarly, the instability
of alginate synthesis under certain in vitro cultural conditions can
be explained on the basis of mutation using a fluctuation test
(Govan et al, 1979). The mucoid characteristic is generally less
stable when the strain is grown in unshaken broth cultures than in
shaken cultures due to the faster growth rate of non-mucoid
revertants under these conditions (Govan et al, 1979). Boyce &
Miller (1980, 1982) have further shown that the Fe^+ or Fe^+ concen¬
tration has a profound effect on the selection of non-mucoid rever¬
tants in unshaken cultures. Mucoid strains grown in medium
containing O.OlmM iron were rapidly outgrown by non-mucoid rever¬
tants, whereas the revertants had less of a selective advantage in
lower iron concentrations.
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Two different approaches have so far been used for the analysis
of loci associated with alginate synthesis in mucoid P. aeruginosa.
Ohman & Chakrabarty (1981) have attempted to develop a genetic
system in a clinical mucoid P. aeruginosa isolate and have obtained
evidence for the chromosomal location of three mutations (alg)
responsible for reversion to the non-mucoid form. Unfortunately it
was not possible to relate the markers on their chromosomal map to
the established PAO map. Our own genetic studies have utilized
mucoid mutants of PAO, isolated according to Govan & Fyfe (1978) or
following selection for resistance to the virulent phages E79 or M6
(Govan, 1975).
We based our approach on the early studies of Markovitz and
colleagues relating to mucoid E. coli (reviewed in Markovitz, 1977),
certain aspects of which I will summarize. Like P. aeruginosa, wild
type E. coli K12 does not appear mucoid when grown on solid media at
37°C, however, unlike P. aeruginosa, this strain does produce an
exopolysaccharide (colanic acid) when grown at 30°C. Mutant strains
of E. coli K12, which produce mucoid growth at 37°C can be isolated
- these mutants are derepressed for colanic acid synthesis. Early
mapping studies revealed that at least two different chromosomal
loci yielded mucoid strains (Markovitz, 1964), and these are
presently designated capR (Ion) and capS. A third locus capT, which
yields mutants producing colanic acid on EMB-glucose medium (capR
and capS mutants are non-mucoid on this medium) at 37°C was later
identified (Markovitz, 1977).
The regulatory role of the capR gene was confirmed by partial
diploid studies. Using an F' derivative carrying the capR"1" allele
(F'13), capR+ was shown to be dominant over the capR6 mutation, i.e.
F'l3capR+/capR6 heterogenotes were non-mucoid (Markovitz, 1964). A
F'capR6/capR"*" strain was also shown to be non-mucoid (Markovitz &
Rosenbaum, 1965). However, a second capR mutation, capR9 was shown
to behave differently fron capR6, i.e. whereas the F'13capR+/capR9
heterogenote was non-mucoid, a capR9/capR+ partial diploid was
mucoid. By cloning the capR"1^ capR6 and capR9 al leles from the F'
plasmids on to a suitable multicopy vector (Zehnbauer & Markovitz,
1980), it has now been shown that capR+ encodes a 94K protein with
DNA-binding activity, whereas the capR6 mutation leads to a
deficiency in this protein. However, capR9 encodes an altered
protein of the same molecular weight which is produced in 5 to 10
fold amounts in excess of the capR"*" product. It has been further
postulated that the capR+ product is subject to autoregulatory
control, a property which is lost with the capR9 mutation.
In addition to the derepression of the enzymes associated with
colanic acid synthesis, mutations in the capR locus have a number of
pleitropic effects, e.g. UV sensitivity, low level resistance to
tetracycline, chloramphenicol and puromycin. These properties are
not the direct result of colanic acid synthesis per se, but reflect
the diverse role of the capR gene product. CapS and capT mutants
also have derepressed levels of the colanic acid biosynthetic
enzymes, but do not share the latter properties associated with
capR. Hence there are several targets on the E. coli chromosome
whose function is to, directly or indirectly, switch on or off the
genes involved in the colanic acid biosynthetic pathway.
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P. aeruginosa alginate is an entirely different polymer from
colanic acid, hence the control of the biosynthetic pathways may be
different. Nevertheless, a similar genetic approach to the problem
was likely to provide useful information.
Prior to the commencement of studies reported in this thesis we
had identified two different phenotypic classes of mucoid strains,
based on the production of mucoid growth on minimal agar (Vogel &
Bonner, 1956). Strains belonging to group 1, e.g. PA0579 and
PA0581, are clearly mucoid on both media after 24 h at 37°C, whereas
group 2 strains, e.g. PA0568 and PA0578 appear rough and non-mucoid
on minimal agar, but mucoid on complex media (Fyfe & Govan, 1980).
Early mapping studies, using FP2 and R68.45-mediated plate
matings indicated that the mucoid characteristic (Muc), could be
transferred between PAO strains by means of conjugation, but could
not be directly selected for. FP2-mediated interrupted matings
confirmed that one particular muc mutation, muc-36, was linked to
the chromosomal markers his-5075 and cys- 5605 (at that time located
at 12 mins on the PAO map), and was apparently distal to those
markers with respect to the FP2 origin (Fyfe & Govan, 1980).
Unexpectedly, muc-36 showed no linkage to markers in the 15-20 min
region of the chromosome, hence no further mapping of this locus was
possible. However, the relocation of his-5075 and cys-5605 from 12
min to the chromosomal region close to the major PF2 origin (Soldati
et al, 1984), resolved many linkage anomalies observed by ourselves
and other workers, and allowed further progress to be made in the
mapping of muc loci. The results of this form part of this thesis.
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b) Antibiotic hypersensitivity
In the course of studying the intrinsic resistance of
P. aeruginosa strain PAO, various loci associated with this
characteristic have been mapped on the chromosome. Mills & Holloway
(1976) reported the isolation of an aeruginocin-tolerant PAO mutant
(tolA) which was also hypersensitive to aminoglycoside antibiotics.
This mutation mapped at approximately 10 mins on the chromosome map.
A second locus associated with the resistance of P. aeruginosa to
aminoglycosides (in particular kanamycin, neomycin, paromomycin and
ribostamycin) , has been designated aphA (Okii et al, 1983). This
locus encodes an aminoglycoside inactivation enzyme and maps between
35 and 40 mins.
Intrinsic resistance of P. aeruginosa to the ^B-lactam
antibiotics is based mainly on 2 mechanisms, hydrolysis by ,B-
lactamases and exclusion of the antibiotics from their target sites
in the inner membrane by the outer membrane (Richmond & Curtis, 1974
1974; Zimmerman, 1979). Several chromosomal loci associated with
inducible ^-lactamase production (bla) have been mapped (Matsumoto &
Terawaki, 1982). Zimmerman (1979) has isolated a P. aeruginosa
mutant (779/61) with increased sensitivity to a wide range of
antibiotics including JJ-lactams, due to an apparent increase in
outer membrane permeability. This mutant and its parent strain 799
have been utilized in various studies on the structural basis of the
intrinsic resistance of P. aeruginosa (Zimmerman, 1980; Angus et al,
1982; Kropinski et al, 1982; Darveau & Hancock, 1983; Livermore,
1984). However, 799/61 was derived following multiple mutagenesis
steps and attempts to determine the genetic basis of the antibiotic
hypersensitivity associated with this strain have so far been
unsuccessful (Angus et al, 1982).
There have been several other reports of P. aeruginosa mutants
with increased susceptibility to various antimicrobial agents
(Noguchi et al, 1980; Kropinski et al, 1978; Ohmori et al, 1977),
however, the interest in these strains was biochemical rather than
genetic.
The genetic basis of antibiotic hypersensitivity as expressed
in clinical P. aeruginosa isolates has not, to my knowledge, been
reported. May & Ingold (1972) postulated that the intrinsic
resistance of non-respiratory P. aeruginosa isolates might be
plasmid-encoded, and that this plasmid may sometimes be lost during
growth in the respiratory tract. However, no evidence was presented
in support of this hypothesis.
c) Serum sensitivity and polyagglutinability
Alterations in LPS structure would appear to be the structural
basis for these characteristics according to Hancock et al (1983)
and Meadow et al (1984), thus mutations in certain genes associated
with the biosynthesis of LPS would be expected to give rise to serum
sensitivity and/or loss of the O-specific antigen. To my knowledge,
there are no reported systematic genetic studies on LPS synthesis in
P. aeruginosa, or the genetic basis of these characteristics in
clinical isolates.
However, there are a number of reports on PA strains arising
from strains of various serotypes following prolonged storage at
room temperature (Homma et al, 1972; Kawaharajo, 1973). In
addition, it has been reported that lysogeny with certain phage
could cause changes in the somatic antigens of P. aeruginosa (Liu,
1969; Bergen & Midtvedt, 1975).
64
CHAPTER V
EPIDEMIOLOGICAL TYPING OF P. AERUGINOSA STRAINS FROM
CHRONIC RESPIRATORY INFECTIONS
There are several systems available for the epidemiological
typing or "fingerprinting" of P. aeruginosa strains, including
biotyping, antibiograms, serotyping, phage typing and bacteriocin
(pyocin) typing (Brokopp & Farmer, 1979). In general, typing is
performed to establish relationships between different P. aeruginosa
isolates, usually associated with an outbreak of infection, in order
to determine the origin and route of infection.
In the case of P. aeruginosa isolates from chronic respiratory
tract infections, we are not primarily concerned with tracking down
the source of strains, but rather in establishing the relationships
between heterogeneous isolates from single and consecutive sputum
specimens. If genetic studies on the characteristics associated
with these isolates are to be meaningful, it is essential to
demonstrate that isolates expressing different characteristics are
closely related, having evolved in vivo, and not merely present in
the same specimen due to infection with multiple, unrelated strains.
According to Brokopp & Farmer (1979), an ideal typing system
must be based on a stable genetic property of the organism.
However, apparent genetic stability is dependent on how well adapted
the bacterial population is to its environment. If the population
is in the process of adapting, due to strong selective pressures,
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certain properties may be extremely unstable. Consequently, a
system which is adequate for the typing of strains from one
ecological niche may be totally inadequate for the typing of strains
from another.
The purpose of this chapter is not to review the literature
associated with the typing of P. aeruginosa, as this has been
covered elsewhere (Bergan, 1975; Govan, 1978; Lanyi & Bergan, 1978;
Bergan, 1978; Brokopp & Farmer, 1979; Pitt, 1980). Rather it is to
examine the biological basis of the various available typing systems
and to consider which would be the most useful for determining the
relationships between strains expressing characteristics such as
alginate synthesis, antibiotic hypersensitivity, serum sensitivity
and PA, all of which potentially alter the cell surface.
Biotyping
Various definitions of biotyping have been used, ranging from
characterization of the entire genotype and phenotype of the
organism based on all the biological properties which can be
measured, to the more restricted definition preferred by Brokopp &
Farmer (1979) as the measurement of the following characteristics:
colony type, haemolysis of red blood cells from different animals,
pigment production, growth on selective media, production of a
characteristic odour, and results of biochemical tests required for
identification.
P. aeruginosa is considered to be a fairly "tight" phenotypic
species, especially on the basis of physiological and nutritional
characteristics (Stewart & Widanapatirana, 1981; Brokopp & Farmer,
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1979). However, because there is considerable variation between
strains on the basis of colonial morphology, pigment production
etc., biotyping is sometimes useful.
Severe limitations with respect to the reliability of
biotyping, used on its own for epidemiological purposes, have been
reported by Bobo et al (1973). In this study, colonial dissociants
of an epidemic P. aeruginosa strain gave extremely variable results
on the basis of pigment production, antibiotic sensitivity and
haemolysis of sheep red blood cells. Gaby (1946) and Zierdt &
Schmidt (1964) have also described the different characteristics
often associated with different colony types obtained from a single
strain. On the basis of these observations, biotyping would not be
appropriate for the typing of P. aeruginosa isolates from chronic
respiratory tract infections, as different colonial types would be
considered to be different strains.
Antibiograms
The antibiogram of a bacterial strain is defined as the
susceptibility of that strain to a range of antimicrobial agents,
usually determined by standardized single disk methods (Brokopp &
Farmer, 1979). However, the differences in antibiotic
susceptibilities encountered between different P. aeruginosa
isolates from single sputum specimens (Seale et al, 1979; Thomassen
et al, 1979) suggest that this would be an unsuitable typing method
for determining the relationships between such isolates.
Serological typing
Various different schemes have been developed for the
serological typing of P. aeruginosa (reviewed by Lanyi & Bergan,
1978), the majority of which are based on detection of the heat
stable O-antigens. The scheme for O-serotyping used most
extensively in this country is the International Antigenic Typing
Scheme (IATS) which defines a total of 21 serotypes (Pitt, 1980).
Construction of systems based on heat labile (H) antigens have also
been attempted with varying success (Lanyi & Bergan, 1978; Pitt,
1980), however all tend to give poor differentiation when used
alone.
Lanyi & Adam ( 1 973) (cited by Lanyi & Bergan, 1978)
demonstrated that the P. aeruginosa O-antigens corresponded with
phenol extracted LPS. Chester et al (1973) further showed that
serological specificity is limited to the high molecular weight
fraction, thought to correspond to the polysaccharide side chains,
and Koval & Meadow (1975) reported that some amino sugars were
specific for certain antigens.
O-serotyping is an extremely quick and reliable method which
gives reasonable differentiation for the majority of P. aeruginosa
clinical isolates. However, Penketh et al (1983b) have reported
that only 32% of P. aeruginosa isolates from CF patients were
typable using this method, due to loss of the specific 0-type
reaction and expression of PA. In a study on colonial dissociation
in clinical P. aeruginosa isolates, Sheehan et al (1982) reported a
sputum isolate which displayed serological non-identity with its
colonial segregants, i.e. of the three colonial morphotypes
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identified, two were serotype 0:11 and the other was untypable. No
such dissociation was observed among blood isolates in this study.
Thus it is apparent that serotyping is not the method of choice for
establishing relationships between P. aeruginosa isolates from
chronic respiratory tract infections.
Bacteriophage typing
Various phage typing procedures have been developed for
P. aeruginosa (reviewed by Bergan, 1978), and most of these are
based on the sensitivity of the bacterial strains to a set of
virulent phages. The interaction between phage and bacterium is
dependent on the presence of a specific receptor site on the
bacterial surface.
One of the most extensively used sets of typing phages (a basic
set of 18 phages) was first described by Lindberg & Latta (1974),
and recently, the bacterial receptor sites for most of these phages
have been partially characterized (Mutharia & Hancock, 1982).
According to these workers, the receptor sites of phages 44, 109,
352, 1214, and F8 reside in the LPS, whereas others have protein or
pilus receptors.
On the basis that serum sensitive and PA strains of
P. aeruginosa probably have altered LPS, sensitivity to phages with
LPS receptor sites may be altered. In addition, difficulties in the
phage typing of mucoid strains have been reported (Bergan, 1978).
Consequently, the use of phage typing for P. aeruginosa will not be
pursued further in this thesis.
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Pyocin typing
(i) On the basis of pyocin production. Pyocins (aeruginocins)
are the bacteriocins of P. aeruginosa, and so far three main
categories have been identified. R-pyocins are morphologically
similar to the tails of contractile phages (Govan, 1974 a, b) and in
some cases show immunological cross-reactivity with various phages
(Ito & Kageyama, 1970). F-pyocins are flexuous structures which
resemble tails of non-contractile P. aeruginosa phage (Govan,
1974b). The third category is made up of the low molecular weight
(approximately 10^ daltons) S-pyocins (Ito et al, 1970) which can be
distinguished from the particulate varieties (i.e. R-pyocin and F-
pyocin) on the basis of the size of the inhibition zone produced
against a sensitive P. aeruginosa strain on agar medium. R and F-
type pyocins are not readily diffusible and give rise to a narrow
zone of inhibition, whereas S-pyocins produce a wide zone of
inhibition. S-pyocins are generally considered to be trypsin
sensitive, however a trypsin-resistant class has also been
identified (Govan, 1978).
The most widely used and recommended method for typing, based
on pyocin production, is that described by Govan & Gillies (1969)
and Govan (1978). This method uses a cross-streaking technique for
the detection of pyocin activity against 13 indicator strains, and
gives fairly good strain discrimination with over 100 pyocin 'types'
isolated, but has a number of technical disadvantages. These
include (i) the 48h period required to obtain a result; (ii) the
need to remove the producer strain growth before application of the
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indicator strains, which is both messy and time-consuming; (iii)
the inability to reliably type mucoid P. aeruginosa in the absence
of a modification (Williams & Govan, 1973), which is also extremely
time consuming and labour intensive, and impractical when large
numbers of strains are to be typed. However, the advantage of
pyocin typing from the point of view of establishing relationships
between serum sensitive and PA strains is that it does not rely on
the structure of cell surface components.
(ii) On the basis of pyocin sensitivity Several methods for
typing P. aeruginosa on the basis of sensitivity to a set of pyocin
preparations have been described (Tagg & Mushin, 1973; Rampling
et al, 1975). However, like phage, the receptor sites for pyocins
are cell surface components, and in the case of R-pyocins reside in
the core part of the LPS (Meadow & Wells, 1978). The receptors of
F- and S-pyocins are less well characterized.
In conclusion, it appears that typing based on pyocin
production would provide the most meaningful results in the case of
P. aeruginosa isolates from chronic respiratory infections.
However, various technical aspects of the present published pyocin
typing method (Govan, 1978) could be improved and it would be an
advantage if the time required to obtain a result could be reduced.
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Aims of this thesis
The research presented in this thesis forms part of an ongoing
programme studying the epidemiological typing of P. aeruginosa, and
the association of P. aeruginosa with chronic respiratory infection
in CF patients.
The phenotypic heterogeneity of P. aeruginosa isolates from
single and consecutive sputum specimens from CF patients, and the
emergence of strains expressing unusual characteristics such as
alginate synthesis and antibiotic hypersensitivity, suggest that
adaptability is a significant factor for P. aeruginosa in this
important and debilitating type of chronic infection. Hence, the
major aim of this thesis was to examine the genetic basis of this
adaptability. However, prior to the initiation of a genetic
analysis, it was important to confirm that this observed hetero¬
geneity was not merely due to mixed infection with multiple
unrelated strains.
The areas of research covered in this thesis form three
distinct sections, with the following specific aims:-
1. To modify the pyocin typing method previously developed inour
laboratory (Govan, 1978), to overcome certain technical dis¬
advantages, and to improve the discriminatory power of the
present technique, by taking into account not only the presence
or absence of pyocin activity, but also the nature of the
pyocins (i.e. particulate or diffusible) produced. Results
presented in Chapter VII.
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2. a) To apply the classical genetic techngues of conjugation and
transduction to the precise mapping of (muc) loci associated
with the normal repression of alginate synthesis in
P. aeruginosa strain PAO.
b) To study the control of alginate synthesis associated with
one particular muc locus, through the use of R* plasmids.
c) To use an R'muc+ plasmid to compare muc mutations in PAO
and clinical mucoid strains. Results presented in Chapter
VIII.
3. To determine the genetic basis of antibiotic hypersensivity in
strain 492c and several other respiratory isolates, and to
compare this form of hypersensitivity with the antibiotic
hypersensitivity of the laboratory mutant 799/61 derived by




A. MEDIA AND REAGENTS
1. Complex Media
Nutrient Broth (NB) was Oxoid No. 2 CM67.
Nutrient Yeast Broth (NYB) was Oxoid No. 2 supplemented
withO.5% (w/v) yeast extract (Oxoid L21)
Nutrient Agar (NA) was Oxoid Columbia Agar Base CM331.
Pseudomonas Isolation Agar (PIA) was manufactured by Difco.
Diagnostic Sensitivity Test Agar (DSTA) was Oxoid CM261.
Tryptone Soya Agar (TSA) was Oxoid CM131.
Tryptone Soya Blood Agar (TSBA) was TSA supplemented with 5%
defibrinated human blood.
Desoxycholate Citrate Agar (DCA) was Oxoid CM227.
MacConkey Agar (MCA) was Oxoid CM7b.
Semi-solid Agar Layers (SSA) were 1% Bactopeptone (Difco) in
0.5% Bacteriological agar (Oxoid Lll).
All commercial media were prepared according to the manu¬
facturers" instructions. Media were sterilized by autoclaving at
15 psi for 15 min.
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2. Minimal Media
Minimal Agar (MA) as described by Vogel & Bonner (1956) was
used in genetic experiments when auxotrophic markers were selected.
P medium (Leisinger et al, 1972), containing 20mM L-proline as
the sole carbon and nitrogen source was used for testing strains
carrying pru markers.
0 medium (made according to P medium), containing 20mM L-
ornithine as the sole carbon and nitrogen source was used for
testing strains carrying oru markers.
3. Amino Acid Supplements
Amino acids were added to MA to give a final concentration of
ImM (except for isoleucine which was added to give a concentration
of 50uM). Stock solutions of amino acids with a concentration of
50mM were prepared, sterilized by filtration and kept over
chloroform.
4. Antibiotic Supplements
Antibiotics used were the following: ampicillin (Penbritin;
Beecham), benzyl penicillin (Crystapen; Glaxo), carbenicil1in
(Pyopen; Beecham), cefoxitin (Mefoxin; MSD), cefuroxime (Zinacef;
Glaxo), cephaloridine (Ceporin; Glaxo), chloramphenicol
(Chloromycetin; Parke Davis), flucloxacillin (Floxapen; Beecham),
gentamicin (Roussel), kanamycin (Bristol Laboratories), mecillinam
(Leo Pharmaceuticals), methicillin (Celbenin; Beecham), naladixic
acid (Winthrop), novobiocin (Sigma), rifampicin (Roche),
streptomycin (Glaxo), tetracycline (Glaxo), tobramycin (Lilley) and
trimethoprim (Trimethoprim lactate*, Wellcome).
*1.3g of trimethoprim lactate is equivalent to lg trimethoprim.
5. Preparation of Plate Media
Following sterilization by autoclaving at 15 psi for 15 mins,
agar media were allowed to cool to 45-50°C before the addition of
supplements, at the appropriate concentrations. All agar media,
except TSA and TSBA were dispensed as 15ml volumes in plastic petri
dishes. TSA plates (for use in pyocin typing by the spotting
method) contained 10ml of medium in plastic petri dishes, whereas
TSBA plates (for use in pyocin typing by the cross-streaking method)
contained 20ml of medium in glass petri dishes. All plate media
were dried at 48°C, inverted, without lids for approximately 15 min.
Plate media were stored at 4°C. DSTA plates supplemented with
antibiotics for use in MIC determinations were used with in 2 days.
6. Preparation of SSA
Following sterilization, the SSA was dispensed in 2.5ml volumes




Physiological saline was 0.9% w/v NaCl.
Antisera for O-serotyping corresponded to the International
Antigenic Typing Scheme (Lanyi & Bergan, 1978) and were kindly
donated by Dr Ty Pitt of the Division of Hospital Infection, Public
Health Laboratory Service, Colindale.
Ethylmethanesu1phonate (EMS) was manufactured by Koch-Light
Laboratories Ltd.
B. BACTERIAL STRAINS, PLASMIDS AND PHAGE
The bacterial strains and plasmids used in each section of the
research work are described at the beginning of the relevant Chapter
in the Results. Phage F116L (Krishnapil lai, 1971) was used for
transductions, and phage F116c (Watson & Holloway, 1976), a clear-
plaque mutant of F116L, was used for strain construction.
C. METHODS
1. Storage and propagation of bacterial strains
Longterm storage of bacterial strains was at -70°C in< 10% w/v
skim milk (Oxoid L31). Bacterial suspensions for storage in this
way were prepared by emulsifying several single colonies from an NA
or PIA plate in 1ml volumes of skim milk contained in plastic screw-
top vials. Stock NYB bacterial cultures were used forinoculating
NA, PIA or other selective media to obtain fresh single colonies for
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experimental purposes. These stock cultures were obtained by
inoculating a single fresh bacterial colony into a loz vial
(McCartney bottle) containing 10ml NYB and incubating overnight at
37°C in an orbital incubator (Gallenkamp) rotating at 140 revs min-
Stock cultures were stored at 4°C and used within two weeks.
All NB and NYB bacterial cultures were incubated as above
unless otherwise stated. Plate cultures were incubated at 37°C
unless otherwise stated.
2. Storage and propagation of transducing phage
Longterm storage of phage preparations (in NB) was at -70°C.
Stock preparations were maintained at 4°C. High titre preparations
for transductions were obtained using the following procedure (plate
harvest method): 0.1ml aliquots of a stock phage preparation
(containing approximately lO-'pfu ml~l) were added to 3 x 2.5ml
volumes of molten SSA, previously seeded with 0.1ml aliquots of a
NYB culture of the donor bacterial strain. The molten SSA was then
overlayed on to 3 NA plates and allowed to set. Following 18h at
37°C, the plates showed just confluent lysis of the bacterial lawn
and the layers were scraped into 10ml NB in a McCartney bottle.
After standing at room temperature for 15 min, the mixture was
vortexed on a rotamixer (Hook & Tucker Ltd.) and centrifuged at
5,000rpm for 30 min in a Bactifuge (Heraeus Christ). The super¬
natant was then filtered through a millipore filter (pore size
0.2um) and assayed using the spot method. Transducing preparations
were used within 2 weeks.
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3. Pyocln typing by the cross-streaking method
The procedure used was described by Govan (1978).
As suggested in this review, the recognition of S-pyocin
activity was incorporated into the typing scheme. Thus, a test
strain was allocated to a pyocin type not only on the basis of the
pattern of inhibition observed against the 13 standard indicator
strains, but was further characterized by noting the presence of
classic S-pyocin activity which causes a zone of inhibition which
extends beyond the original growth area of the producer strain.
Therefore, a strain of, for example, pyocin type 1/a producing S-
pyocin against indicator strains 7 and B, is designated type l/a
(S7,B)»
4. Pyocin typing by the spotting method
Strains of P. aeruginosa to be typed were streaked for single
colonies on to NA and incubated at 37°C overnight. The single
colonies arising from each test strain were used to prepare a
bacterial suspension of 10& to 10^ organisms in 1ml of sterile
physiological saline.
A multipoint inoculator (Model A400: Denley Instruments Ltd.,
Sussex, England) was used to dispense Lul volumes of the bacterial
suspensions onto a set of 13 plates (diameter 90mm), each containing
10ml of TSA. In this way, 20 strains could be typed simultaneously
against each indicator strain. After the spots dried, usually
within a few mintues, the inoculated plates were incubated at 30°C
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for 6h. Subsequently, filter paper disks (50mm diameter; Whatman
Inc., England) were impregnated with chloroform, and the plates were
placed over the disks (ensuring that the disks did not come into
contact with the plates) for 15 min to allow the chloroform vapour
to kill the bacteria. The plates were then exposed to air for 15
min to eliminate residual chloroform vapour. Cultures of the
indicator strains, grown without aeration in NB for 4h at 37°C
(giving a cell density of approximately 10? organisms ml"^) were
applied to the plates by adding 0.1ml of each indicator culture to
2.5ml of molten SSA held at 45°C and poured as overlays (i.e. a
separate indicator strain was applied to each of the 13 plates).
When the overlays had set (within 1 min), the plates were incubated
for 18h at 37°C. Pyocin types were determined as described for the
cross-streaking method.
5. Induction of pyocin production by exposure to UV
The method used was based on that described by Kageyama (1975).
Plates inoculated with the producer strains (as described for the
Spotting method of pyocin typing) were incubated at 30°C for 4h.
Plates were then exposed to UV irradiation using a Phillips TUV 30
watt bulb (output 20p watts cm~2) for 15 sees. Following a further
2h incubation at 30°C, pyocin production was detected and described
for the Spotting method.
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6. The killing of producer strains by exposure to UV
Producer strain growth resulting on the TSA plates after 6h at
30°C was exposed to UV irradiation (20ju watts cm-^) for 13 mins.
7. Serotyping
This was performed using the slide agglutination method as
described by Lanyi & Bergan (1978), except that the test strains
were grown on NA rather than blood agar.
8. The spot method for the assay of phage
A dry NA plate was flooded with a 10-fold dilution of an 18h
NYB culture of the propagating bacterial strain. After removal of
excess culture, the plate was left to dry at room temperature.
Serial 10-fold dilutions of the phage preparation were made in NB
(from 10l to 109). 20jul volumes of the 10^, 10^, 10^ and 109
dilutions were applied to the surface of the seeded plate using a
micropipette (Finnpipette, Jenkins Scientific Ltd). After the drops
had dried the plate was incubated for 18h at 37°C and the phage
titre estimated by counting the plaques from a dilution giving rise
to 20-200 such plaques.
9• Isolation of auxotrophic mutants
Auxotrophic mutants were obtained following EMS mutagenesis
(Waton & Holloway, 1976) and carbenici11in enrichment (Watson &
Holloway, 1978).
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10. Isolation of mucoid mutants
Spontaneous mucoid mutants were obtained using the
carbenicillin semi-selection method described by Govan & Fyfe (1978)
or by the phage selection method (Govan, 1975) using phage F116c.
11. Isolation of non-mucoid revertants
Spontaneous non-mucoid revertants were isolated according to
Govan et al (1979).
12. Isolation of rifampicin resistant (RIFr) mutants
Spontaneous RIFr mutants were isolated by spreading 0.2ml
aliquots of the appropriate 18h NYB bacterial culture onto three
DSTA plates supplemented with 250,ug rifampicin ml-!, and incubating
at 37°C for 24-48h.
13. Isolation of carbenicillin hypersensitive mutants
An exponential phase NYB culture was mutagenized with EMS
(Watson & Holloway, 1976). The mutagenized culture thus obtained
was diluted 100-fold in fresh NYB and incubated for 18h at 37°C
(with agitation) to allow expression of mutations. This 18h culture
was diluted 10^ in saline and O.lul aliquots spread over a series of
NA plates. The plates were allowed to dry and incubated for 18h at
37°C. The single potential mutant colonies thus obtained (50-200
per plate) were screened for hypersensitivity to carbenicillin by
replica plating to DSTA plates containing 5ng carbenicillin ml-^ and
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then to fresh NA plates (to provide master plates). Master plates
and carbenicil 1 in plates were incubated for 18h at 37°C and the
colonies arising on both sets were compared. Potential
carbenicil 1 in hypersensitive clones failed to grow on DSTA+ 5;ug
carbenicil 1 in ml-* but were present on the master plates. These
were purified on NA and further characterized by determining the MIC
of carbenicillin and other antibiotics.
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14. Construction of strains carrying R68.45
Donor strains carrying the plasmid R68.45 were constructed and
tested for donorability as described by Haas & Holloway (1976).
15. Plate matings between PAO strains
The procedure used for plate matings mediated by FP2 and R68.45
was described by Stanisich & Holloway (1972).
16. Plate matings between a non-PAO donor and a PAO recipient
The procedure used was essentially the same as for plate
matings between PAO strains, except that NYB cultures of the PAO
recipient strains were incubated for 18h at 43°C rather than 37°C,
as growth at this temperature (i.e. 43°C) renders P. aer uginosa
phenotypically restriction deficient (Rolfe & Holloway, 1966).
17. Transductions
The procedure used was described by Krishnapillai (1971).
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18. Construction of strains using transductions
Transductions using F116c were performed as described by
Krishnapillai (1971), however, transductants were purified several
times on the selective medium and then on NA to remove residual
virulent phage. Only transductants which remained sensitive to
F116c were retained.
19. Characterization of recombinants or transductants.
The segregation of unselected markers was determined by
partially purifying the recombinants (or transductants) by spotting
the colonies to plates of the same medium on which the cross was
performed (50 colonies/plate). After overnight growth at 37°C,
these plates were used as master plates in replica plating or
spotting to the appropriate medium for scoring the marker of
interest, i.e. supplemented MA or MA for auxotrophic markers, P
medium for Pru, 0 medium for Oru, PIA for Muc, DSTA supplemented
with appropriate antibiotics for markers associated with antibiotic
hypersensitivity, or resistance markers associated with R68.45
(Muc+/~ could also be scored on DSTA).
20. Testing recombinants for sensitivity to UV
The construction of strains carrying the rec-102 marker
required the screening of recombinants for coinheritance of one of
the characteristics associated with rec-102, i.e. UV sensitivity
(UVS). Recombinants obtained in a plate mating between a rec-102
donor strain and a rec+ recipient were partially purified as
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described in the previous section and then patched onto duplicate NA
plates. One of the NA plates was then exposed to UV irradiation
(20>i watts cm"2) for 5 seconds. Following 18h incubation of the
plates at 37°C, UVS recombinants on the irradiated plate gave rise
to growth of single colonies only within the area of patch
inoculation, whereas wild type recombinants gave rise to heavy
confluent growth. UVS recombinants were then purified from the non-
irradiated NA plate.
21. Patch matings
Patch matings were used in the isolation of R' derivatives of
R68.45 and were performed as described by Holloway (1978).
22. Broth matings
The transfer of R68.45 and R' plasmids between bacterial
strains was performed using broth matings. 1ml of a 5h NYB culture
of the donor strain was added to 1ml of an 18h NYB culture of the
recipient, and the mating mixture incubated for lV2h at 37°C
without agitation. The mating mixture was then either streaked for
single colonies on to appropriate selective plate medium, or
serially diluted in physiological saline and 0.1ml of the
appropriate dilutions spread on to selective medium. Selective
plates were incubated at 37°C for 48h.
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23. Antibiotic sensitivity testing
Exponential phase NYB cultures of the bacterial strains were
diluted in physiological saline to a concentration of approximately
1C)5 organisms ml~l. A multipoint inoculator (Mode A400: Denley
9 3
Instruments Ltd.) was used to dispense aliquots (containing 10^-10
cells) on to DSTA plates appropriately supplemented with the
antibiotics. A control DSTA plate containing no antibiotic was also
included. The MIC was read as the lowest concentrationof antibiotic
causing complete inhibition of growth after 18h incubation at 37°C.
24. Testing bacterial strains for serum sensitivity





DEVELOPMENT OF A REVISED PYOCIN TYPING METHOD FOR P. AERUGINOSA
Bacterial Strains. Fifty pyocinogenic strains of P. aeruginosa from
the laboratory culture collection were employed as producers in the
development of the revised (spotting) pyocin typing method, and
these strains were used to compare the results obtained using this
method with those obtained with the standard cross-streaking method.
Thereafter, an additional 500 clinical isolates of P. aeruginosa,
from the Royal Infirmary of Edinburgh and the Royal Hospital for
Sick Children, Edinburgh, including mucoid isolates from CF patients
and PA strains, were used to evaluate the spotting method. The 13
indicator strains 1 to 8 and A to E were those described by Govan &
Gillies (1969).
1. Development of the Spotting Method for Pyocin Typing
The spotting method as described in Materials & Methods is
shown in diagrammatic form in Figure 3. The essential aspects of
the method can be summarized by the following:- (i) Producer strain
suspensions, containing 108 to 109 bacteria ml-1, are applied to
standard plates containing 10ml TSA, using a multipoint inoculator.
(ii) Following inoculation, the plates are incubated for 6h at 30°c
to allow producer strain growth, (iii) Producer strain growth is
killed using chloroform vapour. (iv) NB cultures of the indicator
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Figure 3 The spotting method of pyocin typing.
SSA overlays, and applied to the typing plates, (v) The typing
plates are incubated for 18h at 37°C.
Certain aspects of the spotting metnod are based on the cross-
streaking method as described by Govan (1978), e.g. the use of TSA
for producer strain growth, incubation of producer strains at 30°C,
the use of chloroform vapour to kill the producer strains, and the
cultural conditions used for the indicator strains. The idea for
using a spot inoculation technique and a 6h incubation time for the
producer strains was based on the method for pyocin detection
described by Kageyama (1975).
Figure 4 illustrates the four main inhibition zones detectable
using the spotting method. The zone of bacterial growth following
inoculation with the multipoint inoculator and 6h incubation was
generally 5mm diameter. If the test strain failed to produce
detectable pyocin against an indicator, this area of growth was
visible beneath the indicator lawn, but there was no inhibition of
the indicator. Production of R- or F-pyocin by the test strain
resulted in an inhibition zone 5 to 7mm in diameter, with a sharp
edge. S-pyocins generally produced inhibition zones of 9 to 12mm
diameter, often with a diffuse edge. In addition to pyocin
activity, phage activity could often be detected using the spotting
method, characteristically giving rise to a mottled or "moth-eaten"
inhibition zone. The recognition of phage activity was often useful
as an additional epidemiological marker.
Figure 5 shows two typical routine typing plates obtained using
the spotting method.
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Figure 4 Examination for pyocin activity against indicator strain
8 in four strains of P. aeruginosa by the spotting
method. The left plate shows the test strains A, b, C
and D after 6h at 30°C and before addition of the
indicator strain. The right plate shows the inhibition
zones associated with the same four strains after
addition of the indicator strain in an agar overlay, and
subsequent incubation for 18h at 37°C. Strain A shows no
pyocin activity(-); strain B shows S-pyocin activity (+s)
characterized by an inhibition zone extending beyond the
area of original growth; strain C shows a restricted
inhibition zone characteristic of R- and F-pyocins (+);
strain D shows a mottled inhibition zone typical of phage
activity (-0).
Figure 5 Typical routine typing plates obtained by the spotting
method, (a) Indicator strain 5; (b) indicator strain B.
During the development of the spotting method, certain
variables were assessed for their effect on pyocin production and
detection. These results are summarized in Table 2.
2. Evaluation of the Spotting Method
2a. Comparison between spotting and cross-streaking methods
For comparative purposes, 50 strains of P. aeruginosa were
pyocin typed using both methods. Of these 50 strains, 27 gave
identical results using the two methods, including the detection of
S-pyocin activity. Nine strains gave the same pyocin type, but the
cross-streaking method failed to detect S-pyocin activity against
one or more of the indicators. Fourteen, strains gave a different
pyocin type depending on the method used; in 12 strains, the
spotting method detected pyocin activity against certain indicators
which the cross-streaking method failed to detect, and in the
remaining 2 strains, pyocin activity was detected by the cross-
streaking but not the spotting method.
2b. S-pyocin production as a further epidemiological discriminator
An additional 500 clinical isolates of P. aeruginosa were
pyocin typed by the spotting method. Ninety-nine percent of these
strains were typable and 74% produced S-pyocin activity against one
or more of the 13 indicator strains. All indicator strains showed
some degree of sensitivity to S-pyocin activity and amongst the 500
strains typed, 63 different "S-patterns" were distinguished,
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TABLE 2 The effects of varying particular aspects of the spotting
method on pyocin production and detection.
Variation in method Result
Substitution of NA for TSA
Use of a larger test strain
inoculum (i.e. suspension
approx. 10^ cells ml
Incubation of test strains
for 18h
Incubation of test strains
for 37°C
Induction of pyocin pro¬
duction in test strains by UV
No consistent differences
Too much growth after 6h resulting
in an uneven overlay lawn
Needed to remove test strain
growth prior to pouring indicator
overlays. In some cases, S-pyocin
activity was not detectable
Variable. Most pyocins produced
at both temperatures. Certain
S-pyocins apparently not produced
at 37°C (or may have been
degraded by other bacterial
products)
No advantage. Some pyocins
inhibited. Phage induction.
Killing test strains with UV Poor result. Phage induction.
92
suggesting that there are many different S-pyocins and/or many
clinical P» aeruginosa isolates produce multiple S-pyocins. The
most common "S-patterns" were S5 (11«3% of those strains exhibiting
S-pyocin activity), S5>B (9.7%), S7 (8.9%) and S7>B (8.6%).
As an example of the improved discrimination provided by the
recognition of S-pyocin activity, 37 clinical P. aeruginosa isolates
belonging to the common pyocin type 3/e could be subdivided into 6
groups on the basis of their S-pattern (see Table 3). It was also
interesting to note that serotyping was of no value for the
subdivision of these 3/e strains as 33 of the 37 were serotype 0:6
and the remaining 4 were PA.
2c. Typing of mucoid P. aeruginosa by the spotting method
Thirty mucoid isolates of P. aeruginosa from the sputa of six
CF patients were pyocin typed by the spotting ihethod. These
included multiple isolates from single sputum samples. All 30
strains gave clear typing patterns with 13 strains producing S-
pyocins against one or more of the indicators. Multiple isolates
(differing on the basis of antimicrobial susceptibilities) from five
of the patients were shown to be of the same pyocin type (different
types for each patient), whereas the sixth patient harboured strains
of 2 distinct types, 29/f (S5) and 13/k.
2d. Typing of PA strains
During the course of these studies a number of the
PA,
P. aeruginosa strains were shown to beAand hence not able to be
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TABLE 3 The subdivision of 37 P. aeruginosa isolates of pyocin type

















assigned a particular serotype. In each case, pyocin typing




FURTHER STUDIES ON THE GENETIC BASIS OF ALGINATE SYNTHESIS
IN P. AERUGINOSA
Bacterial Strains and Plasmids. The P. aeruginosa strains and
plasmids relevent to this chapter are described in Table 4.
la) Further phenotypic characterization of mucoid P. aeruginosa
The early recognition of heterogeneity amongst mucoid mutants
of P. aeruginosa strain PAO was based on differential expression of
alginate synthesis by different strains on MA (Fyfe & Govan, 1980).
Examples of the two phenotypic groups identified on this basis are
illustrated in Figure 7. The addition of NA and DCA for the
purposes of phenotypic characterization, increased the number of
distinguishable "medium-dependent" mucoid groups from two to four
(see Table 5). Similar phenotypic characterization of mucoid
P. aeruginosa isolates from the sputa of 17 CF patients (100
colonies tested from each sputum sample), indicated that all these
patients harboured strains belonging to group 1, 11 patients
harboured group 2 strains, 6 patients yielded group 3 strains and 5
patients yielded group 4 mucoid strains in addition to their group 1
strain. Thus, all four groups appear to be clinically relevent,
though on the basis of isolation frequency, groups 1 and 2 are
probably of greater significance than groups 3 and 4.
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TABLE 4 Strains and plasmids of P. aeruginosa relevent to this
chapter
Strain




























leu-38, str-2 , muc-23
FP2+
Isaac & Holloway, 1968
Stanisich & Holloway, 1961








Fyfe & Govan, 1980
















Obtained from D. Haas
Obtained from 0. Haas
RIFr mutant of PA0961
Meile et al, 1982
Royle et al, 1981
RIFr mutant of PA01042
Mucoid mutant of PA0964























492a RIFr Prototrophic, mucoid,
RIFr
1949 RIFr Prototrophic, mucoid,
RIFr
2246 RlFr Prototrophic, mucoid,
RIFr
2263 RIFr Prototrophic, mucoid,
RIFr
Mucoid mutant of PA0964
Mucoid mutant of PA0964
Mucoid mutant of PA0964
Pro+ transductant of PA01042
obtained using F116c
Mucoid mutant of PA038
Mucoid mutant of PA038
Described in Section 2a
Cys+Pur+ muc-2 recombinant
obtained in plate mating
between PA0568 and PAO6506
Cys+Pur+ muc-22 recombinant
obtained in plate mating
between PA0578 and PA06506
Royle & Holloway, 1981
RIFr mutant of a clinical
mucoid isolate
RlFr mutant of a clinical
mucoid isolate
RIFr mutant of a clinical
mucoid isolate






K68.45 CBrXCrKMrTra Cma IncP-l
pJF4 CBrTCrPru+Oru+Muc+ Tra
IncP-l







Haas & Holloway, 1976




R' derived from R68.45
See Section 2g
R' derived from R68.45
See Section 2g
R' derived from R68.45
See Section 2g
The genotype symbols used are the same as in Fig. 2. RIFr
designates resistance to rifampicin; CBr, resistance to
carbenicillin; Tcr, resistance to tetracycline; KMr, resistance to
kanamycin; Tra, transferability; Cma, chromosome mobilizing
ability.
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Figure 7 Two mucoid strains PA0568 and PA0579 after 24h incubation
at 37°C on PIA (left plate) and MA supplemented with
leucine (right plate). PA0579 (on the left of each
plate) produces alginate on both media; whereas PA0568
(on the right of each plate) produces alginate on PIA,
but apparently not on MA.
/
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TABLE 5 Phenotypic characterization of mucoid strains of
P. aeruginosa isolated in vitro and from patients with CF
Type of growth on indicated medium
Mucoid Group PIA NA DCA MA
1 + + + +




+ = mucoid growth resembling Phillips colonial type 5
(Phillips, 1969) after incubation at 37°C for 24h.
- = non-mucoid growth.
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During the course of the genetic mapping studies (to be
described), it became apparent that the number of mucoid pbenotypic
groups further increased with the addition of more growth media.
For example, when five group 2 mucoid FAQ strains were grown on MCA
and P medium, four subgroups were identified. Table 6 summarizes
the "medium-dependent" expression of alginate synthesis on MA, MCA
and P medium associated with all muc mutations mapped in this study
(all were associated with mucoid growth on PIA, NA and DCA). The
phenotypic characteristics associated with a particular muc mutation
was constant regardless of the genetic background of the strain
carrying the mutation.
lb) The mapping of muc mutations by FP2-mediated and R68.45-
mediated conjugation
Figure 6 shows the locations of genetic markers relevant to
this study on the PAO map.
Previous studies had shown that muc-2, muc-22, muc-23 and muc-
25 were all linked to cys-5605 and his-507 5 by FP2-mediated
conjugation (Fyfe & Govan, 1980), but the anomoious locations of
these auxotrophic markers at the time, prevented precise mapping of
the muc loci.
The relocation of cy s and his, and the isolation of the
recipient strain PA01042 (Royle et a1, 1981) with 3 auxotrophic
markers (pur-67, cys-59 and proB65) in the vicinity of the major FP2
origin, suggested that matings between mucoid donors and PA01042
might provide conclusive linkage data. Consequently, plate matings
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TABLE 6 The "medium-dependent" expression of alginate synthesis
associated with different muc mutations
Type of growth on indicated
*
medium




muc-22 - + +
muc-23 + + +
muc-25 + + +
muc-37 - - +
muc—38 - + -
muc-39 - - +
muc-40 - + -
muc-45 + + +
muc-52 + + +
*
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■thr-9001
rec-102
Figure 6 The P. aeruginosa PAO chromosome map showing the
locations of markers relevent to this chapter. Marker
designations are the same as for Fig. 2.
were performed between PA01042 and the mucoid strains PA0578 (muc-
22) and PA0579 (muc-23), selecting for Pur + , Cys+ and Pro +
recombinants. The recombinants obtained for each selected marker
were then scored for the coinheritance of muc and the unselected
auxotrophic markers. The results thus obtained are shown in Table
7, and are based on the analysis of 100 recombinants for each
selected marker.
Tnese results clearly indicate that muc-22 and muc-23 are
mutations in two distinct loci, both linked to cys-59 but on
opposite sides of this marker. The gene arrangement consistent with
the recombinant analysis data is illustrated in Figure 8.
pur-67 muc-22 cys-59 muc-23 proB65
.4
0' FP2 0' FP2
major minor
Fig. 8 Approximate locations of muc-2 2 and muc-2 3 relative to
pur-67, cys-59 and proB65 based on results obtained in
FP2-mediated plate matings.
At this point it was tempting to conclude that mutations
occuring at either of these muc loci could be distinguished on the
basis of their phenotypic characteristics, i.e. expression of
alginate synthesis on. MA. However, when simiiar crosses were
performed using the mucoid donor strains PA0568 (muc-2) and PA0581
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TABLE 7 Recombinant analysis following plate matings between the
mucoid donors PA0578 and PA0579 and the non-mucoid (muc+)
recipient strain PA01042.
% Coinheritance of unselected marker
Donor Selected
marker
muc pro+ $X1+ pur+
PA0578 (muc-22) proB65+ 1 4 <1
cys-59+ 34 33a 6b
pur-67+ 10 2 5
PA0579 (muc-23) proB65+ 8 4 <1
cys-59+ 38 35c 10d
pur-67+ 2 2 4
>
a 30% of these recombinants had coinherited muc-22
b 100% of these recombinants had coinherited1 muc-22
c 97% ofthese recombinants had coinherited muc-23
d 0% of these recombinants had coinherited muc-23
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(muc-25), recombinant analysis revealed that like muc-22, both muc-2
and muc-25 are located between pur-67 and cys-59, despite the fact
that PA0581 is a group 1 mucoid strain like PA0579. The lack of
association between medium-dependent alginate expression and
location of the muc mutation was further demonstrated when muc-45
and muc-52 (both giving rise to a group 1 phenotype), were mapped
between cys-59 and pur-67 by R68.45-mediated plate matings.
lc) The mapping of muc mutations by transduction
To my knowledge, no selectable markers have been mapped between
cys-59 and proB, so no further mapping of muc-23 has been possible,
and the location of this mutation with respect to the major FP2
origin is provisional. However, it was possible to proceed further
with the mapping of muc mutations located between pur-67 and cys-59,
as the two catabolic loci pru (proline utilization) and oru
(ornithine utilization) have recently been mapped in this region
(Soldati et al, 1982).
Although it is possible to transduce most mucoid strains using
F116L (PA0579 is an exception as it is apparently "resistant" to
F116L), it is very difficult to obtain high titres of transducing
phage propagated on mucoid strains by the plate harvest method,
presumably because the phage receptors on the bacterial surface are
masked by the exopolysaccharide when the strain is grown on solid
medium. Consequently, the mapping of muc-22 by transduction
required the isolation of a "suppressed" non-mucoid revertant of
PA0578, i.e. a non-mucoid derivative in which alginate synthesis is
switched off in some way by a second mutation unlinked to muc. Such
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"suppressed" revertants are still able to transfer muc in matings,
and are relatively common amongst non-mucoid revertants of PA0568,
PA0578 and PA0579, but not PA0581.
Twelve non-mucoid revertants of PA0578 were crossed with
PA01042, selecting for cys+, and 20 recombinants from each scored
for Muc+/~ following transfer of partially purified colonies to P1A.
PA0578rh was chosen as a typical "suppressed" revertant and used to
propagate a transducing preparation of phage FllbL. PA0954 (oru-
292) and PA0964 (pru-354) were transduced using this F116L
preparation and selection was made for 0ru+ and Pru+ transductants.
These transductants (200 in each case) were then scored for the
coinheritance of muc-22. In this way, pru-354 and muc-22 were shown
to be 20% cotransducible, whereas oru-292 and muc-22 were <0.5%
cotransducible. Similarly, muc-2 was shown to be 49% cotransducible
with pru-354, following the isolation of a "suppressed" non-mucoid
revertant of PA0568, PA0568K^. However, repeated attempts to
isolate such a revertant of PA0581 were unsuccessful so it has not
yet been possible to map muc-25 by transduction.
Further muc mutations (muc-37, muc-38, muc-39 and muc-40) were
shown to be cotransducible with pru-354 with frequencies ranging
from 32% to 46%. The strains carrying these mutations (PA06502,
PA06503, PA06504 and PA06505) were all mucoid derivatives of PA0964,
so it was possible to transduce these strains with F116L propagated
on PA01, selecting for pru+ and score for the coinheritance of muc"*".
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Id) Demonstration of close linkage between muc-2 and muc-37
The cotransduction frequencies between pru-354 and the muc
mutations muc-2 and muc-37 were 49% and 32% respectively, and
strains carrying these muc mutations could be distinguished pheno-
typically on the basis of alginate synthesis or lack of it on P
medium (see Table 6). To determine whether muc-2 and muc-37 could
be separated genetically, F116L propagated on PA0568ri was used to
transduce PAO6502 selecting for Pru+ transductants. Figure 9
indicates how non-mucoid transductants could arise if muc-2 and muc-
37 are genetically separable with muc-2 closer to pru-354 than muc-
22 (as suggested by the cotransduction frequencies).
donor chromosome segment
recipient chromosome segment
+ + + non-mucoid pru+ transductant
Fig. 9 The mechanism by which a muc"*" transductant could be
obtained from a muc x muc cross.
However, the examination of 200 Pru+ transductants revealed no
non-mucoid colonies suggesting that muc-2 and muc-37 are mutations
in the same locus or very closely linked loci.
+ muc-2 +
1 I I 1
muc-37 •+■ pru
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le) A-three-factor cross to determine the gene order for oru-292,
pru-354 and muc-37
The plasmid R68.45 was transferred into PA0954, and the
resulting strain used as donor in a plate mating with PA06502
selecting for Pru+. In order to determine the relative locations of
oru, pru and muc, 100 recombinants from this cross were partially
purified on P medium and then replica plated to 0 medium and PIA to
score for coinheritance of oru and muc"*".
Figure 10 shows the two possible gene arrangements for these 3
loci and Table 8 shows the results of recombinant analysis
indicating the minimum numbers of cross-overs required to obtain
each class of recombinant, based on the two gene arrangements.
a oru pru muc ^ oru muc pru
Fig. 10 The two possible gene arrangements for oru, pru and muc.
Based on the assumption that a class of recombinant requiring
four cross-overs would be extremely rare, and would certainly not be
expected to occur with a frequency of 5%, the results shown in Table
8 are consistent with the gene order shown in Figure 10a, i.e. oru -
pru - muc.
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TABLE 8 The results of recombinant analysis following a plate








pru-354 oru-292+ muc-37+ 40 2 2
oru-292+ muc-37- 1 2 2
oru-292" muc-37+ 54 2 2
oru-292~ muc-37~ 5 2 4
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Summary of results presented in Section 1
(i) There are at least 2 distinct loci on the PAO chromosome which
are associated with the control of alginate synthesis. One of these
loci lies between cys-59 and proB and only one mutation at this site
(muc-23) has been mapped so far. A second muc locus (or cluster of
closely linked loci is cotransducible with pru-354, distal to oru-
29 2. Six independent muc mutations appear to be alleles at this
locus, i.e. muc-2, muc-22, muc-37, muc-38, muc-39, and muc-40.
Three additional mutations, muc-25, muc-45 and muc-52 are likely to
be closely linked to this region on the basis of conjugational
linkage to the flanking markers cys-59 and pur-67.
(ii) Mucoid strains display considerable heterogeneity on the basis
of medium-dependent expression of alginate synthesis. However, the
genetic basis of this heterogeneity is not apparent.
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2a) The construction of the Rec~ derivatives, PA06519 and PA06520
for use in the isolation of R'muc and R'muc+ plasmids
The isolation and maintenance of R' plasmids derived from
R68.45 are dependent on the availability of recA P. aeruginosa
strains carrying the markers of interest (Holloway, 1978). As it
was not possible to select directly for R' plasmids carrying inuc+/~,
it was decided to select for R' pru"*~ plasmids and screen these for
the presence of muc+ or the relevent muc allele (depending on the
donor strain used). Hence it was necessary in the first instance to
construct two recA recipient strains, PA06519 (pru-354, muc-37, rec-
102) and PA06520 (pru-354, rec-102) by the series of steps to be
described.
(i) A Pro+ derivative of PA01042 was obtained following trans¬
duction with F116c propagated on PA01. This step was
necessary to remove the proB65 marker leaving a strain with
the genotype thr-9001, pur-67, cys-59 (PA06506).
(ii) It was necessary to construct donor derivatives of PA0964 and
PA06502 so that pru-354 and muc-37 could be transferred into
PA06506. Hence, Met- auxotrophs of these strains were
isolated to provide a contraselective marker which did not
interfere with Pru, and R68.45 was transferred into these
derivatives to give PA0964 Met-.R68.45 and PAO6502 Met-
.R68.45.
(iii) PA0964 Met-.R68.45 and PA06502 Met~.R68.45 were plate mated
with PA06506 selecting for the coinheritance of Pur+ and
Cys+, since pru-354 and muc-37 lie between pur-67 and cys-59.
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The recombinants thus obtained were checked for the
inheritance of muc-37 and/or pru-354. In addition it was
important to ensure that R68.45 was not present in the recom¬
binants. The resultant strains at the end of this step had
the genotypes pru-354 thr-9001 and pru-354, muc-37, thr-9001.
(iv) Fruh et al (1983) have shown that rec-102 (a recA-1ike
mutation) is 62% linked to thr-9001 in R68.45-mediated plate
matings. Hence, the rec-102 donor strain PT066 R68.45 was
crossed with the two strains constructed in step (iii),
selecting for Thr+ recombinants. Thirty such recombinants
from each cross were then tested for the coinheritance of
rec-102 on the basis of UV sensitivity and inability to form
transductants despite retaining sensitivity to phage F116L.
Once again, recombinants which had inherited R68.45 were not
considered. Thus, PA06519 (pru-354, muc-37, rec-102) and
PA06520 (pru-354, rec-102) were the resultant strains at the
end of this procedure.
2b) The isolation of R'pru+ plasmids
PA08 R68.45 was patch mated with PA06519 and plated on to P
medium. After 3 days incubation at 37°C, 41 Pru+ colonies had
grown up and these were purified by streaking for single colonies on
fresh P medium.
There are several possible mechanisms by which these colonies
could have arisen: (i) R'pru"1" plasmids arising at a low frequency
in the R68.45 donor could have transferred to PA06519 by
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conjugation, thus producing a merodiploid. Such strains would
express the antibiotic resistance pattern associated with R68.45
(CBr, Tcr, KMr) and be able to transfer pru+ at a high frequency to
both a kec+ or Rec- recipient. In addition, loss of plasmid markers
from a merodiploid strain would be associated with loss of the Pru+
characteristic, (ii) Rare chromosomal recombinants may have arisen
if the rec-102 mutation in PA06519 was.leaky. Colonies resulting
from this mechanism would not be able to transfer pru+ at a high
frequency and would not require the presence of the plasmid for
continued expression of Pru+. (iii) The colonies may be Pru+
-tWuj
revertants of PA06519, in which case^would not be expected to carry
the plasmid.
The 41 Pru+ isolates were screened for CBr by patching on to
DSTA + 500,ug ml-l carbenici 11 in so that any Pru+ revertants of
PA06519 could be discarded. However, all were found to be CBr. In
27 of the isolates, the Pru+ characteristic was unstable as sub¬
culture on P medium gave rise to large and small colonies. The
small colonies failed to grow on further subculture on fresh P
medium, although they retained CBr, suggesting that in these strains
pru~*~ was indeed carried on the plasmid, but was lost at a high
frequency, rather than the whole plasmid being lost. These
unstable isolates were discarded. The remaining 14 isolates grew
well on further subculture to P medium and were screened for KMr and
Tcr by patching on to DSTA + 500jug ml~l kanamycin and DSTA + lOOjug
ml_l tetracycline respectively, and scored for alginate production
on these complete media (this characteristic could not be scored on
P medium as PA06519 is non-mucoid on P medium). Nine of the 14 Pru+
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isolates were KMr,Tcr and remained mucoid, whereas the other five
were non-mucoid, Tcr but KMS. One of the mucoid isolates and one of
the non-mucoid isolates were tested for the ability to transfer pru+
at a high frequency to a RIFr derivative of PA06519 (PA06519 RIFr).
Both were able to transfer pru"*" at the same frequency as CBr in a
patch mating, so it was concluded that these strains contained
R'pru~*~ plasmids and were designated PA06519 pJF4 (the non-mucoid
isolate) and PA06519 pJFb (the mucoid isolate). Figure 11 shows
PA06519, PA06519 pJF4 and PA06519 pJF6 on PIA after 24h at 37°C.
2c) pJF4 carries muc+ in addition to pru+
The non-mucoid phenotype of PA06519 pJF4 suggested that either
(i) pJF4 carried muc+ in addition to pru+, and muc+ was dominant
over muc-37, or (ii) pJF4 had transferred from PA08 to a non-mucoid
revertant of PA06519 during the patch mating (so pJF4 carried pru"1"
only). To distinguish between these two possibilities, a broth
mating was performed between a 5h NB culture of PA06519 pJF4 and an
18h NB culture of PA06519 RIFr. After ll/2h at 37°C, viable counts
were determined of the CBr and Pru+ transconjugants (on DSTA + 500;ug
ml~l carbenicil 1 in, 250jug ml~l rifampicin and P medium + 25Qug ml-^
rifampicin respectively). In each case, the viable counts were 1 x
105 organisms ml_l, and 99% of the transconjugants were non-mucoid,
thus confirming that Pru+ and Muc+ were transferred together with
CBr. The viable count of the donor culture (estimated on P medium)
was 7.8 x 107 organisms ml 1, indicating the transfer frequency of
pJF4 to a Rec- recipient in a 1V2h broth mating was approximately
10~3 per donor. A similar transfer frequency was obtained whenthe
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a
Figure 11 The appearance of the mucoid Rec- recipient strain
PA06519 (a), and the same strain carrying R' plasmids
pJF4 (b) and pJF6 (c), following 24h incubation at 37°C
on PIA
same culture of PA06519 pJF4 was broth mated with the Rec+ mucoid
recipient PA06502 RIFr. In this mating, 95% of the CBr transcon-
jugants were non-mucoid (i.e. Muc+) and Pru+, with the remaining 4%
mucoid (Muc-) and Pru~, indicating that pJF4 is less stable in Rec+
background than a Rec~ background.
2d) The association of Muc+ and KMS in pJF4
Viable counts of the 5h NB culture of PA06519 pJF4 described in
the previous section were also estimated on DSTA, DSTA + 500ng ml~*l
kanamycin, DSTA + 500,ng ml-* carbenicil 1 in and DSTA + 100>ig ml"^
tetracycline, and compared with the viable count obtained on P
medium. These results are shown in Table 9 and clearly show that
PA06519 pJF4 is KMS but segregates mucoid and non-mucoid KMr
colonies at frequencies of approximately lO-^ and 10--' respectively.
The viable counts on DSTA, DSTA + carbenicillin, DSTA + tetracycline
and P medium were not significantly different indicating that pru+,
muc+, CBr and Tcr are stably maintained when PA06519 pJF4 is
cultured under the conditions described.
To determine the nature of the KMr revertants, 25 mucoid and 25
non-mucoid colonies were tested for the other pJF4 markers. All
colonies were CBr and Tcr, and all the non-mucoid colonies were
Pru+, but unable to transfer KMr to PA06519 RIFr (despite being able
to transfer all the pJF4 markers), suggesting that KMr in these
strains resulted from a chromosomal mutation. All the mucoid KMr
colonies were Pru- indicating that the chromosomal markers had Deen
lost from pJF4 (i.e. pJF4 had reverted to R68.45) in these strains.
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TABLE 9 The viable counts of a 5h NB culture of PA06519 pJF4
on different selective media
Viable Count (organisms ml~l)
Medium
Non-mucoid Mucoid
DSTA 1.5 X aoot-H <1.5 x 107
DSTA + carbenicillin 2.0 X 00o <2.0 x 107
DSTA + tetracycline 3.3 X 107 <3.3 x 106
DSTA + kanamycin 1.1 X 103 1.4 x 102
P 7.8 X 107 ND
ND = not determined
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Thus it appears that the acquisition of the chromosomal DNA segment
carrying muc+ and pru+ by R68.45, resulting in pJF4 (and the other
R'pru+muc+ plasmids) was associated with "switching off" KMr>
perhaps due to the insertion of the chromosomal DNA into the Km
gene. This mechanism of R' formation was apparently not operating
when the R'pru"1" plasmids, e.g. pJF6, were derived.
2e) Additional chromosomal markers associated with pJF4
Markers in the vicinity of muc and pru on the PAG chromosome
map include oru, cys and pur. To determine whether pJF4 carried the
wild type alleles of any of these markers, broth matings were set up
between PA06519 pJF4 and PA0961 RIFr (to test for oru+) and PA01042
RIFr (to test for cys+ and pur+). Selection was made for CBr
transconjugants and 50 such colonies from each mating were scored
for the coinheritance of the wild type allele of the relevant
chromosomal marker. A high percentage coinheritance would indicate
that pJF4 carried the wild type allele in question, and
consequently, pJF4 was shown to carry oru+, but not cys"1" or pur"1".
2f) The transfer of pJF4 to other mucoid PAO strains
To determine whether pJF4 could "switch off" alginate synthesis
in PAO strains with muc mutations other than muc-37, the R' plasmid
was transferred into PA0568, PA0578, PA0579, PA0581 and PA06513 in
broth matings followed by selection for CBr transconjugants on DSTA
+ 500^ig ml~l carbenicil 1 in , 250,ug ml~l streptomycin. On this
medium, the transconjugants could be scored directly for alginate
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production. To ensure that any effect on the expression of alginate
synthesis was due to the merodiploid state of the muc locus, control
crosses were set up between PA06519 pJF6 and the mucoid recipients.
All strains except PA0579 were rendered non-mucoid by pJF4, no
strains became non-mucoid with the acquisition of pJF6.
Thus it appears that the plasmid determined muc+ allele in pJF4
is dominant over muc-2, muc-22, muc-25, muc-45 and muc-37 (i.e. the
muc mutations which are closely linked to pru), when those muc
mutations are carried onthe chromosome. On the basis of the early
work on the control of colanic acid synthesis in E. coli by
Markovitz and colleagues (reviewed in Markovitz, 1977), this result
was consistent with the hypothesis that muc+ codes for a cytoplasmic
repressor which is involved in the regulation of the alginate bio-
synthetic pathway.
Alginate synthesis in PA0579 is not switched off by pJF4, as
this R' plasmid doesnot carry the muc-23+ allele, and a double dose
of the muc-37+ gene product cannot apparently override the effect of
the muc-23 mutation.
2g) Isolation of R' plasmids carrying muc-2, muc-22 and muc-45
^■n E« coli K12, a mutation at the capR locus leads to
derepression of colanic acid synthesis. One particular mutation at
this locus, capR6 is recessive to capR"*" in a merodiploid, regardless
of whether the mutant gene is chromosomal or F' determined
(Markovitz, 1977). However, a second mutation at the same locus,
capR.9, is dominant over the wild type allele when the former is F"
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associated, i.e F'capR9/capR+ merodiploid strains were mucoid,
whereas F'capK"*~/capR9 strain was non-mucoid.
To determine the allele dominance of muc-2, muc-22 and muc-45,
R68.45 was first transferred into strains carrying these mutations
(PA06527, PA06529 and PA06513 respectively). PA0568 and PA0578
could not be used as suitable backgrounds for muc-2 and muc-22 in
this experiment as they contained FP 2. R' pru+ plasmids were
obtained from patch matings between the rec-102 non-mucoid recipient
PA06520, and each of the mucoid donor strains, and when streaked on
to DSTA + 500pg ml-l carbenicil1 in and incubated for 24h at 37°C, a
proportion of the R'pru"*" plasmids from each of the matings was
mucoid,indicating that they carried the appropriate muc mutation
which was dominant over the chromosomal muc+. These R'plasmids were
designated pJF54 (R'muc-22), pJF55 (R'muc-2) and pJF36 (R'muc-45).
Figure 12 shows PA06520, PA06520 pJF54, PA06520 pJF55 and PA06520
pJF56 on PIA after 24h incubation at 37°C. R'muc-45/muc+ and R'muc-
22/muc+ are distinctly mucoid, whereas, the R'muc-2/muc+ strain is
only slightly mucoid. Each of these R' plasmids was KMr and Tcr.
2h) The transfer of pJF4 into mucoid P. aeruginosa isolates from
CF patients
In PAO, pJF4 "switches off" alginate synthesis in mucoid
strains with muc mutations linked to pru, suggesting that pJF4 could
be used as a probe to determine whether an unknown muc mutation,
e.g. in a clinical mucoid strain mapped in this region or elsewhere.
Consequently, RIFr mutants were isolated of the five clinical
P. aeruginosa strains 492a, 1949, 2246, 2249 and 2263. These
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Figure 12 The appearance of the non-mucoid Rec~ recipient strain
PA06520 (a) and the same strain carrying the R' plasmids
pJF54 (b), pJF55 (c) and pJF56 (d), following 24h
incubation at 37°C on PIA.
strains were mucoid isolates from different CF patients. pJF4 was
transferred into the RIFr derivatives in the usual way, selecting
for CBr transconjugants. In four of the five strains (492a RIFr was
the exception), the CBr transconjugants were non-mucoid, suggesting
that 1949, 2246, 2249 and 2263 have muc mutations which are linked
to pru. It is not known whether the muc mutation in 492a is like
muc-23, or is in a hitherto unmapped muc locus
Summary of the results presented in Section 2
(i) The construction of suitable Rec~ strains for the isolation
of R'muc and R'muc"1" plasmids is described.
(ii) Fourteen stable R'pru+ plasmids were isolated following a
patch mating between PA08.R68.45 and the Rec- mucoid (muc-37)
strain PA06519. Five of these also carried muc+. The
plasmids chosen as representatives of the R'pru+muc"1" and
R'pru"*" classes were pJF4 and pJF6 respectively.
(iii) pJF4 (and the other R'pru+muc+ plasmids) were KM®, unlike
R68.45 and pJF6. Reversion to KMr in pJF4 was associated
with loss of pru"*~ and muc+.
(iv) In addition to pru"1" and muc"*", pJF4 also carries the wild type
allele at the oru locus.
(v) In a merodiploid, the plasmid-determined muc"1" allele was
dominant over the chromosomal mutations muc-2, muc-22, muc-25
and muc-45 in addition to muc-37.
120
(vi) Merodiploid strains carrying a wild type chromosomal allele
and either muc-2, muc-22 or muc-45 as the plasmid-associated
marker were slightly mucoid.
(vii) pJF4 "switched off" alginate synthesis in 4/5 clinical mucoid
strains isolated from CF patients.
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CHAPTER IX
GENETIC STUDIES ON ANTIBIOTIC HYPERSENSITIVITY IN P. AERUGINOSA
Bacterial strains. The bacterial strains used in this study
are listed in Table 10. Donor strains carrying the plasmid R68.45
were constructed as described in Chapter VI, Materials and Methods.
1. Antibiotic Sensitivity of P. aeruginosa Strains 492a and 492c
It has previously been reported that 492c is more sensitive
than 492a to the antibiotics carbenici11 in, azlocillin,
piperacillin, ticarcillin, methicillin, tetracyline and trimethoprim
(Irvin et al, 1981).
Table 11 shows the MIC's of an extended range of antibiotics
for 492a and 492c. To summarize these results, 492c is
hypersensitive (>10 times more sensitive than 492a) to the ^B-lactam
antibiotics carbenicillin, methicillin, flucloxacil 1 in, mecillinam
and cefuroxime, and the quinolone, naladixic acid. Increased
sensitivity (4 to 8 times more sensitive than 492a) to trimethoprim,
chloramphenicol and novobiocin was also noted for 492c. No
difference in sensitivity between the two strains was observed for
benzyl penicillin, ampicillin, cefoxitim, cephaloridime, rifampicin,
streptomycin, gentamicin, tobramycin or kanamycin.
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TABLE 10 Strains of P. aeruginosa used in the study of antibiotic
hypersensitivity
Strain Genotype/Description* Reference/Origin
PA01 Prototrophic, chl-2 Holloway, 1969
PA02 ser-3 Isaac & Holloway,
1968
PA04 arg-47, pyrB52 Holloway collection
PA08 met-28, ilv-202. str-1 Isaac & Holloway,
1968
PA038 leu-38 Stanisich & Holloway,
1969




PA0505 raet-9001, amiE200 Rella & Haas, 1982
PA0969 proC130 Rella & Haas, 1982
PA06002 met-9001. amiE200. nalB4 Rella & Haas, 1982
PA06006 proC130, nalB9 Rella & Haas, 1982
PA06511 proC130, blsA2 Carbenicillin hyper¬
sensitive mutant of
PA0969




PA06526 blsA2 Pro+ transductant of
PA06511 obtained
using F116c
GMA037 hisV5037 Mee & Lee, 1967
492a Clinicai isolate, mucoid,
prototrophic, tspAl
Irvin et al, 1981





492c Clinical isolate, mucoid,
prototrophic, blsAl, tpsAl




519c Clinical isolate, mucoid,
prototrophic, antiobic
hypersensitive




2358 Clinical isolate, non-mucoid,
prototrophic, antibiotic
hypersensitive















































met-28, trp-6, lys-12, his-4
ilv-226, blsB3
trp-6, lys-12, his-4, ilv-226,
pro-82, blsC4
lys-12, his-4, ilv-226, pro-82,
blsC4







from cross 61 Leu-
R68.45 x PA0222
CEFsMet+ recombinant









* The genotype symbols are the same as those defined in Fig. 2 bis
designates sensitivity to ,B-lactam antibiotics, tps, sensitivity
to trimethoprim, naladixic acid and novobiocin. CEFS is defined
as sensitive to 100/Ug cefuroxime ml"~l, TPS is defined as
sensitive to lOOjug trimethoprim ml~l, R1FS is defined as
sensitive to 50^ig rifampicin ml~l
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2. The Mapping of Loci Associated with Antibiotic Hypersensitivity
in 492c
Figure 13 indicates the locations of genetic markers relevant
to this chapter on the PAO chromosome map.
2a) The transfer of two genetic determinants associated with anti¬
biotic hypersensitivity from 492c to PAO
A donor derivative of 492c was prepared by first isolating an
auxotrophic mutant (Leu~)> to provide a means of contraselection,
and then transferring R68.45 into this mutant, thus giving 492c Leu"
R68.45.
Plate matings were performed between 492c Leu" R68.45 and
PA0222 (a recipient strain with multiple auxotrophic markers). One
hundred recombinants for each marker were scored for coinheritance
of sensitivity to cefuroxime (CEFS) by spotting the purified recom¬
binants onto DSTA + lOQug cefuroxime ml~l (the MIC of cefuroxime for
PA0222 was 200;ug ml-*). Increased sensitivity to cefuroxime rather
than carbenicil1 in was scored initially to avoid any problems
associated with the inheritance of R68.45 by some of the
recombinants (R68.45 codes for the TEM-2 ^-lactamase which is active
against carbenicil1in, but not cefuroxime). Recombinant analysis
revealed that 36% of the met-28"t" recombinants were CEFS, as were 20%
of the trp-6+ recombinants. Less than 1% of the recombinants for







































Figure 13 The P. aeruginosa PAO chromosome map showing the
locations of markers relevant to this chapter. Marker
designations are the same as for Fig.2.
On the basis of this result, a plate mating was performed
between 492c Leu" R68.45 and PA08 (met-28, i 1 v-202) in order to
precisely map the locus associated with CEFS. Following selection
for Doth auxotrophic markers, recombinant analysis was performed as
before, except that recombinants were also scored for sensitivity to
trimethoprim (TPS) on DSTA + 100;ug trimethoprim ml-* (the MIC of
trimethoprim for PA08 is 200jug ml~l). The results of this
recombinant analysis are presented in Table 12, and clearly show
that CEFS and TPS do not always co-segregate. All CEFS recombinants
were TPS, however 7% of the TPS colonies were resistant to lOCUig
cefuroxime ml-* (CEFr).
Further characterization of the 3 classes of recombinants thus
identified, i.e. CEFSTPS, CEFrTPs and CEFrTPr, was performed by
determining the MIC's of all the antibiotics to which 492c had been
shown to be more sensitive in this study (carbenici11 in,
raethicil1 in, f1uc1oxaci11 in, cefuroxime, mecillinam, chloram¬
phenicol, trimethoprim, naladixic acid and novobiocin). On this
basis, the CEFrTPr recombinants (3 tested) were indistinguishable
from PA08. The CEFSTPS recombinants (8 tested) could be divided
into 2 further groups on the basis of the MIC's of trimethoprim,
naladixic acid and novobiocin. Three such recombinants were hyper¬
sensitive to these antibiotics with relative MIC's (i.e.
MIC for recombinant ofl/20. 1/16 and 1/50 respectivelv. The other 5
MIC tor PA08
CEFSTPS recombinants were moderately sensitive with relative MIC's
of 3/10 for trimethoprim, 1/4 for naladixic acid, and hypersensitive
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TABLE 12 Results of recombinant analysis following plate matings
between 492c Leu" R68.45 and PA08
Percentage coinheritance of unselected character
Selected Marker CEFS TPS Met+ Ilv+
met-28+ 80 82 - 77
ilv-202+ 75 88 87
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to novobiocin (relative MIC = 1/10). All 8 recombinants were
equally sensitive to the ^B-lactam antibiotics, and chloramphenicol,
and with the exception of cefuroxime (relative MIC = 1/4), were as
sensitive as 492c.
The third class of recombinant, CEFrTPs (5 tested) was
moderately sensitive to trimethoprim and naladixic acid with
relative MIC's of 3/10 and 1/4 respectively, and hypersensitive to
novobiocin (relative MIC = 1/50).
From these results, it was concluded that the antibiotic hyper¬
sensitivity of 492c is associated with two separate genetic
determinants, both linked to met-28 and ilv-202, and transferable to
PAO. The first of these determinants (blsAl) encodes for hyper¬
sensitivity to carbenici11in, methicillin, f1uc1oxaci11 in,
mecillinam and novobiocin, and increased sensitivity to chloram¬
phenicol, trimethoprim and naladixic acid. The second determinant
(tpsAl) also encodes for hypersensitivity to novobiocin and
increased sensitivity to trimethoprim and naladixic acid, but has no
effect on sensitivity to ^-lactams or chloramphenicol. Table 13
presents the MIC's of the relevent antibiotics for PA08 and three
typical prototrophic recombinant strains PAJ1 (blsAl, tpsAl), PAJ2
(blsAl) and PAJ3 (tpsAl), obtained from the mating between 492c Leu"
R68.45 and PA08. Figure 14 indicates the approximate locations of
blsA and tpsA relative to met-28 and ilv-202, based on the results
of that plate mating (shown in Table 12).
130
TABLE 13 Antibiotic sensitivities of PA08 and recombinant strains
PAJ1, PAJ2 and PAJ3, obtained foilowing a plate mating
between 492c Leu" R68.45 and PA08
MIC Cug ml"1)






Carbenicillin 40 0.4 0.4 40
Methicillin 500 10 10 500
Flucloxacillin >500 50 50 >500
Mecillinam 500 10 10 500
Cefuroxime 400 100 100 100
Chloramphenicol 40 20 20 40
Trimethoprim 200 10 60 60
Naiadixic acid 80 5 20 20
Novobiocin 500 10 50 10
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30'
tpsA ilv-202 met-28 blsA
Fig. 14 Approximate locations of b 1 sA and tpsA on the basis of
results presented in Table 11.
2t>) Evidence for tpsAl in 492a
A comparison between the results presented in Tables 10 and 12
indicates that PA08 and 492a are similar with respect to antibiotic
MIC's, with the exception of trimethoprim. 492a is inhibited by
40pg trimethoprim ml-l, whereas the MIC for PA08 is 200jug ml-l (a 5-
fold difference). In addition, the increased sensitivity to
trimethoprim of 492c compared with 492a (relative MIC = 1/8) is of
the same order as the difference in MIC between PAJ1 and PAJ3
(relative MIC = 1/6). 492a is also more sensitive to naladixic acid
than PA08. Despite the fact that 492c is resistant to novobiocin,
it was proposed that the tpsAl allele might be present in both 492a
and 492c, and that the antibiotic hypersensitivity associated with
the latter strain can be explained on the basis of a single mutation
at the blsA locus (i.e. blsAl).
To test this hypothesis, a donor derivative of 492a (492a Leu-
R68.45) was constructed as described for 492c. 492a Leu- R68.45 was
subsequently plate mated with PA08, selecting for Met+ and Ilv+
recombinants. The results of recombinant analysis (performed as
described for the mating 492c Leu- R68.45 x PA08) were consistent
with the hypothesis, i.e. 492a Leu- R68.45 transferred TPS to PA08,
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but not CEFS, and the gene associated with TPS mapped in the same
region as tpsAl.
2c) The association between tpsAl, serum sensitivity and PA
Both 492a and 492c are serum sensitive and PA, so it was
thought that the presence of tpsAl in these strains might be
associated with one or both of these characteristics. To test this
possibility, the recombinant strains PAJ1, PAJ2 and PAJ3, along with
PA08 as control, were tested for serum sensitivity and agglutin-
ability with multiple typing sera. However, all four strains were
serum resistant and retained the type II serotype characteristic of
PAO indicating that at least when transferred into PA08, tpsAl was
not associated with these characteristics.
2d) Mapping of blsA and tpsA by transduction
From the recombinant analysis following plate matings, it was
possible to assign the chromosomal locations illustrated in Figure
14 for blsA and tpsA. However, to map these loci with respect to
other markers in the 30 min region, transductiona1 analysis was
performed.
In the case of blsAl, a preparation of phage F116L was grown on
PAJ2, and used to transduce recipient strains carrying the
auxotrophic markers met-28 (PA08), ilv-202 (PA08), proC130 (PA0969)
and pyrB52 (PA04). Selection was made for these markers and
cotransduction of blsAl scored on DSTA + 3^ig carbenicillin ml~l.
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However, in the case of tpsAl, transducing preparations of
F116L could not be propagated on PAJ3 or any other recombinants
containing this marker, as they did not appear to support vegetative
growth of F116L. Evidence that tpsAl strains retained the receptors
for the phage was provided by the observation that such strains were
good recipients in F116L-mediated transductions. Consequently, the
transductional mapping of tpsAl was performed following the con¬
struction of an ilv-2U2 tpsAl derivative, PAJ6, via the intermediate
strain PAJ5 (see Table 9 for genotype). PAJ6 was used as recipient
in transductions mediated by F116L propagated on either PA01
(prototrophic), PA02 (ser-3) or GMA 037 (his V5037). In each case,
selection was made for Ilv+ transductants and these were scored for
the coinheritance of tpsAl (on DSTA + 100;ug trimethoprim ml-*), and
where appropriate, the unselected auxotrophic marker. Figure 15
shows the locations thus obtained for blsA and tpsA.
ser-3 tpsA hisV ilv-202 met-28 proC pyrB blsA
i i i i i i i i
30 24
57 15
Fig. 15 Map locations obtained for b 1 sA and tpsA following
transductional analysis. Values above arrows indicate
percentage cotransduction using phage F116L. Arrowheads
point to the unselected marker.
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3. The Mapping of Loci Associated with Antibiotic Hypersensitivity
in Clinical P. aeruginosa Isolates 519c and 2358
P. aeruginosa strains 519c and 2358 were isolated from
different CF patients. They express similar antibiograms to 492c,
but are different pyocin types from 492c and from each other. 519c
is mucoid and 2358 is non-mucoid.
To determine whether the genetic basis of antibiotic
hypersensitivity was similar in these strains to that demonstrated
in 492c, donor derivatives were constructed (519c Leu- R68.45 and
2358 Leu- R68.45) as described for 492c, and these strains were
plate mated with PA08, selecting for Met"1" and Ilv+ recombinants.
Analysis of 100 of each recombinant class was performed by scoring
for the coinheritance of CEFS and TPS (as with 492c). These results
are shown in Table 14, and clearly indicate that the donor
derivatives of 519c and 2358 can transfer CEFS and TPS to PA08, and
that the loci associated with these characteristics are closely
linked to met-28 and ilv-202 and do not always cosegregate, i.e. the
results were very similar to those obtained for 492c.
4a) Isolation of a blsA Mutant of PA0969
If 492c arose from 492a by a single mutation at the blsA locus,
it was proposed that a similar blsA mutant could be isolated from a
PAO strain.
The strain chosen for the isolation of this mutant was PA0969
(proC130) and so following mutagenesis with EMS, approximately 5000
potential mutant colonies were screened on DSTA + 5,ug carbenicillin
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TABLE 14 Results of recombinant analysis following plate matings
between the donor derivatives 519c Leu- K.68.45, 2358 Leu-
R68.45 and recipient PA08
Percentage coinheritance of
unselected character
Donor Selected marker CEFS Tps
519c Leu" R68.45 met-28+ 79 98
ilv-202+ 62 87
2358 Leu- R68.45 met-28+ 84 90
ilv-202+ 74 77
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ml_l. Only one such colony was sensitive to this concentration of
carbenicil1in, and fortuitously, the mutation responsible for this
increased sensitivity was 33% cotransducible with proC, and 44%
cotransducible with py rB using F116L. This mutant strain was
designated PA06511 (bls-2) and was found to be more sensitive than
PA0969 to cefuroxime, trimethoprim, naladixic acid, novobiocin and
chloramphenicol.
A comparison of the percentage cotransduction between blsAl and
proC (24%), and bls-2 and proC (33%), suggested that bls-2 was
closer to proC than b1sAl. However, when F116L.PAJ2 was used to
transduce PA06511 selecting for proC*"» <0.3% of these transductants
were able to grow in the presence of 5,ug carbenicil 1 in ml-,
indicating that b1sA1 and bls-2 are very closely linked.
Consequently bls-2 was renamed b1sA2.
4b) The relationship between blsA and nalB
Rella & Haas (1982) have described a class of mutants (nalB) in
P. aeruginosa PAO which show increased resistance to naladixic acid,
novobiocin, carbenicil 1 in and several additional Ji-lactams, e.g.
piperacillin, azlocillin, ticarcillin and cefsulodin.
The existence of such mutants suggested that the antibiotics to
which nalB mutants are more resistant may be the same ones to which
b1sA mutants are more sensitive. To test this, the MIC's of
cefuroxime, trimethoprim, methicillin, chloramphenicol, ampicillin
and benzyl penicillin were determined for two nalB mutants PA06002
(nalB4) and PA06006 (nalB9) and their respective parent strains
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PA0565 and PA0969. As expected the nal B strains showed increased
resistance to the first four antibiotics, with the following
relative MIC's (with respect to the parent strains): cefuroxime, 3;
trimethoprim, 6; methicillin, 5; chloramphenicol, 10. No
increased resistance to ampicillin or benzyl penicillin was observed
for the nalB strains.
The nalB locus has been mapped at 32 min on the PAO chromosome,
and is 32% cotransducible with pyrB, using phage G101 (Rella & Haas,
1982). To determine the location of b1sA with respect to nalB,
reciprocal transductions were performed using F116L propagated on
proC+ strains carrying mutations at these loci, i.e. PA06002 (nalB4)
and PA06526 (b1sA2), and the equivalent proC recipients, i.e.
PA06511 (b1sA2) and PA06524 (na1B). The results of these
transductions are presented in Table 15, and indicate that blsA and
na 1B are separate, but closely linked loci, with nalB mapping
between proC and blsA.
5. The Mapping of Loci Associated with Antibiotic Hypersensitivity
in 799/61
5a) The transfer of two determinants associated with CKFS into PAO
The mutant strain 799/61 is highly sensitive to a large number
of different antibiotics (Zimmerman, 1979), including those to which
492c is hypersensitive, and in addition ampicillin, cefoxitin,
benzyl penicillin, cephaloridine and rifampicin (to which 492c is
not unduly susceptible).
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TABLE 15 Results of F116L-mediated transductions to determine the
relationship between nalB and blsA
Percentage cotransdcution
with proC"*"*
F116L grown on Recipient (proC) blsA2 nalB4 wild type
PA01 (wild type) PA06511 (blsA2) - - 33
II PA06524 (nalB) - - 43
PA06002 (nalB) PA06511 (blsA2) - 27 <0.5
PA06526 (blsA2) PA06524 (nalB) 19 - 3
* 200 proC"1" transductants were scored for the coinheritance of
nalB4+/~ and blsA2+/~ where appropriate, on DSTA + 50;ug and 5;ug
carbenicillin ml-^, respectively
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In order to compare the genetic basis of antibiotic
hypersensitivity in 799/61 with that demonstrated in 492c, 519c,
2358 and PA06511, a donor derivative of 799/61 (61 Leu- R68.45) was
constructed. This was performed in the same way as for the clinical
isolates, however, selection for transfer of R68.45 into 61 Leu-,
following a broth mating, was made on MA + leucine + 50/ig
carbenicil1 in ml-*, as no transconjugants were obtained when
selection was made on the same medium supplemented with 500,ug
carbenici 11 in ml-l (the concentration used to select for R68.45
transconjugants of 492c Leu-, 519c Leu- and 2358 Leu-).
Plate matings were performed between 61 Leu- R68.45 and PA0222,
selecting for all the recipient auxotrophic markers. As only small
numbers of recombinants were obtained (6 to 36 per marker), all were
scored for the coinheritance of CEFS. None of the recombinants
selected for the inheritance of ilv-226+, his-4+ or lys-12+ had
coinherited CEFS, whereas 2/13 met-28+, 1/32 trp-6+ and 17/36 pro-
8 2+ recombinants had coinherited this characteristic. A
representative of the pro+ CEFS recombinants was designated PAZ1,
a met"** CEFS representative was designated PAZ2, and the trp+ CEFS
strain, PAZ3 (this strain was also met"1").
Similar matings performed between a donor derivative of 799 and
PA0222 did not produce any CEFS recombinants.
When R68.45 was transferred into PAZ3 and the resultant donor
crossed with PA08, 93% of the met-28+ recombinants and 82% of the
ilv-202"1" recombinants had coinherited CEFS» suggesting a location
for this determinant close to blsA.
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An initial screening of the antibiotic sensitivities of PAZ1,
PAZ2 and PAZ3 suggested that while PAZ2 and PAZ3 had probably
inherited the same determinant which rendered the strains
hypersensitive to carbenici 11 in and more sensitive to cefuroxime,
methicillin, mecillinam and novobiocin, PAZ1 had either inherited an
additional antibiotic hypersensitive determinant or a completely
Orv
different one. This conclusion was basedAthe finding that PAZ1 was
hypersensitive to naladixic acid, cefoxitin and rifampicin, in
addition to carbenicil1 in, and was more sensitive than PAZ2 and PAZ3
to cefuroxime, methicillin, mecillinam and novobiocin.
5b) Mapping bls-3 and bls-4 by F116L-mediated transduction
It was possible to confirm that PAZ1 and PAZ3 carried different
determinants associated with antibiotic hypersensitivity (initially
designated bls-3 and bls-4) using transductional analysis.
Transducing preparations of F116L were propagated on PAZ1 and PAZ3.
F116L.PAZ1 was used to transduce PA0222 (selecting for pro-82+) and
PA038 (selecting for leu-38+). F116L.PAZ3 was used to transduce
PA0969 (selecting for proC*) and PA08 (selecting for met-28+). One
hundred transductants for each selected marker were scored for the
coinheritance of the appropriate bis determinant on DSTA + 5jug
carbenici11 in ml~l. Results indicated that bls-3 is 40%
cotransducible with pro-82 (at 40 min) and <1% cotransducible with
leu-38. Thus, bls-3 was renamed blsB3 as it is obviously a
different locus from b1sA. In contrast, bls-4 was 19%
cotransducible with proC and 9% cotransducible with met-28
indicating a location very close to blsA. however, blsA and bls-4
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were shown to be distinct loci by transducing PA06511 (proC130,
blsA2) with F116L.PAZ3. Selection was made for proC+ transductants,
and 100 such transductants scored on DSTA + 5;ug carbenicil 1 in ml-*.
Consequently 4% of the transductants were able to grow on this
medium and shown to be wild type with respect to carbenicil 1 in
sensitivity. Thus, bls-4 was designated blsC4.
These results are consistent with the gene arrangement
illustrated in Figure 16.
ilv-202 met-28 proC pyrB nalB blsA blsC
Fig. 16 Location of blsC relative to blsA and other markers in the
30 min region.
Evidence that the antibiotic hypersensitivity associated with
PAZ1 was due to blsB3 and not a combination of b 1 sB3 and b 1 sC4 was
obtained by screening the antibiotic sensitivities of a number of
pro+blsB3 transductants of PA0222. These were found to be the same
as for PAZ1.
A derivative of PAZ3 carrying blsB3 in addition to blsC4 (PAZ4)
was constructed using F116c propagated on PAZ1 to transduce PAZ3
selecting for pro-82"1". One hundred of these transductants were
scored for coinheritance of blsB3 on DSTA + 50;jg rifampicin ml~^»
PAZ4 was a representative of the rifampicin sensitive transductants.
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5c) Antibiotic sensitivity associated with blsB3 and blsC4
Table 16 shows the MIC's of 14 antibiotics (to which 799/61 is
hypersensitive) for PA0222, PAZ1, PAZ3 and PAZ4. With the exception
of cephaloridine, PAZ4 (blsB3, blsC4) is extremely sensitive to all
of these antibiotics.
The two genetic determinants blsB3 and blsC4 may or may not be
responsible for the total antibiotic hypersensitivity of 799/61,
however, when transferred into PA0222, the combination of these two
mutations significantly lowers the MIC's of at least 13 antibiotics
for this strain.
Summary of results presented in this chapter
1. A comparison of the antibiotic MIC's for the related clinical
P. aeruginosa isolates 492a and 492c revealed that 492c is
hypersensitive (>10 times more sensitive than 492a) to the
antibiotics carbenici11in, methicillin, f1uc1oxaci11 in,
mecillinam, cefuroxime, and naladixic acid, and considerably
more sensitive (4-8 times more sensitive than 492a) to
trimethoprim, chloramphenicol and novobiocin. The MIC's of
benzyl penicillin, ampicillin, cefoxitin, cephaloridine,
rifarapicin, streptomycin, gentamicin, tobramycin and kanamycin
were identical for the two strains.
2. Two genetic determinants associated with the antibiotic hyper¬
sensitivity of 492c, were identified and mapped in the 30 min
region of the chromosome, following plate matings between a
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TABLE 16 Antibiotic sensitivities of PA0222, PAZ1, PAZ3 and PAZ4
MIC (<ug ml 1)






Carbenicillin 20 0.4 0.6 40.2
Cefuroxime 200 10 40 5
Cefoxitin 400 20 400 <10
Cephaloridine >600 600 >600 600
Methicillin 400 10 50 41
Mecillinam 600 50 100 10
Flucloxacillin >600 100 >600 50
Ampicillin 100 50 100 5
Benzyl Penicillin 600 200 400 50
Trimethoprim >400 60 >400 20
Naiadixic acid 400 40 400 20
Novobiocin 400 50 100 <10
Rifampicin 20 41 20 41
Chloramphenicol >100 20 >100 20
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donor derivative of 492c (492c Leu" R68.45) and PA08. These
determinants were designated blsAl and tpsAl.
3. The tpsAl determinant (associated with increased sensitivity to
trimethoprim, naladixic acid and novobiocin) was also
identified in 492a.
4. tpsAl did not appear to be associated with serum sensitivity
and PA which are characteristic of both 492a and 492c.
5. Transductional mapping using F116L located tpsA between the
markers ser-3 and hisV, and blsA distal to pyrB, in the 30 min
region of the chromosome.
6. The genetic basis of antibiotic hypersensitivity in the
unrelated clinical isolates 519c and 2358 appeared to be very
similar to that demonstrated for 492c.
7. A blsA mutant of PA0969 was isolated following EMS mutagenesis.
8. Transductional analysis revealed that blsA and nalB are closely
linked, but separate loci.
9. A donor derivative of the Zimmerman hypersensitive mutant
799/61 was constructed, and used to transfer two determinants
associated antibiotic hypersensitivity into PA0222.
10. One of these determinants, blsB3 was cotransducible with pro-82
and was associated with hypersensitivity to JB-lactams,
trimethoprim, naladixic acid, novobiocin, rifampicin and
chloramphenicol.
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The second determinant blsC4 was closely linked, but distinct







It was stated in Chapter 1 to this thesis that P. aeruginosa is
a catabolical 1 y versatile organism, capable of thriving in a wide
variety of ecological niches, and can be considered a saprophyte,
commensal, plant and animal pathogen.-
What is it about this species that renders it so versatile? It
is likely that genetic make-up is ultimately responsible.
The ability of P. aeruginosa to colonize, and express
pathogenicity in one particular environment, i.e. the respiratory
tract of the CF patient, is providing a challenging topic of
research for workers of various backgrounds, ranging from clinicians
and physiologists, to bacteriologists, geneticists and biochemists.
Clinicians are approaching the subject from the point of view of the
patient, by considering the pathological role of P. aeruginosa in
the lung, and attempting to develop an effective therapeutic regime.
Determination of the host and bacterial factors responsible for the
early colonization of the respiratory tract by P. aeruginosa, in
this particular patient group, is of interest to both clin^jcians and
scientists alike, and has obvious implications for the prevention of
subsequent pulmonary infection. However, from the point of view of
microbial genetics, the growth and adaptation of P. aeruginosa in
the potentially hostile environment of the CF respiratory tract, and
the emergence of certain unusual characteristics which may or may
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not contribute directly to pathogenesis, continues to provide an
intriguing topic of study.
The main aim of this thesis was to apply classical genetic
techniques to the analysis of the mechanisms associated
with the emergence of two of these characteristics, i.e. alginate
synthesis and antibiotic hypersensitivity, which are common in
P. aeruginosa isolates from the sputa of CF patients suffering from
chronic, debilitating pulmonary infection.
It could be argued that the bacteria isolated from sputum do
not provide a good sample of the population present at the site of
infection. however, Thomassen e t a 1 (1 984) have recently
demonstrated that the bacterial populations isolated from sputum and
thoracotomy specimens from CF patients are indeed comparable.
Before considering the possible clinical implications of the
results presented in this thesis, and because of the three different
areas of research represented, I shall discuss these three
independently with particular reference to current knowledge in the
fields of (i) P. aeruginosa typing, (ii) alginate synthesis in
mucoid P. aeruginosa, and (iii) intrinsic antibiotic resistance.
The application of pyocin typing to P. aeruginosa epidemiology
Revision of the Govan & Gillies pyocin typing method was under¬
taken to improve the application of this useful epidemiological tool
for studies involving mucoid strains and multiple isolates from
single specimens.
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The spotting method has succeeded in shortening the time
necessary to obtain a typing result from 48h to 24h, which although
not comparable with the speed of serotyping, is nevertheless a
significant improvement.
Application of the producer strains by means of a multiple
inoculator, and elimination of the necessity to scrape off producer
strain growth prior to adding the indicators, has meant a
significant reduction in work load required for pyocin typing,
particularly when large numbers of strains are involved.
The epidemiological value of distinguishing between S-pyocin
production and R- or F-pyocin production was emphasized in this
study, not only by the increased discrimination provided, but also
by the high frequency of strains (74%) producing S-pyocins.
These improvements in technique and discriminatory power over
the original cross-streaking method have resulted in greater
potential of pyocin typing for most epidemiological purposes. One
exception could be if only two or three strains are to be typed
where the use of 13 plates might seem excessive.
It is interesting to note that the spotting method described
here has recently been adapted successfully for the development of a
bacteriocin typing scheme for P. cepacia (G. Harris & J.R.W. Govan,
personal communication).
The method for pyocin detection described by Kageyama (1975),
in which the spotting method was partially based, used a 'stab'
Inoculation technique for the application of producer strains. In
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addition, pyocin production was induced by exposing the plates to UV
following several hours incubation. In this study, the use of these
procedures provided no advantages in terms of pyocin detection for
typing purposes. Other differences between Kageyama's method and
the method described in this thesis include the use of NA (by
Kageyama) instead of TSA. No significant differences were noted
between these two media, however, TSA was the medium of choice as it
has been used successfully for pyocin typing using the cross-
streaking method (Govan, 1978).
in this study, changing the incubation temperature was found to
yield variable results, as different pyocins apparently have
different optimum temperatures for production. This effect was not
investigated systematically, however, the fact that certain S-
pyocins were detected following incubation of the producer strains
at 30°C, but not at 37°C, suggested that 30°c was a more suitable
incubation temperature for typing purposes, thus confirming the
findings of Gillies & Govan (1966).
It is interesting to speculate as to why the spotting method is
more effective than the cross-streaking method for the pyocin typing
of mucoid P. aeruginosa strains. Williams & Govan (1973) believed
that the reason for non-typability of certain mucoid strains was
that the alginate inhibited the diffusion of pyocins into the
medium.
However, in this study, incubation of 30 mucoid P. aeruginosa
isolates for 6h (i.e. under the conditions of the spotting method)
resulted in detectable pyocin diffusion into the TSA medium. In the
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case of some mucoid strains, no alginate could be detected
(visually) following this short incubation, and indeed, mucoid
strains have been shown to vary with respect to the stage of the
growth cycle at which alginate is synthesized, i.e. in some strains
alginate is synthesized constitutively (Mian et al, 1978), whereas
in others it is a secondary metabolite with maximum rate of
synthesis in the stationary phase (N. Piggott, PhD Thesis, Edinburgh
University, 1979).
It is possible that the copious mucoid growth following the
overnight incubation associated with the cross-streaking method,
resulted in binding of certain pyocins which would then be removed
along with the growth.
As expected, no problems were encountered in the pyocin typing
of PA strains, as pyocin production does not appear to be influenced
by surface changes of the cell.
Finally, the results obtained in this thesis from the typing of
multiple P. aeruginosa isolates fromsingle and consecutive sputum
specimens from five CF patients confirmed that in general, each
patient was colonized (infected) with one particular strain on the
basis of pyocin type, but that different isolates of that strain
exhibited heterogeneous phenotypes with respect to alginate
synthesis, antibiotic susceptibility etc. However, one of the six
patients was found to harbour two different P. aeruginosa strains,
and this may be relatively common, though the clinical significance
of multiple colonization is unclear.
152
Alginate synthesis in mucoid P. aeruginosa
Early genetic studies in our own laboratory (Govan & Fyfe,
1978; Fyfe & Govan, 1980) had suggested that all strains of
P. aeruginosa carry the genetic information necessary for the
synthesis of alginate but that this information is normally
repressed by some unknown mechanism. In addition, evidence for the
chromosomal location of at least one gene associated with the
repression of alginate synthesis in strain PAO had been obtained.
The research presented in Chapter VIII of this thesis was
designed to obtain further information concerning the breakdown of
the normal repression of alginate synthesis in both strain PAO and
mucoid P. aeruginosa isolated from clinical specimens.
Firstly, a phenotypic screening of a large number of
independent mucoid isolates, was performed with the view of
identifying potentially different genotypes resulting in the
derepression of alginate synthesis. Indeed, various different
mucoid phenotypes within strain PAO were distinguished on the basis
of their "medium-dependent" expression of alginate synthesis, and it
was expected that variants expressing different mucoid phenotypes
would result from mutations at different loci, as was the case with
colanic acid synthesis in E. coli (Markovitz, 1977). Similar
phenotypic differences among clinically isolated mucoid
P. aeruginosa strains have been reported by Pugashetti et al (1982).
In addition, these workers noted variation between strains with
respect to alginate structure (e.g. ratios of D-mannuronosyl to L-
guluronosyl moieties, and acetyl content of the polymers), and
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stability of the mucoid phenotype on in vitro culture. However,
there was no obvious correlation between these features.
Similarly, Piggott (PhD Thesis, Edinburgh University, 1979) examined
the composition of polymers obtained from various mucoid PAO
derivatives (including PA0568 and PA0579), and noted that the
mutants varied considerably, despite having been derived from the
same parent strain.
However, phenotypic characterization provided little
information regarding the number of genes associated with the
repression of alginate synthesis. When ten independently isolated
muc mutations in PAO were mapped by means of FP2-mediated
conjugation and/or F116L-mediated transduction, nine were found to
be closely linked to each other, near the catabolic marker pru, and
the tenth, muc-23 (which gave rise to medium-dependent expression of
alginate synthesis similar to several of the other nine mutations),
mapped at a different site.
Thus, it appears that the genetic basis of the variability of
expression of alginate synthesis, at least in strain PAO is not
readily explained on the basis of numerous loci associated with the
repression of this characteristic. If indeed more than two loci are
involved, they must be very closely linked.
Because of the close proximity of one of the two muc loci to
the selectable catabolic marker, pru, it was possible to isolate R"
plasmids carrying the muc"1" allele and various mutations at that
locus.
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Using these R' plasmids, preliminary studies on the expression
of muc were performed. Merodiploid strains carrying the plasmid-
determined muc"1" allele were invariably non-mucoid, suggesting that
the muc+ gene codes for a cytoplasmic regulatory product (as is the
case with the capR gene product in E. coli) which is able to replace
the non-functional mutant product.
Interestingly, merodiploid strains carrying a wild type
chromosomal allele, and either muc-2, muc-22 or muc-45 as the
plasmid determined marker, appear slightly mucoid on solid medium.
This could be explained on the basis that these mutant genes code
for a defective regulatory product which is synthesized in greater
amounts when the gene is plasmid-determined (perhaps because the R'
plasmids are present in multiple copies). However, it should be
possible to isolate a muc mutant which produces no gene product, and
such a mutation should be recessive to muc+ in the merodiploid
state, whether plasmid-determined or chromosomal.
Recently, Darzins & Chakrabarty (1984) have reported the
cloning of genes controlling alginate biosynthesis from a mucoid CF
isolate of P. aeruginosa. These workers obtained three recombinant
plasmids (derived from broad host range vector pCA3) containing DNA
inserts from the mucoid strain 8830. These inserts were considered
to carry information associated with alginate biosynthesis as they
were able to complement various Alg~ mutations (of which they had
identified four complementation groups). One of these recombinant
plasmids, pADl, was shown to induce alginate synthesis in PAO in a
manner similar to the R' plasmids pJF54, pJF55 and pJF56. However,
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the locus carried on pADl, which complemented alg-2 2, has been
mapped at approximately 19 mins on the PAO chromosome by virtue of
the fact that pADl carries argH"1" on the same 7.5 kb DNA fragment.
Hence the a 1 g-22 locus is unlikely to correspond to either of the
muc loci mapped in the course of this thesis.
Goldberg & Ohman (1984) have also used cloning techniques to
identify genes associated with alginate biosynthesis in a clinical
mucoid strain fo P. aeruginosa. As with Darzins & Chakrabarty,
these workers are primarily concerned with alg loci which are
associated with the instability of alginate synthesis, and thus, not
necessarily equivalent to the muc loci described here.
Following the isolation of the R' plasmids described in this
thesis, it should be possible to physically characterize the muc
gene and eventually identify its product. Shinomiya et al (1983)
have used a similar approach for the characterization of the genetic
determinant of pyocin R2 in P. aeruginosa strain PAO. Following the
construction of R' plasmids carrying the chromosome segment
containing the pyocin R2 gene cluster, these workers performed
deletion mapping to further define the region and ultimately
identified the pyocin R2 region as an insertion of 13 kb long,
following heteroduplex analysis.
Recently, Darzins et al (1985) have succeeded in cloning the
gene, pmi, coding for phosphomannose isomerase and have shown that
mutations in this gene can lead to an Alg~ phenotype, thus
emphasizing the essential role of this enzyme in the alginate
biosynthetic pathway of their P. aeruginosa strain 8830.
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An unexpected result from the k'studies reported in this thesis
was the observation that pJFA and similar R'pru+muc+ derivatives
were KMS, and that the KMr phenotype returned when Pru+ and Muc+
were lost indicating that the presence of the chromosomal insert was
responsible for inhibiting the expression of KMr. The mechanism by
which R' plasmids are derived from k68.45 was thought to be
associated with the presence of the DNA sequence 1S21 which maps
close to the KMr determinant and contains two copies of a direct
repeat, between which the chromosomal insert was thought to reside
(Willetts e t a 1 , 1981). However, Moore e t a 1 (1983) have
demonstrated that in the case of one R' plasmid derived by them, the
chromosomal insert did not lie between the two copies of the direct
repeat, but rather, one of the copies appeared to have been excised
on the formation of the k'.
Furthermore, Beeching et al (1983), working with the closely
related plasmid, R68.44, have demonstrated that the mobilization of
a catabolic gene from the chromosome of P. putida, to form an R'
plasmid, was not linked topographically with 1S21. Consequently,
these workers have suggested that there may be mechanisms of R'
formation which have nothing to do with the chromosome-mobilizing
properties of the plasmid, i.e. the plasmid may simply act as a
vector for transposable elements which leave the chromosome
independently of any p 1 a sm id-de te rmined mechanism. Indeed,
O
transposable elements residing in the P. aeruginosa chromsome have
been identified (Nash 4 Krishnapillai, 1982; Sinclair & Holloway,
1982).
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With particular reference to alginate synthesis, Darzins &
Chakrabarty (1984) have proposed that "the native genetic variation
evident in P. aeruginosa suggests that a genetic mechanism other
than point mutation may be responsible for the frequency of changes
seen and the aspects of the phenotype involved". Examples of
genetic rearrangements controlling microbial characteristics include
(i) flagella phase variation in Salmonella typhimurium, where an
invertible DNA sequence containing a promotor element controls the
transcription of the H2 gene (Simon et al, 1980); (ii) pilus
expression in Neisseria gonorrhoeae, where the conversion of the
pilated to non-pilated state involves a chromosomal rearrangement
(Meyer e t a 1 , 1982), and (iii) the antigenic variation in
Trypanosome brucei which involves genomic rearrangements (Williams
et al, 1979).
It would be interesting to determine whether the chromosomal
region adjacent to pru, carrying the muc locus contains a transposon
which could be associated with the expression of alginate synthesis.
The fact that the region appears to be responsible for the
derepression of alginate synthesis in nine out of ten mucoid
derivatives of strain PAO and four out of five clinical mucoid
isolates suggests that a mechanism other than point mutation is not
unreasonable.
No light has so far been shed on the mechanism of control
exerted by the muc gene product on the alginate biosynthetic
pathway. Before this can be determined, the alginate biosynthetic
pathway in P. aeruginosa must be completely elucidated and further
genetic studies will need to be combined with biochemical ones.
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The biosynthetic pathway leading to alginate in P. aeruginosa
has been the subject of considerable interest and controversy since
the mid 1970's. However, it is only in the last couple of years
that a clear picture has begun to emerge.
The pathway shown in Figure 17 is a hypothesis based on the
reports of several authors, the contribution of whom will be
described. Firstly, the work of Banerjee et al (1983) provided
evidence for the primary role of the Entner-Doudoroff pathway, and
the importance of glyceraldehyde 3-phosphate in the synthesis of
alginate from substrates such as glucose and gluconate. This
followed studies of alginate synthesis in resting cell suspensions
of mutants of a clinical mucoid strain of P. aeruginosa which were
specifically defective in carbohydrate metabolism. Supporting
evidence was provided by Lynn and Sokatch (1984) following studies
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of the pathway taken by C from glucose substrates with carbon
atoms specifically labelled with this isotope. Similarly, the
role of fructose 1,6-bisphosphate aldolase was confirmed by
Banerjee et al (1985) who demonstrated that a mutant deficient in
this enzyme synthesized very little alginate from glucose and
gluconate, but synthesized appreciable amounts from mannitol and
fructose. Hence, glucose and gluconate must be converted to
fructose 1,6-bisphosphate via the Entner-Doudoroff pathway and
fructose 1,6-bisphosphate aldolase.
The section of the pathway leading from fructose 6-phosphate to
alginic acid is based on that originally proposed for the marine
brown alga Fucus gardneri (Lin & Hassid, 1966), and later
Azotobacter vinelandii (Pindar & Bucke, 1975), and subsequently for
P. aeruginosa (Piggott et al, 1981; Sutherland, 1982). However,
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Fig 17. Proposed metabolic pathway for sugars leading to the biosynthetic
pathway for alginate in P. aeruginosa [based on the studies of
Banerjee et al (1983), Lessie & Phibbs (1984), Banerjee et al
(1985), Darzins et al (1985), Piggott et al (1981) and Pugashetti
et al ( 1983)].
The following abbreviations were used:
G6P, glucose-6-phosphate; 6PG, 6-phosphogluconate;
KDGP, 2-keto 3-deoxy 6-phosphogluconate; Glyceraldehyde 3-P,
glyceraldehyde 3-phosphate; DHAP, dihydroxyacetone phosphate;
ocGP, ^glycerophosphate; FBP, fructose 1,6-bisphosphate; F1P,
fructose 1-phosphate; F6P, fructose 6-phosphate; M6P, mannose
6-phosphate; M1P, mannose 1-phosphate; Zwf, glucose 6-phosphate
dehydrogenase; Edd, 6-phosphogluconate dehydrase; Eda, 2-keto
3-deoxy 6-phosphogluconate aldolase; Tpi, triose phosphate
isomerase; Fba, fructose 1,6-bisphosphate aldolase; Fdp,
fructose 1,6 diphosphatase; Pgi, phosphoglucose isomerase; pmi,


























it is only recently that the role of fructose 6-phosphate as the
precursor for alginate synthesis in P. aeruginosa has been
confirmed. This was following the work of Darzins et al ( 1985) who
successfully cloned the gene coding for the enzyme phosphomannose
isomerase (pmi) from a strain of E. coli and transferred it to
various alg mutants of P. aeruginosa. The demonstration that the
cloned gene complemented one particular class of alg mutant
indicated that the mutation giving rise to the Alg phenotype in
that class was in the P. aeruginosa pmi gene, and that this enzyme
is crucial for alginate biosynthesis in P. aeruginosa. Hence, the
conversion of fructose 6-phosphate to mannose 6-phosphate appears
to be the essential link between basic carbohydrate metabolism,
common to all strains of P. aeruginosa, and the enzymes and
intermediates specifically associated with alginate biosynthesis,
only expressed by muc mutants.
In E. coli K12, phosphomannose isomerase is involved in both
colanic acid synthesis and the utilization of mannose as a carbon
source, indicating the bidirectional nature of the E. coli enzyme
(Markovitz, 1977). However, P. aeruginosa is unable to utilize
mannose as sole carbon source, either due to lack of an uptake
mechanism for mannose and/or the unidirectional nature of the P.
aeruginosa phosphomannose isomerase (i.e. the enzyme will only
catalyse the reaction fructose 6-phosphate—^mannose 6-phosphate and
not the reverse). From the work of Darzins et al (1985), it would
appear that the P. aeruginosa enzyme is indeed unidirectional, which
is understandable on the basis of the lack of any DNA homology
between the E. coli and P. aeruginosa pmi genes.
With respect to the enzymes catalyzing the steps leading from
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mannose 6-phosphate to alginic acid, Piggott et al ( 1981)
demonstrated elevated levels of GDP mannose pyrophosphorylase and
GDP mannose dehydrogenase in mucoid P. aeruginosa PAO strains.
Pugashetti et al (1983) have also shown elevated levels of the
latter enzyme in a mucoid P. aeruginosa strain, compared with 18/20
non-mucoid revertants of that strain. The polymerization and
acetylation steps probably take place at the level of the membrane
and may involve lipid intermediates (Sutherland, 1982).
Apparently, D-mannuronic acid is converted to L-guluronic acid by
an extracellular epimerase, though it is still unclear whether this
epimerization step takes place at the monomer or polymer stage.
Alginate synthesis by P. aeruginosa outside the environment of
the CF lung is rare, suggesting that this property provides no
selective advantage to the organism in its natural habitat.
Consequently, a system of repression has evolved allowing the
maintenance of the biosynthetic genes to provide the species with
added adaptive potential. It would be interesting to establish
whether one or both of the muc loci described in this thesis exert
control over the alginate biosynthetic pathway by specifically
repressing the transcription of the pmi gene, or whether the control
mechanism involves the additional repression of other enzymes in the
pathway. No doubt, this will soon be determined, however, it is
sobering that after thirty years research, the mechanism by which
capR regulates the colanic acid biosynthetic genes in E. coli (i.e.
at the level of transcription) has only recently been elucidated
(Trisler & Gottesman, 1984).
With respect to the evolutionary aspects of alginate
biosynthesis in bacteria, it will be interesting to compare the
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pathways in P. aeruginosa and A. vinelandii, in view of the close
relatedness demonstrated between these two species on the basis of
various characteristics e.g. close immunological relatedness of
isofunctional proteins (Durham & Ornston, 1980), significant rRNA
homology (De Vos, 1980), and a shared antigenic site on the major
outer membrane protein H2 (Hancock et al, 1982). In view of the
common ecological niche, i.e. the soil, shared by the genera
Pseudomonas and Azotobacter, this is perhaps not surprising.
However, unlike the pseudomonads, the majority of wild type A.
vinelandii strains synthesize alginate, which in turn plays a
crucial role in the cellular differentiation cycle of this organism
leading to encystment (Lin & Sadoff, 1968; Eklund et al, 1966;
Page & Sadoff, 1975).
The loss of intrinsic antibiotic resistance in P. aeruginosa
There is currently great interest in the structural basis of
the intrinsic antibiotic resistance normally associated with
P. aeruginosa. However, there have been few reports in the
literature of genetic studies relating to this characteristic, other
than plasmid-mediated antibiotic resistance (Jacoby, 1984).
It is generally believed that the intrinsic resistance of
P. aeruginosa is associated with low permeability of the outer
membrane of the bacterial cell envelope such that most antibiotics
are excluded from their target sites on the cytoplasmic membrane or
in the cytoplasm (Costerton & Cheng, 1975; Richmond & Curtis, 1974;
Zimmerman, 1979; Yoshimura & Nikaido, 1982) Alternatively, some
workers have argued that the penetration barrier may not be imposed
by the outer membrane, but by a protein-glycoprotein layer adjacent
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to the cytoplasmic membrane, or a periplasmic protein (Scudamore &
Goldner, 1982).
Different approaches to the study of intrinsic antibiotic
resistance in P. aeruginosa have been used by different workers,
e.g. (i) the isolation of antibiotic hypersensitive, or resitant
mutants of PAO (Mills & Holloway, 1976; Noguchi et al, 1980;
Kropinski et al, 1978; Godfrey & Bryan, 1982; Nicas & Hancock,
1983); (ii) a comparison between the P. aeruginosa strain 799 and
its antibiotic hypersensitive mutant 799/61 (Zimmerman, 1979;
Zimmerman, 1980; Angus et al, 1982; Kropinski et al, 1982; Darveau &
Hancock, 1983); or (iii) the study of clinical isolates differing
in antibiotic susceptibility (Curtis et al, 1981; Irvin et al, 1981;
Godfrey et al, 1981; Williams et al, 1984; Livermore, 1984).
The isolation of the related (on the basis of pyocin type)
P. aeruginosa strains 492a and 492c from the same CF sputum
specimen, differing markedly in antibiogram, provided an ideal
starting point for the study of the structural and genetic basis of
antibiotic sensitivity/resistance in association with this
particular clinical situation.
May & Ingold (1972) had reported that 33% of their
P. aeruginosa sputum isolates were more susceptible to carbenicillin
than strains from other sources. These workers examined only single
isolates from each specimen, hence it is not known whether these
sputum specimens contained heterogeneous strains with respect to
this characteristic. In a study of 33 sputum samples from 22 CF
( l«W)
patients, Irvin et al .reported that 12 of these patients harboured
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P. aeruginosa strains sensitive to ljug carbenicil 1 in ml~l and that
from eight patients, isolates with normal carbenici11 in
susceptibility (i.e. MIC of 20 to 80;ug carbenicil 1 in ml-*) were
present simultaneously.
In this thesis, the MIC's of 18 antibiotics, in addition to
carbenicillin, were determined for 492a and 492c. The latter strain
was shown to be hypersensitive to methicillin, f1uc1oxaci11 in,
mecillinam, cefuroxime and naladixic acid, and was also more
sensitive than 492a to chloramphenicol, tetracycline, trimethoprim
and novobiocin. Because these antibiotics are associated with a
range of different target sites and modes of action, this suggested
that either 492c differed from 492a on the basis of several
characteristics or a single difference in 492c accounted for its
susceptibility to all these antibiotics, probably due to a change in
outer membrane permeability. It is interesting that 492c is no more
sensitive than 492a to the aminoglycosides, or the JB-lactams benzyl
penicillin, ampicillin, cephaloridine or cefoxitin. Presumably,
even if 492c was more permeable to benzyl penicillin, ampicillin and
cephaloridine, these ^-lactams would be broken down before reaching
their target sites by the inducible type Id JB-lactamase produced by
the cells (Richmond, 1978). Cefoxitin, on the other hand, is
resistant to the Id ^-lactamase, hence there can be no increased
permeability to this antibiotic, despite the fact that 492c is
hypersensitive to the closely related ^B-lactam, cefuroxime.
The possibility that 492c may have altered penicillin-binding
proteins (PBP's) has not been investigated in this thesis. However,
Curtis et al (1981) have examined the PBP's of two unrelated
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clinical P. aeruginosa strains differing similarly, to 492a and 492c
in their susceptibilities to ^-lactam antibiotics, and found no
significant differences. It was concluded that the strains differed
with respect to their permeability barriers rather than PBP target
affinity. Similarly, no differences in PBP's have been demonstrated
for strains 799 and 799/61 (Zimmerman, 1980).
Livermore (1984) has recently reported a study of the PBP's and
outer membrane permeability of clinical P. aeruginosa Isolates
resistant to carbenicil 1 in (MIC >128/ug ml-*) independently of
lactamase production. These strains are relatively common (Williams
et al, 1984) and are also resistant to other ,8-lactams, naladixic
acid, chloramphenicol and tetracycline, but not to aminoglycosides -
a phenotype very similar to the nalB mutants in PAO (Rella & Haas,
1982). No evidence for altered target proteins was obtained for
these strains and it was concluded that a reduction in outer
membrane permeability was apparently responsible for the observed
resistance.
The genetic studies described in Chapter IX used a combination
of classical techniques to map two loci (blsA and tpsA) associated
with antibiotic hypersensitivity in strain 492c by transferring to a
PAO recipient. Similar interstrain crosses involving R68.45
have been used successfully In the mapping of xcp loci (Wretlind &
Pavlovskis, 1983; Wretlind et al, 1983), and could also be used for
the genetic analysis of other characteristics expressed by clinical
strains, but not normally expressed by PAO (e.g. serum sensitivity).
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When transferred into PA08, both the b 1 s A1 and t p s A1
determinants contributed to the antibiotic hypersensitive phenotype,
although tpsAl alone only caused increased sensitivity to naladixic
acid, trimethoprim and novobiocin, and was also present in 492a.
The tpsA locus may not be associated with outer membrane
permeability, but rather some intracellular function in view of the
fact that the vegetative growth of F116L is apparently inhibited in
strains carrying tpsAl.
In contrast, the _b_l_sA2_ gene was associated with
hypersensitivity (or increased sensitivity) to ^B-lactams,
chloramphenicol, trimethoprim, naladixic acid and novobiocin,
strongly suggesting increased permeability as the likely mechanism.
A phenotypically similar PAO mutant (PA06511) was shown to carry a
mutation in a locus indistinguishable from blsA.
The close promixity of blsA and nalB (which is associated with
decreased permeability to the same antibiotics) on the PAO
chromosome suggests that this region may contain a cluster of genes
controlling the permeability of the P. aeruginosa outer membrane to
these antibiotics, and possibly to other substances as well.
It would be very interesting to determine whether the
carbenicil1in resistant isolates described by Livermore (1984) and
Williams et al (1984) carry mutations in the nalB locus, in view of
their phenotypic similarity ot PAO nalB mutants. The clinical
significance of this chromosomal region is apparent from the fact
that two further antibiotic hypersensitive P. aeruginosa isolates
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from CF patients carry blsAl-like mutations. Whether or not all
\
clinical hypersensitive isolates are of a similar genotype remains
to be determined. The hypothesis that a mechanism other than point
mutation is operating to modify the outer membrane permeability of
P. aeruginosa in certain selective environments would be an
interesting one to test using the recombinant DNA techniques now
available.
A genetic analysis of the antibiotic hypersensitivity in the
mutant strain 799/61 was included in this thesis for two reasons.
Firstly, to demonstrate that the approach used in mapping of blsAl
and tpsAl could also be applied to the genetic analysis of 799/61,
where previous approaches to this problem had been unsuccessful
(Angus et al, 1982). Secondly, because of the importance of this
strain in current studies on the structural basis of the intrinsic
resistance of P. aeruginosa.
Strain 799/61 was isolated from 799 following multiple
exposures to both EMS and N-methyl-N'-nitro-N-nitrosoguanidine and
final screening on plates containing 0.5;ug ml~l cephalosporin C
(Zimmerman, 1980). Hence it was not unexpected that at least two
separate mutations were responsible for the extreme antibiotic
sensitivity of this mutant. One of the mutations transferred from
799/61 to PA0222 (blsC4), was very closely linked to blsA and gave
rise to a similar phenotype with respect to antibiotic hyper¬
sensitivity. The other mutation identified, blsB3, was cotrans-
ducible with pro-82 and gave rise to hypersensitivity to a wide
range of antibiotics, from the relatively hydrophilic ,8-lactams to
the hydrophobic agent, rifampicin. In view of the fact that the
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double recombinant strain PAZ4 (blsB3, blsC4) remains resistant to
cephaloridine (to which 799/61 is hypersensitive), it is likely that
at least one additional mutation is responsible for the phenotype of
799/61, and this may be associated with the inducibility of the Id
^-lactamase (799/61 is known to be defective in this function,
Zimmerman, 1979).
The hypersensitive recombinant strains described in this thesis
are now being used to examine the structural basis of antibiotic
resistance and sensitivity in P. aeruginosa (B. Angus & R.E.W.
Hancock, personal communication).
The low permeability of the P. aeruginosa outer membrane to
hydrophilic solutes (including )5-lactams) is largely due to the
properties of the major outer membrane porin protein F (Hancock
et al, 1979; Benz & Hancock, 1981; Yoshimura & Nikaido, 1982;
Yoshimura et al, 1983). It is believed by most workers that this
protein potentially forms relatively large water-filled channels or
pores inthe outer membrane, but that only 0.2 - 1% of these are
normally "open" (Angus et al, 1982; Yoshimura et al, 1983). It has
been said that wild type P. aeruginosa behave like porin deficient
mutants of E. coli (Hancock , 1980). The molecular mechanism
underlying this remains unclear, though some workers believe that
the association between protein F and the LPS is crucial in
determining what proportionof the porin molecules form open,
functional pores (Angus et al, 1982; Kropinski et al, 1982; Hancock,
1984). This hypothesis is largely based on the finding that 799/61
has an altered LPS (Darveau & Hancock, 1983) though it has not been
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shown conclusively that this is associated with increased outer
membrane permeability.
Genetic and functional studies of the P. aeruginosa outer
membrane are at present in their early stages. However, certain
approaches applied to similar problems in E. coli may provide clues
as to the direction to follow in the future, even though the answers
may prove to be different.
In E. coli K12, there are two-major outer membrane porin
proteins, OmpF and OmpC (reviewed by Nikaido & Vaara, 1985) which
are coded for by the chromosomal genes ompF and ompC respectively
(Reeves, 1979). It has been shown that the OmpF and OmpC proteins
facilitate the penetration of ^-lactams through the outer membrane
(Jaffe et al, 1982; Nikaido et al, 1983), and mutants lacking these
proteins can be obtained by selecting for resistance to cefoxitin
(Jaffe et al, 1982). In contrast, a hyperpermeable E. coli mutant,
DC2 (Richmond et al, 1976) appears to have no alteration in outer
membrane proteins, and it has been suggested that the mutation
creates a bypass of the porin system (Jaffe et al, 1982). Another
class of E. coli mutants hypersensitive to both hydrophobic and
hydrophilic agents have mutations at the envA locus. Such mutants
have no obvious outer membrane protein or LPS defects but may have
altered levels of phospholipids in their outer membranes (Boman
et al, 1974; Grundstrom, 1980).
A combination of recombinant DNA and biochemical analysis has
been used very neatly to determine the gene product associated with
tolC locus in E. coli K12 (Morona et al, 1983). tolC mutants become
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tolerant to collcin El, have an altered bacteriophage sensitivity
pattern, lack the OmpF protein and become hypersensitive to
detergents, dyes and certain antibiotics. Polyacrylamide gel
electrophoresis (PAGE) of a TolC strain did not at first reveal the
absence of any protein band which might have been the to 1C gene
product. However, cloning of the t o1C gene allowed the
amplification and identification of the product as an outer membrane
protein required at a post-transcriptional step inthe expression of
OmpF.
To return to antibiotic hypersensitivity in association with a
clinical situation, it is interesting to consider the case of
N. gonorrhoeae, where 15% of clinical isolates in one study were env
mutants (Eisenstein & Sparling, 1978). Sarubbi et al (1975) have
shown that there are three env loci on the N. gonorrhoeae
chromosome, two of which are very closely linked, and one
genetically separate. To explain this observation, it has been
proposed that wild type enteric bacteria possessing outer membranes
of low permeability to hydrophobic molecules may have a selective
I
advantage when exposed to intestinal bile salts and long chain fatty
acids. However, for a mucosal surface pathogen, such as the
gonococcus (and possibly P. aeruginosa in the respiratory tract), it
may be advantageous to be more flexible with respect to the
structure of the outer membrane (Lysko & Morse, 1981). Whether or
not the structural basis of antibiotic hypersensitivity is similar
in N. gonorrhoeae and P. aeruginosa remains to be seen, but it is
interesting to note that the porins in the outer membrane of
N. gonorrhoeae are large like those of P. aeruginosa, excluding only
170
those saccharides of MW >6,000 (Douglas et al, 1981, cited by
Hancock, 1984).
Clinical implications
A noted CF researcher has concluded that "an understanding of
the basic biology of Pseudomonas in the CF respiratory tract is
crucial to the achievement of infection control" (Thomassen et al,
1977).
The research presented in this thesis was not primarily
designed to examine the therapeutic problems of pulmonary infection
due to P. aeruginosa, but rather to approach a better understanding
of the basic biology of pulmonary isolates of P. aeruginosa.
It had long been assumed that classic, non-mucoid P. aeruginosa
in the CF respiratory tract were of no clinical significance, and a
careful, statistically validated study has recently confirmed this
view (Henry et al, 1982). However, transition to the mucoid form is
correlated with deterioration in lung function, and mucoid
P. aeruginosa are thus considered pathogens.
The clinical relevance of the other characteristics associated
with P. aeruginosa pulmonary isolates from chronically ill patients
(i.e. antibiotic hypersensitivity, serum sensitivity, loss of the
specific 0-antigen and PA) has so far received less attention.
Penketh et al (1983b) attempted to correlate the clinical condition
of a group of CF patients with the characteristics expressed by
their P. aeruginosa isolates (i.e. serum sensitivity, loss -of 0-
antigen and PA). They observed that patients carrying strains which
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expressed some, but not all of these characteristics, i.e.
"intermediate" strains, were poorer clinically than those patients
carrying classic strains or strains expressing all characteristics.
This could be interpreted to mean that the process of surface
adaptation of the organisms within the CF lung upsets some kind of
equilibrium between bacteria and the host defences, which results in
greater damage to lung tissue, mediated by either the host or the
bacteria or both. Once the organisms have adapted, the equilibrium
is restored.
It is is not clear, at present, in what order these
characteristics are expressed by pulmomary isolates of P. aeruginosa
in association with chronic illness, and if they emerge in the same
order in each case. The genetic basis of alginate synthesis and
antibiotic hypersensitivity have been shown to be different and
distinct from serum sensitivity and PA. However, it is possible
that serum sensitivity and PA could result from a single genetic
change.
It would be reasonable to propose that initial colonization of
the upper respiratory tract or tracheobronchial mucin of the CF
patient (or bronchiectic) by a classic, non-mucoid strain of
P. aeruginosa would eventually give rise to a large population of
cells at these sites. Mucoid mutants arising from this population
would then multiply to form gel-enclosed microcolonies, better able
to resist phagocytosis by alveolar macrophages and thus capable of
colonizing the smaller airways. Once established in the protected
microenvironment of a blocked airway, surrounded by an alginate gel,
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growth under such conditions may favour a more permeable outer
membrane, providing better access to the limited nutrients. Thus,
the antibiotic hypersensitive strains would be selected for.
Presuming that this characteristic is actually expressed in vivo, it
would appear that the aggressive intravenous antibiotic therapy
often administered to these patients results in insufficient levels
of antibiotic to kill even hypersensitive organisms, at the site of
infection. This could be the result-of poor access to the lung, or
alternatively binding and breakdown of the antibiotic by the
abnormal secretions, and alginate.
It is possible that serum sensitivity and PA emerge prior to
alginate synthesis and antibiotic hypersensitivity, as these
characteristics may be associated with evasion of antibody-mediated
killing.
P. aeruginosa products, such as exotoxin A and elastase, may or
may not directly cause damage to lung tissue during chronic
infection. However, the presence of large numbers of bacteria in
the lungs, particularly of a CF patient, is associated with a poor
prognosis. The process by which the organisms become established in
large numbers in the lungs is long and involves a number of genetic
changes which are then selected for in a particular environment. It
is important to understand this process of adaptation and the
potential of P. aeruginosa in this situation. There is no clear-cut
distinction between P. aeruginosa the harmless colonizer, and
P. aeruginosa the pathogen - one emerges from the other, and to
treat the patient only when obvious signs of deterioration become
evident is to "close the door after the horse has bolted".
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It is important to determine the factors responsible for the
intial colonization of the respiratory tract by P. aeruginosa and to
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In the Gillies and Govan method of pyocin typing for Pseudomonas aeruginosa a cross-streaking technique
was used, and 105 main types and 25 subtypes were identified by the patterns of inhibition observed on 13
indicator strains. Disadvantages of the technique included the need to remove test strain growth before
application of the indicator strains, the 48-h period needed to obtain a result, and the inability to reliably type
mucoid P. aeruginosa. Recent studies have enabled us to overcome these disadvantages and significantly
improve the speed and application of pyocin typing. Our revised technique utilizes the same 13 indicator strains
which are already used internationally. Test strains were rapidly applied to the surface of agar plates with a
multiple inoculator. After incubation for 6 h and exposure to chloroform, the indicator strains were applied in
agar overlays without prior removal of the test strain growth. After 18 h of incubation, the pyocin type was
recognized by inhibition of particular indicator strains. Additionally, the activity of particulate (R and F) and
nonparticulate (S) pyocins could be distinguished on the basis of inhibition zone size, which thus allowed
further discrimination. The revised technique allows typing within 24 h, increases the number of identifiable
types, and can be used to type mucoid strains.
In the last three decades, Pseudomonas aeruginosa has
assumed an increasingly prominent role as the etiological
agent in a variety of serious infections in hospitalized
patients (12). At particular risk are patients who have
suffered major trauma or burns and are exposed to intensive
care units (16). Also at risk are normal individuals exposed
to a compromising occupational or recreational environ¬
ment, e.g., a deep-sea diving bell, in which outbreaks of
acute and painful otitis externa due to P. aeruginosa have
been reported (1), or the jacuzzi, in which P. aeruginosa has
been implicated in the irritating skin rash known as "hot
tub" or jacuzzi syndrome (17).
The increased importance of P. aeruginosa as an opportu¬
nistic pathogen, together with its well-recognized and char¬
acteristic ubiquitous nature, gives rise to many instances in
which reliable and discriminating typing or "fingerprinting"
of strains is required to investigate outbreaks of nosocomial
infection and to aid effective infection control.
Several biological criteria have been assessed for typing P.
aeruginosa, including pigmentation, antibiograms, and phage
sensitivity. However, the two most reliable and generally
accepted methods are serotyping and pyocin (aeruginocin)
typing (2,14). A number of pyocin typing methods have been
described, but in independent comparative experience and
reviews (2, 11) it has been suggested that the most suitable
method is that developed in our laboratory (4, 7, 8).
In our pyocin typing technique (7), a cross-streaking
method is used which can identify 105 main types on the
basis of pyocin production by test strains and the recognition
of different inhibition patterns observed against eight indica¬
tors, labeled 1 through 8, and further subdivision into 25
possible subtypes with five additional indicator strains,
labeled A through E. Thus, the discriminatory potential of
the method is good and superior to serotyping. However, in
epidemiological studies, as with serotyping, the majority of
strains fall into a limited number of types or subtypes. Thus,
further discrimination would be an advantage. Other disad¬
vantages of this method are (i) the 48 h required to obtain a
result; (ii) the need to remove the producer strain growth
* Corresponding author.
before application of the indicator strains, which is a messy
and time-consuming procedure; (iii) the inability to reliably
type mucoid strains of P. aeruginosa, which have become a
serious problem in respiratory infections in patients with
cystic fibrosis; we have previously described a modified
pyocin typing method for mucoid P. aeruginosa (18), but the
method involves preparation of pyocin-containing extracts
from aerated broth cultures, and although simple to perform,
it is time consuming and labor intensive; and (iv) the fact that
the technique, as first described in 1966 (4), did not distin¬
guish between the different classes of pyocin produced by P.
aeruginosa, i.e., the particulate R- and F-pyocins (5, 6) and
the diffusible S-pyocins (9). It has been suggested (7) that the
ability to distinguish between particulate and nonparticulate
pyocins on the basis of inhibition zone size would provide
additional valuable strain discrimination in pyocin typing.
Our continued studies on the production and detection of
individual pyocins, including their production by mucoid P.
aeruginosa, have led to the reduction or elimination of these
disadvantages and, thus, to significant improvements in the
speed, sensitivity, and application of pyocin typing for
epidemiological purposes.
This paper follows a preliminary report (J. A. M. Fyfe and
J. R. W. Govan, Abstr. Annu. Meet. Am. Soc. Microbiol.
1983, C35, p. 317) and describes the development and
evaluation of a revised technique for pyocin typing. In the
revised technique, the use of the original 13 indicator strains
and the inhibition patterns previously described (7) are
retained. The main practical modifications to the previously
described cross-streaking technique (7) are that the test
strains are applied by a spotting method and the indicator
strains are incorporated in agar overlays without prior
removal of the test strain growth.
MATERIALS AND METHODS
Bacterial strains. Fifty pyocinogenic strains of P. aerugi¬
nosa were employed initially to compare the pyocin typing
results obtained by the standard cross-streaking method and
a modified spotting method. Thereafter, an additional 500
clinical isolates of P. aeruginosa, including mucoid strains,
were used to evaluate the use of the spotting method.
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FIG. 1. Examination for pyocin activity against indicator strain 8
in four strains of P. aeruginosa by the spotting method. The left
plate shows the test strains A, B, C, and D after 6 h of incubation at
30°C and before addition of the indicator strain. The right plate
shows the inhibition zones produced by those strains after addition
of the indicator strain in an agar overlay and subsequent incubation
for 18 h at 37°C. Strain A shows no pyocin activity (—); strain B
shows S-pyocin activity (+) characterized by an inhibition zone
extending beyond the area of original growth; strain C shows a
restricted inhibition zone characteristic of R- and F-pyocins (+);
strain D shows a mottied inhibition zone typical of phage activity
(-0).
Pyocin typing by the cross-streaking method. Pyocin typing
by the cross-streaking method was carried out as previously
described (7). As suggested in this review, the recognition of
S-pyocin activity was incorporated into the typing scheme.
Thus, a test strain was allotted to a pyocin type not only on
the basis of the pattern of inhibition observed against the 13
standard indicator strains, but it was further characterized
by noting the presence of classic S-pyocin activity which
causes a zone of inhibition that extends beyond the original
growth area of the producer strain. Hence, for example, a
strain of pyocin type 1/a producing S-pyocin against indica¬
tor strains 7 and B is designated type 1/a (S7iB).
Pyocin typing by the spotting method. Strains of P. aeru¬
ginosa to be typed were streaked for single colonies onto
nutrient agar (Columbia agar base; Oxoid Ltd.. Basingstoke,
London, England) and incubated at 37°C overnight. The
single colonies that arose from each test strain were used to
prepare a bacterial suspension of 108 to 109 organisms in 1 ml
of sterile physiological saline (absorbance at 550 nm, =0.5).
A multipoint inoculator (model A400; Denley Instruments
Ltd., Sussex, England), incorporating 21 stainless steel pins
(one being a marker pin; diameter of each pin, 2 mm; pins
were set 16 mm apart), was used to dispense 1-p.l volumes of
the bacterial suspensions onto a set of 13 plates (diameter, 90
mm) each containing 10 ml of tryptone soy agar (Oxoid). In
this way, 20 test strains could be typed simultaneously
against each indicator strain. After the spots dried, usually
within a few minutes, the plates were incubated at 30°C for 6
h. Filter paper disks (5 cm; Whatman, Inc., England) were
impregnated with chloroform, and the plates were placed
over the disks for 15 min to allow the chloroform vapor to
kill the bacteria. The plates were then exposed to air for an
additional 15 min to eliminate residual chloroform vapor.
Cultures of the indicator strains, grown without agitation in
nutrient broth (Oxoid no. 2) for 4 h at 37°C to a population
size of approximately 107 organisms per ml, were applied to
the plates by adding 0.1 ml of each bacterial indicator culture
to 2.5 ml of molten, semisolid agar (1% peptone; Difco
Laboratories, Detroit, Mich., in 0.5% agar; Oxoid L 11) held
at 45°C and poured as overlays (NB, a separate indicator
strain, was applied to each plate). When the overlays had
set, the plates were incubated for 18 h at 37°C, and the
pyocin types were determined, as with the cross-streaking
FIG. 2. Typical routine typing plates obtained by the spotting
method. (A) Indicator strain 5; (B) indicator strain B.
method, on the basis of the indicator strains inhibited. The
size of the inhibition zones was also taken into account for
the purpose of more detailed strain comparison (Fig. 1) and
determination of S-pyocin activity incorporated into the
typing results as in the cross-streaking method.
RESULTS
Detection of pyocin activity by the spotting method. Incuba¬
tion of the test strains at 30°C on tryptone soy agar for 6 h
resulted in detectable pyocin production on the basis of clear
zones of inhibition of an indicator strain (Fig. 1). S-type
pyocin production could be distinguished from R- and F-
types on the basis of zone size. The area of growth after
inoculation with a multipoint inoculator had a diameter of 5
mm. Inhibition zones due to R- or F-type pyocins ranged
from 5 to 7 mm in diameter and had a sharp edge. S-type
pyocins produced zones of 9 to 12 mm in diameter, and these
often had a diffuse edge. Phage activity could generally be
distinguished from pyocin activity, as the former gave rise to
a mottled inhibition zone. Two typing plates on which the
same 20 test strains were overlaid with indicator strain 5
(Fig. 2a) and indicator strain B (Fig. 2b) are shown. Compar¬
ison of test strains grown on the same set of plates is easier
and more meaningful than comparison of those grown on
individual plates, as in the cross-streaking method.
Comparison between spotting and cross-streaking methods.
For comparative purposes, 50 strains of P. aeruginosa were
typed by both methods. Twenty-seven strains gave identical
results, including the detection of S-type pyocin activity.
Nine strains gave the same pyocin type, although the cross-
streaking method failed to detect S-pyocin activity against
one or more indicators. Fourteen strains gave a different
pyocin type by the two methods. In 12 strains, pyocin
activity was detected by the spotting method, which failed to
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be detected by the cross-streaking method, and in the
remaining 2 strains pyocin activity was detected by the
cross-streaking but not the spotting method.
Value of S-pyocin production as a further epidemiological
discriminator. An additional 500 clinical isolates of P. aeru¬
ginosa were pyocin typed by the spotting method. The
majority of these strains (99%) were typable, and 74%
produced S-pyocin activity against 1 or more of the 13
indicator strains. All indicators showed some sensitivity to
S-pyocins, and 63 different "S-type patterns" were distin¬
guished. The most common of these were S5 (11.3% of those
strains with S-pyocin activity), S5 b (9.7%), S7 (8.9%), and
S7,B (8.6%).
As an example of the improved discrimination provided by
recognition of S-pyocin activity, 34 isolates ofP. aeruginosa,
belonging to the common pyocin type, 1/b, could be divided
into 10 distinct groups on the basis of their S-pattern.
Typing of mucoid strains by the spotting method. Thirty
mucoid strains of P. aeruginosa isolated from the sputa of
six patients with cystic fibrosis were pyocin typed by the
spotting method. These included multiple isolates from
individual sputa. All 30 strains gave clear typing patterns,
with 13 strains producing S-pyocins. Multiple isolates from
five of the patients were shown to be of the same type
(different types for each patient), whereas the sixth patient
harbored strains of two distinct types, 29/f(S5) and 13/k.
DISCUSSION
The revised spotting method of pyocin typing described in
this report has advantages over the cross-streaking method
previously described (7). (i) The time required to obtain a
typing result is reduced from 48 to 24 h. (ii) Up to 20 isolates
can be directly compared on the same set of typing plates.
This is ideal for comparative typing of multiple colonies from
a single specimen to investigate mixed-type infection or to
compare isolates from a single epidemic outbreak, (iii)
Inhibitory activity due to S-pyocins can be more readily
distinguished from R- and F-pyocin activity than when the
cross-streaking method is used, thus providing greater dis¬
crimination in epidemiological studies. In our study, the
epidemiological value of including detection of S-pyocin
activity has been emphasized not only by the increased
discrimination which it provides but also by the high fre¬
quency of S-pyocin production (74%) observed in the 500
test strains examined. This incidence is higher than that
reported in a study carried out in India (38%); in the latter
survey, however, only 29 strains were examined, and the
methods for pyocin production and detection included differ¬
ent cultural conditions and indicator strains (15). (iv) There
is no requirement to remove producer strain growth before
application of the indicator strains; hence, the method is less
tedious and time consuming. Similarly, the application of the
indicator strains in agar overlays rather than as cross-streaks
is more efficient, (v) Finally, the spotting method is more
suitable for typing mucoid P. aeruginosa.
An earlier spotting method for pyocin studies described by
Kageyama, in which different cultural conditions were used
(10), included induction of pyocin production by exposure of
the producer strain to UV light. We made a comparative
study of six standard reference strains with a range of UV
doses and found that under the conditions of the revised
typing technique described in this report, no significant
advantage was gained for typing purposes by inclusion of an
induction stage (unpublished data). In addition, for typing
purposes, an induction stage to enhance pyocin production
in apparently apyocinogenic strains and thus to reduce the
number of untypable strains was unnecessary due to the
very low incidence of such strains (1%) found in our survey.
In a wider context, the question remains as to which is the
most suitable typing system for epidemiological studies of P.
aeruginosa, and realistically, is any one system adequate?
Despite the improvements in pyocin typing described in this
paper, the method still does not match the rapidity of the
other most-suitable typing method, serotyping.
P. aeruginosa is serologically heterogeneous, and identifi¬
cation of group-specific heat-stable lipopolysaccharide anti¬
gens by agglutination forms the basis of O-serotyping proce¬
dures. Several systems have been described and their use
reviewed (2,11.14). O-serogroup sera are available commer¬
cially, but they are expensive and the most widely used
system (Difco) requires a set of antigen suspensions for
characterizing the sera. In addition, the sera can only be
purchased as a complete set of 17 sera.
A major disadvantage of O-serotyping is that the discrimi¬
natory power is only fair (3); further discrimination can be
provided by detection of H-antigens, but the procedures for
H-typing are beyond the scope of many laboratories (14).
The typability of P. aeruginosa by O-serological typing is
usually over 90%, but serotyping is often unsatisfactory for
mucoid P. aeruginosa in which O-antigens may be masked,
typing of colonial dissociants in which serological changes
occur within a single culture, and typing polyagglutinable P.
aeruginosa. The latter, together with mucoid P. aeruginosa,
forms less than 5% of clinical isolates but is frequently
observed in patients with cystic fibrosis (13).
By our use of the revised pyocin typing technique de¬
scribed in this report in combination with O-serotyping it is
concluded that neither system provides all the requirements
of the ideal typing system for P. aeruginosa (unpublished
data). We suggest that both systems offer significant contri¬
butions to epidemiological studies. O-serotyping provides a
rapid indication of antigenic differences when these occur. In
an epidemic situation, however, the value of serotyping is
limited unless the strains isolated belong to unusual sero¬
types. Pyocin typing, as described in this paper, requires a
period of 24 h to achieve a result but provides adequate
discrimination on which to base more confident epidemio¬
logical judgement. We suggest that this revised technique
provides an improved method for both epidemiological stud¬
ies of P. aeruginosa and for basic studies on the wide range
of pyocin activity which can be found in this species.
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Heterogeneity and Reduction in Pulmonary Clearance of
Mucoid Pseudomonas aeruginosa
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Mucoid, alginate-producing Pseudomonas aeruginosa isolated from patients with cys¬
tic fibrosis were studied to determine the extent of heterogeneity of the isolates within
individual sputa. Considerable heterogeneity involving cultural requirements for mu¬
coid colonial growth was observed, and sensitivity to the /3-lactam antibiotic carbenicil-
lin was also variable. For determining if the presence of alginate increased pulmonary
survival of the bacteria, groups of rats were infected by transtracheal instillations of
equivalent numbers of mucoid or nonmucoid P. aeruginosa, and survival was measured
as the percentage of inoculum colony-forming units cultured from lung homogenates.
Increased pulmonary survival of mucoid P. aeruginosa was observed in animals killed
3 hr or 6 hr after infection with unwashed bacteria. No difference in survival between
mucoid and nonmucoid cells was observed when bacteria were washed prior to instilla¬
tion. It was concluded that a single mucoid colony isolated from a sputum does not
fully represent the population of mucoid P. aeruginosa within the patient and that pul¬
monary killing of mucoid P. aeruginosa can be less efficient than that for nonmucoid
strains.
In the late 1960s the pioneering research of
Doggett and Harrison [1] revealed the association
of mucoid Pseudomonas aeruginosa and chronic,
severe pulmonary infection in patients with cystic
fibrosis. Today, P. aeruginosa has become the
most troublesome respiratory pathogen of pa¬
tients with cystic fibrosis [2, 3]. Although research
in the last decade has greatly increased our basic
knowledge of the properties of this organism, the
natural history of pseudomonas infection in pa¬
tients with cystic fibrosis is not fully understood.
Clinical and bacteriologic studies of patients
with cystic fibrosis have indicated that initial in¬
fection occurs with a classic, nonmucoid strain of
P. aeruginosa. Subsequently, a mucoid form
emerges and becomes predominant with concomi¬
tant pulmonary deterioration and a poor progno¬
sis for the patient [1-4]. Nonmucoid and mucoid
forms isolated from the same patient usually
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belong to the same pyocin type [5] and serotype
[6].
The exopolysaccharides produced by mucoid
P. aeruginosa isolated from 10 patients with cystic
fibrosis were shown to be similar and to consist of
an acetylated alginate [7]. In contrast to pseudo¬
monas slime [8], purified pseudomonas alginate is
nontoxic when injected ip into mice (authors' un¬
published results). Several in vitro studies have
indicated that the alginate may be antiphagocytic
[9, 10]. It would seem probable, therefore, that
the function of the alginate is protective in vivo
rather than invasive.
It has been reported [3] that the continuous use
of antibiotics seems to contribute to the emergence
of mucoid strains. Some mucoid variants have
been reported to be slightly more resistant to
^-lactam antibiotics and aminoglycosides than are
related nonmucoid strains, and the isolation of
mucoid, alginate-producing mutants of P. aeru¬
ginosa [11] and other Pseudomonas species [12]
with use of a technique based on enhanced resis¬
tance of these mutants to carbenicillin has been
described. It must be emphasized that generaliza¬
tions cannot be made about the resistance of
mucoid strains or their nonmucoid revertants.
Some revertants retain the enhanced resistance to
carbenicillin of the mucoid parent strain [13];
more striking, perhaps, is that very sensitive
strains of both mucoid and nonmucoid forms of
S874
Mucoid P. aeruginosa S875
P. aeruginosa frequently are isolated from sputa
[14].
This paper reports on the heterogeneity of
mucoid P. aeruginosa isolated in vitro and from
patients with cystic fibrosis and on the use of
transtracheal inoculation in rats to compare the
pulmonary clearance of isogenic mucoid and non-
mucoid strains. The significance of the results
with respect to present knowledge of pseudo-
monas infection in patients with cystic fibrosis is
then discussed.
Materials and Methods
Pseudomonas aeruginosa strains. Mucoid
strains of P. aeruginosa were isolated from sputa
obtained from patients with cystic fibrosis attend¬
ing the cystic fibrosis clinic at the Royal Hospital
for Sick Children, Edinburgh. The mucoid mutant
strain PAO 579 [15] was isolated from a culture of
strain PAO 381 with use of a carbenicillin selec¬
tion technique [11].
Heterogeneity ofmucoid P. aeruginosa in sputa
ofpatients with cystic fibrosis. Sputa of patients
were treated with sputolysin (Calbiochem-Behring,
Bishop's Stortford, England), diluted in sterile
physiologic saline, and plated on Pseudomonas
isolation agar (PIA; Difco, Detroit, Mich.). After
incubation for 24 hr at 37 C, 100 mucoid cfu
resembling Phillips colonial type 5 [16] were sub-
cultured onto nutrient agar (NA; Columbia agar
base, Oxoid, London), blood agar (BA; Columbia
agar supplemented with 5% sterile human blood),
minimal agar (MA, [17]), deoxycholate citrate agar
(DCA; Oxoid CM227), and diagnostic sensitivity
test agar (Oxoid) containing 5 qg of carbenicillin/
ml (Beecham Research Laboratories, Brentford,
England) and examined for mucoid growth after
24 hr at 37 C.
Pseudomonas alginate. The exopolysaccharide
produced by mucoid strains grown on PIA was
extracted, purified to an asbestos-like powder,
and identified as alginate as previously described
[11]. Gelatinization of the exopolysaccharide was
examined by preparing a 1% aqueous solution
from dried alginate and adding 3 mM CaCl2.
Animal studies. Pathogen-free male Sprague-
Dawley rats (200 g) were obtained from OLAC
1976 (Bicester, England). The technique used for
transtracheal inoculation of bacteria into a distal
bronchus was that previously described [18]. Cul¬
tures of strains PAO 381 and PAO 579 were
grown in a chemically defined medium [19] with
1% sodium gluconate as the carbon source and
were incubated in an orbital incubator (Gallen-
kamp, London, England) at 140 rpm at 37 C for
18 hr to stationary phase. Strain PAO 579, but not
strain PAO 381, readily produces extracellular
alginate under these in vitro conditions, but no
clearly defined bacterial capsule is observed in
preparations stained with india-ink or ruthenium
red. The bacterial cultures were diluted 1:100 in
PBS (pH 7.0); the 0.1-m inoculum contained MO6
cfu. Washed bacteria were prepared by two cycles
of centrifugation at 3,000 g and resuspension of
bacteria in PBS to yield 107 cfu/ml.
Bacterial quantitation. Animals were killed
with ip pentobarbital, and both lungs and the
heart were removed aseptically and washed with
sterile PBS. The lungs were then excised and
placed in 10 ml of sterile PBS. The tissues were
homogenized in a Waring blender. Serial dilutions
of the homogenate in PBS were plated on DSTA,
and cfu were counted after overnight incubation
at 37 C.
Pyocin typing. The pyocin-typing technique
used was that described by Williams and Govan
[5], with the incorporation of the revised scheme
of Govan [20],
Results
Heterogeneity of mucoid P. aeruginosa. The
heterogeneity of mucoid P. aeruginosa was dis¬
covered by the isolation of variants that produced
alginate only when grown on certain media and, in
addition, by the identification of mucoid variants
that were sensitive to 5 pg of carbenicillin/ml.
Table 1 summarizes the characteristics of four
groups of "medium-dependent variants" of P. aeru¬
ginosa isolated from patients with cystic fibrosis.
These variants were recognized by their ability to
produce mucoid growth resembling the Phillips
colonial type 5 [16] after incubation at 37 C for 24
hr. Mucoid mutants belonging to groups 1-4 were
successfully isolated in vitro from the nonmucoid
strain PAO 381 as single-step mutations with use
of the carbenicillin selection technique. The exo¬
polysaccharide from each mutant gelled rapidly in
the presence of Ca++ (figure 1) and was identified
as an acetylated alginate-like polymer of mannu-
ronic and guluronic acid.
Table 2 summarizes the incidence of each
mucoid group and of the strains of P. aeruginosa
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Table 1. Characterization of medium-dependent
mucoid variants of Pseudomonas aeruginosa isolated in
vitro and from patients with cystic fibrosis.
Type of growth in indicated medium*
Variant group PIA NA/BA DCA MA
1 + + + +
2 + + + -
3 + + - -
4 + - - -
* + = mucoid growth resembling Phillips colonial type 5 after
incubation at 37 C for 24 hr; - = nonmucoid growth; PIA
= pseudomonas isolation agar; NA = nutrient agar; BA =
blood agar; DCA = desoxycholate citrate agar; and MA =
minimal agar [17], See Materials and Methods for further
information about the media.
sensitive to 5 \xg of carbenicillin/ml among all
strains isolated from 17 patients with cystic fibro¬
sis who were chronically infected with this orga¬
nism. Thirty-five sputum samples obtained from
three patients presented a homogenous population
of group 1 mucoid strains of P. aeruginosa. In¬
deed, variants belonging to group 1 were by far
the most common; they were isolated from all 17
patients and from 89% of the individual sputa.
Variants belonging to group 2 were isolated from
65% of patients; group 3 variants, from 35%; and
group 4, from 29%. Strains of P. aeruginosa
sensitive to 5 pg of carbenicillin/ml were isolated
from 65% of the patients. This characteristic was
independent of the mucoid group. Although most
patients harbored mucoid strains from more than
one group simultaneously, no clear transition was
Figure 1. Viscid 1% aqueous solution of alginate ex¬
tracted from Pseudomonas aeruginosa strain PAO 579
(left) and the gel that forms (right) in the presence of
3-mM Ca++.
Table 2. Heterogeneity of mucoid Pseudomonas
aeruginosa isolates from 100 sputum samples obtained
from 17 patients with cystic fibrosis.
Percentage of
Group of sputum samples Percentage





Carbenicillin sensitivet 36 65
NOTE. Data are based on the analysis of 100 mucoid
colonies from each sputum sample.
* See table 1 for characterization of mucoid groups,
t MICs of carbenicillin for isolates were <5 pg/ml.
observed from one group to another. Group 1
variants usually appeared first in the course of in¬
fection and accounted for the majority of P. aeru¬
ginosa isolated from an individual specimen or
patient. However, mucoid variants sensitive to <5
pg of carbenicillin/ml also were found frequently
in large numbers and in one patient accounted for
all isolates of P. aeruginosa. Heterogeneity could
not be explained on the basis of mixed infections
with more than one strain of P. aeruginosa. In
most patients, mucoid variants of different classes
belonged to the same pyocin type.
Pulmonary clearance of P. aeruginosa. We
attempted to identify a possible advantage for
mucoid P. aeruginosa in the respiratory tract by
investigating the clearance of isogenic mucoid and
nonmucoid bacteria from rat lungs. Table 3 com¬
pares the survival of the group 1 mucoid mutant
strain PAO 579 or the nonmucoid parent strain
PAO 381 of P. aeruginosa in homogenized lungs
after transtracheal inoculation. No viable P. aeru¬
ginosa were recovered 24 hr after inoculation with
106 cfu of washed or unwashed bacteria, and no
animals died. Further experiments showed that
few bacteria were recovered after 6 hr. A typical
result for lungs sampled at 3 hr and 6 hr indicated
that the mucoid strain PAO 579 was cleared less
efficiently than the nonmucoid strain PAO 381 (P
< .01, Student's t test). No significant difference in
the clearance rate of strains PAO 579 and PAO
381 was observed when washed cell suspensions
were used. Washing significantly increased the
clearance of strain PAO 579 (P < .001) but not of
strain PAO 381.
Mucoid P. aeruginosa S877
Table 3. Survival of isogenic mucoid and nonmucoid Pseudomonas aeruginosa in rat lungs after transtracheal
instillation.
Percentage of indicated inoculum recovered*
Time after
instillation (hr)
PAO 579 (mucoid) PAO 381
Washed Unwashed Washed Unwashed
3
6
0.32 ± 0.04 19.3 ± 2.15
4.1 ± 0.54
0.30 ± 0.03 1.6 ± 0.62
0.27 ± 0.02
* Expressed as percentage of inoculum cfu recovered from lung homogenates. Values are expressed as mean ± SE; each group
comprised five animals.
Discussion
It is arguable that in no other infection does
P. aeruginosa exhibit the complexity and range of
biological properties that are observed in chronic
pulmonary infection in patients with cystic fibro¬
sis; however, an appreciation of this complexity of
such infection is essential not only to an under¬
standing of the natural history of the infection but
also to an explanation of the apparent contradic¬
tions in the literature that result from generaliza¬
tions on this subject, in particular those dealing
with the nature of the mucoid form.
Mucoid P. aeruginosa frequently are assumed
to be a homogeneous class of the species possess¬
ing basic common properties. Increasingly, how¬
ever, genetic and physiologic studies have revealed
the heterogeneity of this unusual form of the
species.
Genetic studies [15, 21] of isogenic mucoid
mutants of PAO strains have shown that at least
two chromosomal loci are involved in the control
of alginate synthesis. Individual mucoid strains
isolated in vitro or from patients with cystic
fibrosis differ considerably in the amount of al¬
ginate produced under defined conditions; in the
degree of acetylation of the alginate, which is
proportional to viscosity of the polymer; and in
the optimal conditions for alginate synthesis [22].
Extreme sensitivity to carbenicillin in P. aeru¬
ginosa has previously been observed and its as¬
sociation with respiratory isolates noted [23], The
phenomenon frequently is encountered in mucoid
strains but is not dependent on alginate produc¬
tion [14].
The significance of heterogeneity in P. aeru¬
ginosa isolated from patients with cystic fibrosis is
further emphasized by the heterogeneous popula¬
tion of mucoid variants found within individual
sputum samples from patients with cystic fibrosis.
Heterogeneity cannot be explained by simultane¬
ous infection with more than one strain of P. aeru¬
ginosa.
The nature of heterogeneity reported in this
paper involves forms of mucoid P. aeruginosa
that possess identical colonial appearance when
grown on PIA. Other reports [24, 25] have de¬
scribed heterogeneity among strains isolated from
individual sputa of patients with cystic fibrosis
with regard to colonial appearance (e.g., rough,
mucoid, or dwarf) and have noted differences in
antibiotic susceptibility associated with these dif¬
ferent colonial types. It was suggested [24] that
studies of antibiotic susceptibility should be per¬
formed on several colonies of each colonial type
of P. aeruginosa isolated from an individual
sputum sample. We would support this suggestion
and further emphasize that up to 100-fold differ¬
ences in susceptibility to ^-lactam antibiotics can
be found in mucoid colonies, isolated from the
same sputum, that are indistinguishable in colo¬
nial appearance [14].
Two recent reports have provided valuable in¬
sight into the natural history of P. aeruginosa in¬
fection in patients with cystic fibrosis, in particu¬
lar the initial selective adhesion and colonization
of the upper respiratory tract by nonmucoid
strains of P. aeruginosa and the subsequent
emergence of the mucoid form. Woods et al. [26]
reported that in vitro adherence of P. aeruginosa
to buccal epithelial cells was significantly higher in
cells obtained from patients with cystic fibrosis
than in those from control subjects. Mucoid
P. aeruginosa adhered in significantly lower num¬
bers than did nonmucoid forms, and this pili-
mediated adherence varied directly with the loss of
S878 Govan, Fyfe, and Baker
protease-sensitive fibronectin from the cell surface
and the increased levels of salivary proteases
found in patients with cystic fibrosis. In contrast,
Marcus and Baker [27] observed that in ciliated
hamster tracheal epithelium mucoid P. aeruginosa
adhered to the cilia and formed mucoid micro-
colonies, whereas nonmucoid forms showed little
or no adherence.
The results reported in this paper on the clear¬
ance of P. aeruginosa from the lower airways of
rats suggest a further selective advantage for the
mucoid form. We deliberately used the nonmu¬
coid parent strain PAO 381 as the control for
these experiments because of the considerable
physiologic and genetic heterogeneity found in
nonmucoid revertants [13, 28]. As was previously
reported by Blackwood and Pennington [29], we
found no significant difference between mucoid
and nonmucoid organisms when animals were in¬
fected with washed cell suspensions; we did ob¬
serve a difference, however, with unwashed sus¬
pensions. An explanation for these results may lie
in the nature of alginate production in P. aeru¬
ginosa. In contrast to the classic cell-bound
capsule of Klebsiella, the alginate produced by
P. aeruginosa in vitro is in the form of a loosely
associated slime or peripheral capsule [30]. After
centrifugation most of the alginate remains in the
culture supernate. In the course of the short ex¬
perimental period, there would be little prospect
for alginate synthesis in vivo.
The results reported here do not establish that
alginate per se is responsible for enhanced pul¬
monary survival of mucoid strains. The ability of
pseudomonas alginate to gel in normal pulmonary
levels of Ca++ is striking. Further studies are re¬
quired to assess the influence of the characteristi¬
cally increased levels of Ca++ found in patients
with cystic fibrosis and the role of cell-free and
cell-associated alginate in the clearance of P. aeru¬
ginosa.
It is difficult to assess the relevance of in vitro
experiments and animal studies to human disease.
Nevertheless, since a reduced rate of pulmonary
clearance for mucoid P. aeruginosa has been ob¬
served in healthy rats, the selective advantage for
the mucoid form might be even greater in the com¬
promised lungs of patients with cystic fibrosis.
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Chromosomal Loci Associated with Antibiotic Hypersensitivity in
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492a and 492c were two strains of Pseudomonas aeruginosa isolated from the sputum of a patient
with cystic fibrosis. The strains were closely related but expressed different antibiograms. 492c
was hypersensitive (10-100 times more sensitive than 492a) to the ^-lactam antibiotics
carbenicillin, methicillin, flucloxacillin, mecillinam and cefuroxime and the non-/I-lactam,
nalidixic acid. 492c also showed enhanced sensitivity (4-8 times more sensitive than 492a) to
chloramphenicol, trimethoprim and novobiocin. 492a and PA08 expressed similar levels of
antibiotic resistance, except for trimethoprim, to which 492a was five times more sensitive than
PA08. Two genes associated with antibiotic hypersensitivity were mapped in the 30 min region
of the chromosome, by means of R68.45-mediated plate matings between a Leu" mutant of 492c
and PA08, followed by transductional analysis using phage F116L. The first of these genes,
blsAl, was closely linked to nalB, and in a PAO background, was associated with hyper¬
sensitivity to the /Hactams and a moderate increase in sensitivity to chloramphenicol,
trimethoprim, nalidixic acid and novobiocin. A further increase in sensitivity to the latter three
antibiotics was associated with the second gene, tpsAl, which mapped between ser-3 and hisV.
This gene could also be transferred to PAO from 492a, thus 492c could have arisen from 492a in
vivo following a single chromosomal mutation at the bisA locus. Isolation of a bisA mutant of
PA0969 provided further evidence for this theory.
introduction
One of the characteristics most commonly associated with Pseudomonas aeruginosa is an
intrinsic resistance to antimicrobial agents, in particular, the /Mactam antibiotics. Indeed, this
property is generally held responsible for the emergence of P. aeruginosa in the last three decades
as a clinically important opportunist pathogen.
The development of carbenicillin, the first semi-synthetic penicillin with significant anti-
pseudomonas activity, was a significant advance in chemotherapy. However, the minimal
inhibitory concentration (MIC) of carbenicillin for P. aeruginosa is generally 25-50 pg ml"1
(Knudsen et al., 1967), which is beyond the levels attainable in soft tissues, e.g. the lung (Marks
et al., 1971).
May & Ingold (1972) reported that strains of P. aeruginosa isolated from sputum were often
considerably more sensitive to carbenicillin than isolates from other sources. In a study
involving 111 sputum isolates from patients with cystic fibrosis (CF), chronic bronchitis and
bronchiectasis, they found that 35% of strains were sensitive to 6 pg carbenicillin ml"1 and
some had MICs as low as 0-7 pgml"1.
Abbreviations'. CEF, cefuroxime; CF, cystic fibrosis; DSTA, Diagnostic Sensitivity Test Agar; NA, nutrient
agar; NB. nutrient broth; TP, trimethoprim.
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Berche et al. (1979) reported a study on antibiotic susceptibilities of mucoid and non-mucoid
strains of P. aeruginosa. They compared 47 mucoid with 71 non-mucoid isolates on the basis of
sensitivities to 18 antibiotics and concluded that both groups could be divided into two distinct
classes on this basis. Class A contained strains significantly more resistant to antibiotics such as
the aminoglycosides and tetracycline, than those strains allocated to Class B.
While studying the association of P. aeruginosa with chronic respiratory infection in CF
patients, we have also reported the isolation of strains unusually sensitive (hypersensitive) to a
range of antibiotics including the /J-lactams carbenicillin, azlocillin, methicillin and also to
trimethoprim (Irvin et al., 1981). The carbenicillin MICs of these strains were <1 pg ml~1 and
thus comparable with those reported by May & Ingold (1972). In addition, we reported that
hypersensitive and 'normal' isolates could be obtained from the same sputum specimen and that
these strains were invariably of the same pyocin type, indicating a close relationship.
Recently, there has been an increasing interest in the genetic basis of virulence in P.
aeruginosa and various potential virulence factors have been mapped using the genetically
characterized strain, PAO. For example, several chromosomal genes involved in exotoxin A
production have been mapped following isolation of toxin-deficient PAO mutants, and the use
of classical genetic techniques (Gray & Vasil, 1981a; Hanne et al., 1983). Similarly, a
chromosomal gene controlling phospholipase C production has been identified (Gray & Vasil,
1981 b). Both of these potential virulence factors are normally expressed in PAO, but others may
be expressed only following a mutation, for example, alginate production leading to a mucoid
phenotype which is so common in P. aeruginosa isolated from the sputa of CF patients. Mucoid
mutants of PAO have been isolated in vitro and two chromosomal loci involved in the control of
alginate synthesis have been mapped (Govan & Fyfe, 1978; Fyfe & Govan, 1980; J. A. M. Fyfe
& J. R. W. Govan, unpublished).
A third approach to the genetic analysis of virulence involves the transfer of the relevant
gene(s) from a clinical isolate into a PAO background. This approach is applicable to both
chromosomally-encoded and plasmid-encoded characteristics, and has been used in the genetic
analysis of extracellular protease production (Wretlind et al., 1983) and transposable antibiotic
resistance (Sinclair & Holloway, 1982).
In the course of studying the intrinsic antibiotic resistance of P. aeruginosa strain PAO,
various loci associated with this characteristic have been mapped on the chromosome (Mills &
Holloway, 1976; Okii et al., 1983; Matsumoto & Terawaki, 1982). Functional aspects of the P.
aeruginosa outer membrane have been examined using an antibiotic 'supersusceptible' mutant
of strain 799 (Zimmerman, 1980; Angus et al., 1982; Darveau & Hancock, 1983). However,
genetic analysis of this strain proved unsuccessful (Angus et al., 1982).
The genetic basis of antibiotic hypersensitivity as expressed in clinical isolates of P.
aeruginosa has not, to our knowledge, been reported. May & Ingold (1972) postulated that the
normal resistance to carbenicillin might be plasmid-encoded, and that this plasmid may some¬
times be lost during growth in the respiratory tract. However, no evidence was presented to
support this hypothesis. The present paper describes the genetic mapping of antibiotic hyper¬
sensitivity in the clinical isolate 492c (Irvin et al., 1981) by means of inter-strain crosses with
suitably marked PAO recipients, followed by transductional analysis using phage F116L
(Krishnapillai, 1971). A preliminary report of this work has been presented (Fyfe & Govan,
1983).
METHODS
Bacteria and bacteriophages. The bacterial strains used in this study are shown in Table 1. Donor strains
carrying the plasmid R68.45 were constructed according to Haas & Holloway (1976). Phage F116L (Krishnapillai.
1971) was used for transduction and F116c for strain construction.
Media and cultural conditions. Nutrient broth (NB), nutrient agar (NA), and minimal agar have been described
previously (Fyfe & Govan, 1980). Amino acid supplements were added at a concentration of 1 mM. The antibiotics
used were carbenicillin (Pyopen; Beecham), methicillin (Celbenin; Beecham), benzyl penicillin (Crystapen;
Glaxo), ampicillin (Penbritin; Beecham), flucloxacillin (Floxapen; Beecham), mecillinam (Leo Pharmaceuticals),
cefuroxime (Zinacef; Glaxo), cefoxitin (Mefoxin; MSD), tetracycline (Glaxo), trimethoprim lactate (Wellcome),
nalidixic acid (Winthrop), novobiocin (Sigma), rifampicin (Roche), streptomycin (Glaxo), gentamicin (Roussel),
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Table 1. Strains of P. aeruginosa used in this study
Strain Genotype/Description* Reference
PAOl Prototroph, chl-2 Holloway (1969)
PA02 ser-3 Isaac & Holloway (1968)
PA04 arg-47 pyrB52 B. W. Holloway collection
PA08 met-28 ilv-202 str-1 Isaac & Holloway (1968)
PA0222 met-28 trp-6 lys-12 his-4 ilv-226 pro-82 Haas & Holloway (1976)
PA0969 proCHO Rella & Haas (1982)
PA06002 met-9011 amiE200 nalB4 Rella & Haas (1982)
PA06006 proC130 nalB9 Rella & Haas (1982)
PA06511 proC130 blsA2 This paper
PA06524 proC130 nalB4 derivative constructed using F116c This paper
PA06526 Pro+ transductant of PA06511 constructed using F116c This paper
GMA037 hisV5037 Mee & Lee (1967)
492a Clinical isolate, mucoid, prototrophic, tpsA Irvin et al. (1981)
492a Leu" Leucine auxotroph isolated from 492a following EMS This paper
mutagenesis
492c Clinical isolate, mucoid, prototrophic, blsAl tpsAI Irvin et al. (1981)
492c Leu" Leucine auxotroph isolated from 492c following EMS This paper
mutagenesis
PAJ1 Prototrophic, tpsAI blsAl recombinant from cross 492c This paper
Leu"R68.45 x PA08
PAJ2 Prototrophic, bisAI recombinant from cross 492c Leu~R68.45 This paper
x PA08
PAJ3 Prototrophic, tpsAI recombinant from cross 492c Leu"R68.45 This paper
x PA08
PAJ5 met-28 tpsAI, recombinant from cross 492c Leu" R68.45 x PA08 This paper
PAJ6 ilv-202 tpsAI, transductant of PAJ5 using F116c grown on PA08 This paper
met+
* Genotype symbols are the same as those used for E. coli\ blsA designates sensitivity to /J-lactam antibiotics,
tpsA sensitivity to trimethoprim, ami acetamide utilization and str resistance to streptomycin.
tobramycin (Lilley), and kanamycin (Bristol Laboratories). All antibiotics were incorporated in Diagnostic
Sensitivity Test Agar (DSTA; Oxoid) at the appropriate concentration.
Broth cultures were grown in McCartney bottles on an orbital incubator (Gallenkamp) at 140 r.p.m., and all
cultures were incubated at 37 °C, unless stated otherwise.
Isolation of mutants. Auxotrophic mutants were isolated after EMS mutagenesis (Watson & Holloway, 1976)
and carbenicillin enrichment (Watson & Holloway, 1978).
Carbenicillin-hypersensitive mutants were isolated following EMS mutagenesis and screening of colonies by
replica plating onto DSTA plates containing 5 pg carbenicillin ml"1.
Antibiotic sensitivity testing. Exponential phase NB cultures were diluted in physiological saline to a concentra¬
tion of 105 organisms ml"1. A multiple inoculator (Mast) was used to dispense samples (containing 102—103 cells)
onto DSTA plates appropriately supplemented with the antibiotics. The MIC was read as the lowest concentra¬
tion of antibiotic that caused complete growth inhibition after 18 h incubation at 37 °C.
Plate matings. The procedure used was that described by Stanisich & Holloway (1972). Prior to inter-strain
matings, NB cultures of the recipient strains were incubated for 18 h at 43 °C (Rolfe & Holloway, 1966).
Transductions. These were performed according to the method of Krishnapillai (1971).
RESULTS
Antibiotic sensitivities
It has previously been reported that 492a and 492c differ in their sensitivities to carbenicillin,
azlocillin, piperacillin, ticarcillin, methicillin, tetracycline and trimethoprim (Irvin et al., 1981).
We determined the MICs of an extended range of antibiotics for 492a and 492c, and the
results are shown in Table 2. Strain PA08 was also included to confirm that the MICs obtained
for this strain were comparable with 492a and not the hypersensitive 492c. However, 492a was
five times more sensitive to trimethoprim than PA08. Table 2 shows that 492c is generally
hypersensitive to the /I-lactam antibiotics with the following exceptions: benzyl penicillin,











Fig. 1. Genetic map of P. aeruginosa showing markers relevant to this study. Based on Holloway &
Crockett (1982).
Table 2. Sensitivities of P. aeruginosa strains 492a, 492c and PA08 to antibiotics
MIC (pg ml ')
A .
Antibiotic Strain 492a 492c PA08
Carbenicillin 80 0-6 40
Methicillin >500 10 500
Benzyl penicillin 500 500 >1000
Ampicillin 100 100 200
Flucloxacillin >500 50 >500
Mecillinam 500 10 500
Cefuroxime >500 10 400
Cefoxitin 400 400 500
Cephaloridine 500 500 >1000
Chloramphenicol 40 10 60
Tetracycline 10 6 10
Trimethoprim 40 5 200
Nalidixic acid 60 2 80
Novobiocin >500 100 500
Rifampicin 40 40 20
Streptomycin 40 40 >500*
Gentamicin 0-6 0-6 0-6
Tobramycin 0-4 0-4 0-2
Kanamycin 60 60 60
* PA08 is resistant to streptomycin due to the str-1 locus.
ampicillin, cefoxitin and cephaloridine. Increased sensitivity to trimethoprim was confirmed
for 492c, and also noted for nalidixic acid and novobiocin. No differences between 492a and
492c were observed for rifampicin, streptomycin, gentamicin, tobramycin or kanamycin.
Transfer of antibiotic hypersensitivity from 492c to PAO
Figure 1 is a chromosome map of P. aeruginosa PAO showing the locations of markers
relevant to this study. A donor derivative of 492c was prepared by isolating a Leu" mutant, and
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Table 3. Results of recombinant analysis following a plate mating between 492c Leu
and PA08
Percentage co-inheritance of unselected character
t A 1
Selected marker CEF5* TPsf Met+ Ilv +
met-28+ 80 82 - 77
ilv-202 75 88 87
* CEFS designates sensitivity to 100 jag cefuroxime ml-1,
f TPS designates sensitivity to 100 pg trimethoprim ml-1.
transferring R68.45 into this strain. Plate matings were performed between 492c Leu" (R68.45)
and the multiple-marker recipient PA0222. Selection was made for each of the auxotrophic
markers and 100 recombinants for each marker were scored for co-inheritance of cefuroxime
sensitivity (on DSTA plus 100 pg cefuroxime ml-1). Increased sensitivity to cefuroxime rather
than carbenicillin was chosen initially to avoid any problems associated with the inheritance of
R68.45 by some of the recombinants (R68.45 codes for a type Ilia /^-lactamase which is active
against carbenicillin but not cefuroxime). Recombinant analysis revealed that 56% of the met-
28 + colonies were sensitive to 100 pg cefuroxime ml"1 and likewise 20% of the trp-6+ colonies.
Less than 1 % of the recombinants for the other markers, i.e. ilv-226, his-4, lys-12 and pro-82 had
co-inherited this characteristic.
In order to map the locus associated with increased cefuroxime sensitivity more precisely, a
plate mating was performed between 492c Leu" (R68.45) and PA08 (met-28 ilv-202). Selection
was made for both auxotrophic markers and recombinants scored for both cefuroxime and
trimethoprim sensitivity (on DSTA plus 100 pg trimethoprim ml"1). The results of this
recombinant analysis are shown in Table 3, and indicate that cefuroxime sensitivity (CEFS) and
trimethoprim sensitivity (TPS) do not always cosegregate. All CEFS recombinants were TPS, but
a percentage of the TPS colonies were CEFr.
The MICs for representatives of each recombinant class, i.e. CEFS TPS, CEFr TPS and
CEFr TPr, were determined using those antibiotics to which 492c is hypersensitive, i.e.
carbenicillin, methicillin, flucloxacillin, mecillinam, cefuroxime, chloramphenicol, trimetho¬
prim, nalidixic acid and novobiocin.
All CEFr TPr recombinants (three tested) were indistinguishable from PA08 on the basis of
MICs to these antibiotics. The CEFS TPS group (eight tested) could be subdivided on the basis of
their trimethoprim, nalidixic acid and novobiocin MICs. Three recombinants were very
sensitive to these antibiotics with trimethoprim and novobiocin MICs of lOpgml"1, and a
nalidixic acid MIC of 5 pg ml"'. The other CEFS TPS recombinants were moderately sensitive
with the following MICs: trimethoprim 60pgml~', novobiocin SOpgml"1, nalidixic acid
20 pg ml"1. All eight recombinants were equally sensitive to the /I-lactam antibiotics and
chloramphenicol, and with the exception of cefuroxime were as sensitive as 492c. The third class
of recombinant, CEFr TPS (five tested), displayed moderate sensitivity to trimethoprim,
nalidixic acid and novobiocin, with MICs of 60pgml_1, 20pgml_1 and lOOpgml"1,
respectively.
From these results, we postulated that the antibiotic hypersensitive phenotype of 492c is
determined by two separate genes, both linked to met-28 and ilv-202, when transferred into
PA08. We propose to call these genes blsAl, coding for hypersensitivity to certain ^-lactams and
a moderate sensitivity to trimethoprim, nalidixic acid and novobiocin; and tpsAl coding for
increased sensitivity to the latter three antibiotics but not the /Mactams. Table 4 shows the
relevant MIC values for PA08 and three typical recombinant strains PAJ1 (blsAl tpsAl),
PAJ2 (blsAl) and PAJ3 (tpsAl).
Transfer of tpsAl from 492a to PA08
As shown in Table 2, the trimethoprim MIC for 492a is fivefold less than for PA08. In
addition, the increased sensitivity of 492c to trimethoprim, compared with 492a (eightfold), is of
the same order as the MIC difference between PAJ1 and PAJ3 (sixfold) (see Table 4).
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Fig. 2. Approximate locations of blsA and tpsA on the basis of results obtained from plate matings
between 492c Leu" (R68.45) and PA08.
Table 4. Antibiotic sensitivities of PA08 and typical recombinant strains PAJ1, PAJ2 and PAJ3
MIC (pg mb1)
PAJ1 PAJ2 PAJ3
Antibiotic Strain . PA08 (blsAl tpsAl) (blsAl) (tpsA)
Carbenicillin 40 0-4 0-4 40
Methicillin 500 10 10 500
Flucloxacillin >500 50 50 >500
Mecillinam 500 10 10 500
Cefuroxime 400 100 100 400
Chloramphenicol 40 20 20 40
Trimethoprim 200 10 60 60
Nalidixic acid 80 5 20 20
Novobiocin 500 10 50 10
On this basis, we proposed that tpsAl is present in both 492a and 492c, and that the antibiotic
hypersensitivity of the latter strain can be explained by a mutation at the bisA locus, i.e. there is
only a single gene difference between 492a and 492c accounting for antibiotic hypersensitivity.
Using the mapping procedure already described for 492c, a donor derivative of 492a [492a
Leu" (R68.45)] was plate mated with PA08, and the met+ and ilv+ recombinants scored on
DSTA containing either 100 pg trimethoprim ml"1 or 100 pg cefuroxime ml"1. As expected, a
proportion of recombinants failed to grow well on trimethoprim, though all grew well on
cefuroxime.
Mapping of blsA and tpsA by transduction using phage F116L
From the plate mating results, it was possible to assign approximate chromosomal locations to
blsAl and tpsAl relative to ilv-202 and met-28 (see Fig. 2). Flowever, to map these loci more
precisely with respect to other markers in the 30 min region, transductional analysis was
performed.
In the case of blsAl, a preparation of F116L was grown on PAJ2 and used to transduce
recipient strains carrying the auxotrophic markers met-28 (PA08), ilv-202 (PA08), proC130
(PA0969) and pyrB52 (PA04). Selection was made for these markers and cotransduction of
blsAl scored on DSTA plus 5 pg carbenicillin ml"1.
In the case of tpsAl, transducing preparations of F116L could not be propagated on any
recombinants containing this marker, as they did not appear to support vegetative growth.
However, tpsAl strains retained the receptors for this phage as they were good recipients in
F116L-mediated transductions, so in order to map this locus, an ilv-202 tpsAl derivative, PAJ6,
was constructed (via the intermediate strain PAJ5) and used as recipient in transductions
mediated by F116L propagated on either PAOl, PA02 (ser-3) or GMA 037 (hisV5037). In each
case selection was made for ilv+ transductants and these were scored for co-inheritance of tpsA +
and where appropriate, the unselected auxotrophic markers. Figure 3 shows the locations
obtained for bisA and tpsA.
Isolation of a bisA mutant of PA0969
Working on the hypothesis that 492c could have arisen from 492a by a single step mutation at
the bisA locus, we postulated that a similar blsA mutant could be isolated from a PAO strain.
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Fig. 3. Mapping of tpsAl and blsAl by transduction. Values indicate percentage cotransduction using
phage F116L (the mean of several experiments scoring at least 200 transductants). Arrowheads point to
the unselected marker.



















* In each case, selection was made for proC+ and 200 transductants were scored for the co-inheritance of
nalB4+l~ and blsA2*>~ on DSTA plus 50 pg and 5 pg carbenicillin ml"1, respectively.
PA0969 was mutagenized with EMS and the potential mutant colonies screened for hyper¬
sensitivity to carbenicillin by replica plating to DSTA plates containing 5 pg carbenicillin ml"
From approximately 5000 colonies screened, one failed to grow on medium containing
carbenicillin. Fortuitously, this mutant (PA06511) exhibited a similar antibiogram to the blsAl
recombinants, i.e. PA06511 was highly sensitive to carbenicillin, moderately sensitive to
cefuroxime, trimethoprim, nalidixic acid, novobiocin and chloramphenicol, but remained
resistant to cefoxitin, cephaloridine and benzyl penicillin. However, PA06511 was more
resistant to methicillin, mecillinam and flucloxacillin than a bisA1 transductant of PA0969.
F116L transductions revealed 33% cotransduction between proC and the mutant locus.
Furthermore, when F116L propagated on PAJ2 was used to transduce PA06511, selecting for
proC+, <0-5% of the transductants were able to grow on 5 pg carbenicillin ml-1, indicating a
very close linkage between blsAl and the PAO mutation, which, on this basis, we have
designated blsA2.
Relationship between blsA and nalB
Rella & Haas (1982) have described a class of mutants (nalB) in strain PAO which are
resistant to nalidixic acid, novobiocin, carbenicillin and various other /Mactams. We examined
two nalB mutants PA06002 (nalB4) and PA06006 (nalB9) to determine whether they showed
increased resistance to cefuroxime, trimethoprim, methicillin and chloramphenicol. Both
strains showed increased resistance to all four antibiotics with the following relative MICs with
respect to PA0969: cefuroxime, x3; trimethoprim, x6; methicillin, x5; chloramphenicol,
x 10.
nalB has been mapped at 32 min on the PAO chromosome, distal to pyrB using G101 trans¬
duction (Rella & Haas, 1982), so we determined the location of bisA2 with respect to this locus,
using strains PA06511 and PA06002. In order to perform reciprocal transductions, a proC
derivative of PA06002 (PA06524) and a proC+ derivative of PA06511 (PA06526) were
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constructed using F116c. Reciprocal transductions using F116L were performed between the
bisA and nalB strains, in each case selecting for Pro+ transductants and scoring for bisA and nalB
on DSTA plates containing 5 pg and 50 pg carbenicillin ml"1. The results obtained are shown in
Table 5, and suggest that bisA and nalB are separate, but closely linked loci, the gene order being
proC-nalB-blsA.
DISCUSSION
Previous genetic studies on the intrinsic resistance of P. aeruginosa strain PAO have identified
various chromosomal loci associated with this characteristic. Thus we tested the hypothesis that
the loss of intrinsic resistance in 492c was due to a chromosomal mutation, rather than loss of a
plasmid as suggested by May & Ingold (1972). Inter-strain crosses between 492c Leu" (R68.45)
and PA08 identified two distinct loci, in the 30 min region of the chromosome, associated with
antibiotic sensitivity. The first of these, blsA, is associated with sensitivity to the /Tlactams
carbenicillin, methicillin, flucloxacillin, mecillinam and cefuroxime, and also the non-/Mactams
chloramphenicol, trimethoprim, nalidixic acid and novobiocin and cannot be transferred to
PAO from 492a.
The isolation of a blsA derivative of PAO following EMS mutagenesis provides further
evidence that 492c could have arisen from 492a in vivo following a single-step mutation which
was then selected out in the lung environment. This mutation-selection mechanism is also
responsible for the emergence of mucoid strains of P. aeruginosa during the course of chronic
pulmonary infections in CF patients. All strains of P. aeruginosa have the necessary structural
genes to synthesize alginate, but these are normally subject to repression. Mutation in a regulator
gene close to the major FP2 origin results in derepression of alginate synthesis giving rise to a
mucoid strain (Govan & Fyfe, 1978; Fyfe & Govan, 1980; J. A. M. Fyfe & J. R. W. Govan,
unpublished).
Three major questions remain to be answered regarding antibiotic hypersensitivity associated
with respiratory isolates. Firstly, whether all such isolates have the same mutation as 492c or
whether they form a genetically heterogeneous group. We have examined several pairs of strains
(i.e. hypersensitive and 'normal' from the same sputum specimen) isolated from different
patients on the basis of antibiotic sensitivities and in general, the antibiograms have been
similar to 492a and 492c (results not shown). Genetic analysis of one other hypersensitive strain
gave identical results to those obtained with 492c, even though this strain was isolated from a
different patient and was of a different pyocin type. However, further work is required to
determine whether the blsA locus is the only one involved in clinically associated antibiotic
hypersensitivity.
Secondly, we would like to know the structural basis of this characteristic. We have previously
reported that 492c has two extra outer membrane proteins when compared with 492a (Irvin et
al., 1981), but further studies have failed to confirm that these are associated with antibiotic
sensitivity.
Several studies on the structural basis of antibiotic hypersensitivity in P. aeruginosa have been
reported (Noguchi et al., 1980; Curtis et al., 1981; Angus et al., 1982; Zimmerman, 1980;
Kropinski et al., 1982; Darveau el al., 1983) and these have suggested that increased
permeability of the cell envelope is responsible for this characteristic. In the case of 799/61, a
'supersusceptible' mutant of strain 799 (Zimmerman, 1979), alterations in the LPS composition
have been detected (Kropinski et al., 1982; Darveau et al., 1983). Similar mutants (envA) have
been reported in Escherichia coli (Grundstrom et al., 1980; Boman et al., 1974).
The close linkage of bisA and nalB on the P. aeruginosa chromosome is interesting in view of
the fact that nalB mutants are more resistant to those antibiotics to which bisA strains are hyper¬
sensitive, and it is tempting to speculate that these two loci form part of a gene cluster controlling
outer membrane permeability in this organism.
Finally, the clinical and biological significance of antibiotic hypersensitivity remains to be
elucidated. Superficially it appears paradoxical that hypersensitive strains arise in patients
undergoing aggressive antibiotic therapy, often with ^-lactams. The lung, however, is a
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notoriously difficult site in which to achieve therapeutic levels of anti-pseudomonas antibiotics,
and in this environment the vulnerability of hypersensitive strains may be more apparent than
real.
Mutations to increased antibiotic sensitivity are also encountered amongst naturally occurring
gonococci (Eisenstein & Sparling, 1978; Lysko & Morse, 1981) and it has been suggested that
mucosal surface pathogens may find it advantageous to be flexible with respect to outer
membrane structure and that increased permeability may aid colonization in this environment
(Lysko & Morse, 1981).
The emergence of antibiotic-hypersensitive strains of P. aeruginosa during the course of
chronic pulmonary infections, regardless of the selective pressure, provides yet another example
of this organism's ability to adapt to a changing environment.
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Historically, interest in bacterial exopolysaccharid.es has been chiefly
medically orientated. The association of capsule production with virulence
has been noted in several important bacterial pathogens, the earliest example
being Streptococcus -pneumoniae (pneumococcus). The virulence of pneumococci
for man and animals was found to depend on production of a polysaccharide
capsule which surrounds the organism and protects it from phagocytosis. Non-
capsulate mutants of pneumococci occur spontaneously and are easily recognised
on agar medium as they lack the glossy, mucoid appearance characteristic of
wild-type, capsulate strains. These non-capsulate mutants are easily phago-
cytosed in vivo and are avirulent. Griffiths (ref. 1) showed in 1928 that
when a mixture of live, non-capsulate and dead, capsulate pneumococci was
injected into mice, some of the mice died of septicaemia and from the blood of
these mice, live capsula.te pneumococci were isolated. This was the first
demonstration of genetic transformation and was thought by Griffith to be
mediated by the polysaccharide itself. However, it was later shown by Avery
(ref. 2) that DNA was responsible.
Further evidence for the role of capsules as virulence factors was obtained
by comparative observations on capsulate and non-capsulate variants derived
from the same strain of various other bacterial species.
Examples of bacterial species where evidence has been obtained for the
significant virulence-enhancing role of a capsule are Bacillus arthracis.
Yersinia pestis. Klebsiella -pneumoniae. Haemophilus 1 nflu.en7.ae and various
species of Streptococci. It must be emphasised that capsule production per se
is not sufficient to ensure virulence in a bacterial species but it undoubtedly
contributes to the overall pathogenic mechanism.
From the earliest studies it became evident that many harmless, saprophytic-
bacteria, including those found in soil or aquatic environments were heavily
capsulate. The role of exopolysaccharides in nature has not been clearly
established and is probably diverse and complex. It has been suggested that
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they may protect against dessication, phagocytosis and phage attack (refs. 3>
I4), or high oxygen tension (ref. 5), participate in uptake of metal ions
(refs. 3, 1+), as adhesive agents (ref. 6) or ATP sinks (ref. 7) or he involved
in interactions between plants and bacteria (ref. 8) or have a possible role
in developmental systems such as those found in Myxobacteria (ref. 9).
Industrial microbiologists have become increasingly aware of the commercial
potential of procaryotic exopolysaccharides as gelling and emulsifying agents
but at the same time are faced with the troublesome consequences of exopoly-
saccharide production through the formation of bacterial aggregates which
reduce fluid flow in a variety of industrial pipe systems. This phenomenon
of bacterial adhesion through the agency of exopolysaccharides poses a
particular problem in pipe systems which are not readily accessible such as
those found in deep water and/or associated with oil recovery. It is
fascinating to have observed in the last decade the role of exopolysaccharides
in the almost ecumenical development of the various fields of microbiology.
Studies by industrial and agricultural microbiologists on the role of exo¬
polysaccharides in bacterial adhesion as an industrial hazard, or as a mechanism
of specific adhesion to specific plant hosts, would appear to have re-awakened
medical microbiologists to the significant role of exopolysaccharide-mediated
adhesion in explaining the localisation of many pathogenic bacteria to
specific anatomical sites and surfaces.
The consequences of the virtual explosion of interest in adhesion as a
virulence determinant for specific bacterial pathogens have been observed in
several well-known bacterial infections. The adherence and localisation of
Streptococcus mutans to the surface of teeth following conversion of dietary
sucrose to a glucan "cement matrix", and the consequent dental caries which
ensues, is only one of many striking examples in medical microbiology of the
importance of bacterial exopolysaccharides in localisation and adherence of
bacteria to specific human or animal tissues. Knowledge of the determinants
of microbial pathogenicity in human, plant and animal hosts is often thwarted
by the limitation of in vitro experiments and the necessity to assess results
in the context of their relevance in vivo.
The role of exopolysaccharide adhesion in nature and the limitations of
in vitro observations were noted by Costerton et al. (ref. 10). The authors
drew attention to the fact that certain bacteria cultured for long periods
in laboratory conditions lost certain properties normally possessed in their
natural environment. Thus microbes that apparently produce no exopolysaccharide
in vitro appear to have lost the ability. In nature, the same microbes adhere
to a variety of surfaces ranging from the bovine intestine to rocks in fast
moving streams by a tangle of fibres of exopolysaccharide that extends from
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the bacterial surface to form a felt-like glycocalyx surrounding an individual
cell or colony of cells.
On first consideration a precise distinction between the terms capsule and
slime as they are presently used and the term glycocalyx might appear
semantic and unnecessary. However, it is arguable that the concept.of a
distinct bacterial glycocalyx and its role in adhesion in vivo has merit.
The term glycocalyx may be useful if it defines those cell-associated exo-
polysaccharides or protein complexes produced in vivo which resemble bacterial
capsules or slime but which are lost or difficult to observe in vitro.
Within the wide diversity of microbial exopolysaccharides both in relation
to composition and function, bacterial alginate occupies an unusual and
fascinating position.
Alginate is a 1, It linked copolymer of g-D-mannuronic acid and its C-5
epimer a-L-guluronic acid (Fig. 1), and is a commercially important poly¬
saccharide with gelling and colloidal properties. It has a variety of uses,
e.g. as an ingredient of photographic emulsions and dental impression material
and as an additive in various foodstuffs, e.g. ice-cream, jellies and beer











Fig. 1. The structure of alginic acid.
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Together with cellulose, hyaluronic acid and sialic acid, alginate is one
of the few polymers synthesised hy eucaryotic and procaryotic systems. The
present source of commercial alginate is eucaiyotic namely from marine algae.
However, amongst the procaryotes, two bacterial genera are known to contain
species capable of alginate production, Azotobacter and Pseudomonas. The
present chapter attempts to collate our current scanty knowledge of bacterial
alginate in particular its synthesis, regulation and biological significance.
BIOSYNTHESIS AMD FUNCTION OF BACTERIAL ALGINATE
The genera Pseudomonas and Azotobacter
Members of the genus Pseudomonas (refs. 11, 12) are common inhabitants of
soil, fresh water and marine environments. Some species cause diseases of
plants, while others are occasional human and animal pathogens. The cells
are gram negative straight or curved rods 0.5-1 urn by 1.5-1+ urn and are motile
by means of polar flagella. They are strict aerobes, except for those species
which can use denitrification as a means of anaerobic respiration. They are
among the most metabolically versatile organisms known and are able to utilise
a wide variety,of organic compounds as sole sources of carbon and energy. The
most commonly encountered species belong to the fluorescent group, e.g.
P. aeruginosa, P. fluorescens and P. putida. These produce characteristic,
water soluble, fluorescent yellow-green pigments. The G + C content of the
DNA ranges from 58-70 moles %.
Members of the genus Azotobacter (refs. 11, 12) are also soil and water
inhabitants and are able to fix N^ under aerobic conditions. The cells are
gram negative plump rods or cocci, characteristically paired and often con¬
taining granules of poly-B-hydroxybutyrate. In young cultures the cells are
motile by means of polar or peritrichous flagella. Three species, i.e.
A. chroococcum, A. bei.jerinckii and A. vinelandii produce distinctive resting
cells called microcysts which are resistant to dessication. Most strains of
this genus characteristically produce large amounts of exopolysaccharide and
give smooth glistening colonies on agar medium (Fig. 2). Some strains produce
a green fluorescent pigment and the G + C content of the DNA ranges from
63-66 moles %.
The discovery of bacterial alginates
The synthesis of alginate-like polymers by bacteria was first reported
in 1961+, when Linker and Jones (ref. 13) isolated and partially characterised
the exopolysaccharide from a mucoid strain of Pseudomonas aeruginosa (Fig. 3)
isolated from the sputum of a patient with cystic fibrosis (CF). They showed
using paper chromatography that the substance was a polyuronide with properties
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Pig. 2. A strain of A. vinelandii on nitrogen-free medium with glucose.
Pig. 3. Clinical isolates of P. aeruginosa grown for 21+ h on Difoo Pseudomonas
Isolation Agar (PIA). On the left, a classical non-mucoid strain and on the
right, an alginate-producing mucoid strain.
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similar to alginic acid. This finding was confirmed and extended by Carlson
and Matthews (ref. II4) in 1966 in a study of 13 mucoid strains of P. aeruginosa
from CP and non-CP sources. All were found to produce mannuronic and
guluronic acids but the authors were unable to say at this stage whether
these were present as homopolymers or as a heteropolymer. Linker and Jones
(ref. 15) further analysed the polymer from their strain and demonstrated the
presence of acetyl groups as well as confirming the strong resemblance to
algal alginate on the basis of composition, structure and physical properties.
In the same year (1966), Gorin and Spencer (ref. 16) demonstrated that the
polysaccharide produced by a strain of A. vinelandii was similar in most
respects to algal alginate, but was partly acetylated.
Biosynthesis of alginate by A. vinelandii
The production of copious amounts of capsular polysaccharide is character¬
istic of the majority of strains of A. vinelandii isolated from the environment
and the identification of this capsular material as an alginate-like polymer
aroused the interest of industrial biochemists interested in developing an
alternative source of this useful compound. Such workers sought to elucidate
the biosynthetic pathway and the conditions leading to maximal production of
alginate (refs. 17-23).
Haug and Larsen (refs. 17, 18) showed that polymannuronic acid is the first
polymeric product of alginate biosynthesis produced by vegetative cells of
A. vinelandii and that the final polymer contains regions of homo and hetero-
polymeric blocks, much like the alginate from brown algae.
As part of a project to investigate the commercial feasibility of producing
alginate by fermentation, Pindar and Bucke (ref. 19) determined the sequence
of reactions involved in alginate biosynthesis from sucrose in A. vinelandii
NCIB 9068 by feeding radioactive intermediates to cell-free extracts of the
bacteria and by studying the individual enzymes. The pathway previously
determined by Lin and Hassid (refs. 2bt 2$) for the biosynthesis of alginate
in the brown algae Pucus gardneri was used as a starting point (Pig. U) •
It should be noted that in this study it was concluded that the
epimerisation of mannuronic acid to guluronic acid took place at the monomer
level, but in a later study Madgwick et al. (ref. 26) were able to extract a
polymannuronic 5-epimerase from brown algae, the presence of which had been
hard to prove because the algal enzymes are difficult to extract due to the
presence of large amounts of sulphated polysaccharides and phenolic compounds.
The results obtained by Pindar and Bucke for their strain of A. vinelandii
suggested the pathway set out in Fig. $.
No evidence for the formation of free GDP-guluronic acid was found at any
stage in the reaction - the intermediate between GDP-mannose and the polymeric
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Hexokinase
MAHNOSE + ATP MAHNOSE 6-P + ADP
Phosphomannomutase
MANNOSE 6-P MANNOSE 1-P
Guanylytransferase
MANNOSE 1-P + GTP GDP-MANNOSE + PP
Dehydrogenase
GDP-MANNOSE + NAD(P) GDP-MANNTJBONIC ACID + NAP(P)H
5-Epimerase




Pig. 1;. Biosynthetic pathway for the production of alginic acid from mannose
in Pucus gardneri (ref. 25).
material was GDP-mannuronic acid. The composition of the final polymeric
product was analysed using partial acid hydrolysis to isolate homopolymeric
Blocks followed hy fractionation at pH 2.85 to separate polymannuronic acid
Blocks from polyguluronic acid Blocks. This procedure indicated that 86/, of
the polymeric product was in the form of an alternating sequence of mannuronic
and guluronic acid units, 10.1$ was polymannuronic acid Blocks and 3.6/0
polyguluronic acid Blocks, although this composition varied with growth con¬
ditions.
The authors did not determine at what stage the acetyl groups were intro¬
duced or their association with mannuronic acid or guluronic acid units. The
physical location of the polymannuronate epimerase was also to Be determined.
Davidson et al. (ref. 27) later showed that the acetyl groups were
associated with mannuronic acid residues and suggested that they may play a
role in protecting certain of these residues from epimerisation.
An investigation of the physiology of alginate production By A. vinelandii
NCIB 9068 (ref. 20) revealed that in Batch culture, under phosphate-deficient
conditions, alginate synthesis occurred during growth and ceased when the
cells entered stationary phase. In a continuous culture system under phosphate
limitation the rate of alginate synthesis was independent of specific growth
rate. However, by manipulating the conditions of fermentation, e.g. By
altering the calcium ion concentration, the molecular weight and viscosity of
the product could Be varied. Likewise, when growth was limited By a variety
of nutrients (ref. 21) including carbon source (sucrose), the rate of alginate
synthesis varied only slightly. The only exception was oxygen limitation
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Fig. Pathway of biosynthesis of alginio acid in A. vinelandii (ref. 19)•
availability was increased by altering the fermenter agitator speed, the
specific respiration rate went up and the conversion efficiency for sucrose
into alginate fell from an optimum of hV/o to 8% (ref. 22).
In some bacteria, exopolysaccharide synthesis appears to share common
precursors and co-factors with cell wall synthesis (ref. 9)> hence competition
for these intermediates would take place and rate of polysaccharide synthesis
would be influenced by growth rate. However, the apparent independence of
the rate of alginate synthesis from specific growth rate in A, vinelandii 9068
suggests that this system may not operate in this case (ref. 22).
A later study (ref. 23) using a mutant of strain 9068 with enhanced ability
to synthesise alginate, showed that in this strain, alginate production
continued after the cessation of growth. Activities of the enzymes phospho¬
mannose isomerase, GDP marmose pyrophosphorylase and GDP mannose dehydrogenase
were found to correlate with the amount of alginate produced.
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Sucrose was found to be the best carbon source in terms of alginate/
bacterial mass ratio and no alginate was produced when mannose or sorbitol
were used as the carbon source. The authors concluded that the biosynthesis
of alginate is controlled through the specific activities of the enzymes
involved, by an unknown mechanism. No significant regulation through feed¬
back inhibition appears to exist.
Alginate production and cyst formation in A. vinelandii
Concurrent with the studies on the biosynthesis of alginate in A. vinelandii
described in the previous section, Sadoff and his colleagues were investigating
the cellular differentiation cycle leading to encystment and germination in
this organism (refs. 28-33)* The life cycle of A. vinelandii, as observed
by light microscopy is illustrated in Fig. 6.
Cysts are metabolically dormant cells which are more capable of with¬
standing dessication than vegetative cells and are viable in the laboratory







for at least 10 years kept in dry soil. They are also more resistant to
radiation and sonioation than vegetative cells. However, unlike the endo-
spores of gram positive organisms, cysts are not heat resistant.
In 1968, Lin and Sadoff (ref. 28) reported the association of a viscous
polymer with the encystment process of A. vinelandii ATCC 12837* Two other
groups (refs. 3k> 35) later published electronmicrographs of cysts stained
with ruthenium red revealing polysaccharide capsular material external to
the exine (outer coat) region (Fig. 7). Densely stained material along with
unstained regions were seen in the vicinity of the exine, while the intine
(inner coat) was also heavily stained.
The relationship of capsule production and cyst formation in A. vinelandii
ATCC 12837 was demonstrated by Eklund et al. (ref. 36) using three independent
methods.
1. When a phage-induced polysaccharide depolymerase (capable of depoly-
merising the capsular material) was added to encystment medium, the cells
were unable to form typical cysts, exine coats were partially destroyed and
intine was greatly reduced.
2. Under conditions unfavourable to polysaccharide production, i.e. when
ammonium nitrate was present in the culture medium, encystment did not take
place.
Fig. 7* Diagram of a ruthenium red stained cyst of A. vinelandii based on
an electronmicrograph (ref. 3k). C, capsular material, E, exine coat,
I, intine coat.
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3. Non-capsulate mutants of A. vinelandii 12837 were unable to form cysts.
Henoe, although capsule production per se is not necessarily followed by
encystment, it is a mandatory requirement for encystment to occur.
Chemical analysis of cyst fractions revealed that the intine and exine are
rich in protein, carbohydrate and lipid and contain high levels of calcium
and lesser amounts of magnesium (ref. 30)- It had also been noted that the
suspension of mature cysts in EDTA led to the disruption of the exine layer
(refs. 29, 37).
Page and Sadoff (ref. 32) examined the role of cations in the structure
and integrity of mature cysts and the role of calcium in the encystment
process. As part of this study, cyst fractions were examined for the presence
of uronic acids in the form of alginate and for polymannuronic acid 5-
epimerase activity. Mannuronic and guluronic acids in sequences characteristic
of alginate were demonstrated in both the intine and exine cyst fractions.
Proportions of the two uronic acids were found to differ between the two
fractions - the exine was notably rich in polyguluronic acid whereas the intine
was richer in polymannuronic acid, both contained approximately $CP/o hetero-
polymeric blocks. The composition of the intine material resembled the
vegetative ceil capsular material in block composition and mannuronic/
guluronic acid ratio. When calcium ions were omitted from the growth medium,
abortive encystment took place, i.e. the central bodies of the cysts were
normal but a viscous slime, rich in polymannuronic acid was produced rather
than the intine and exine coats. Polymannuronic acid 5-epimerase activity was
detected in the mature cyst central body and the culture fluid. This activity
was stimulated by the addition of calcium to the calcium-free encystment
culture fluid, suggesting that calcium was not required for the production of
the enzyme per se, rather for its activity.
The authors postulated that during encystment, polymannuronic acid is
initially secreted by the cell. In the presence of calcium, extracellular
polymannuronic J-epi^erase converts a large proportion of these residues to
guluronic acid. Guluronic acid residues have a high calcium binding capacity
(ref. 38) and alginate containing a significant amount of guluronic acid forms
a gel in the presence of calcium ions due to the formation of inter-chain
linkages. Alginate in this gel form has an even higher selectivity for
calcium ions. Hence the coalescence of the exine coat would reduce the
availability of calcium for epimerisation of the intine coat, so the propor¬
tion of guluronic acid in this fraction would be lower.
The role of the exine coat would appear to be the maintenance of cyst
rigidity and resistance to dessication. In addition, the properties of
radiation and sonication resistance are dependent on an intact exine (ref. 33)*
The function of the intine layer is less obvious, however, during germination
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there is a gradual loss of its ability to react with electron dense fixatives
and stains (ref. 39) suggesting that the contents of the intine may he used
as growth substrates.
Alginate-producing strains of P. aeruginosa
The increasing interest during the last decade in alginate-producing strains
of P. aeruginosa has arisen for reasons which are in striking contrast to
alginate synthesis in A. vinelandii. As already indicated, alginate pro¬
duction is characteristic of the majority of strains of A. vinelandii. In
contrast, alginate production in P. aeruginosa is extremely uncommon in
strains isolated from a wide variety of human, animal and environmental
sources, (ref. 1+0). The important exception to this rarity is the frequent
emergence of alginate-producing P. aeruginosa in the lungs of CP patients.
The significance of this now classic association in CP is that the increasing
predominance of alginate-producing pseudomonas in the lungs is paralleled with
clinical deterioration,increasing refractoriness to treatment with antibiotics
and a poor prognosis. Unfortunately, concurrent with the increased importance
attributed to alginate-producing P. aeruginosa in the last decade, there has
arisen considerable confusion in the literature regarding the nature of
pseudomonas exopolysaccharide,in particular the distinction between alginate
and the more general term slime which historically has been used to describe
the viscid liquid phase associated with broth cultures of P. aeruginosa grown
under particular conditions. Por the purpose of clarity, an attempt will be
made to rationalise the use of the terms mucoid, slime and alginate in the
light of present knowledge.
The initial recognition of a bacterial characteristic is often made at the
colonial level. In 19^9» Phillips (ref. 1+1), described six colonial types of
P. aeruginosa, viz., typical, coliform-like, rough, rugose, mucoid and dwarf.
The mucoid form (Pig. 3) which produced a large gelatinous colony within 21+ h
at 37°C on blood agar and which was shown to be associated with alginate
production (ref. 13) was observed in only two of the 128 isolates of
P. aeruginosa. The single representative of the dwarf type arose as a variant
from one of the mucoid isolates.
Mucoid strains of P. aeruginosa have been known to microbiologists since
their first reported isolation in 1927 by Sonnensohein (ref. 1+2). Until the
1960's however, only a few further isolations were reported (refs. 1+3, 1+1+).
The relative rarity of mucoid P. aeruginosa prior to the 1960's could be
explained by their colonial resemblance to Klebsiella aerogenes and their
misdiagnosis as this species. In the case of blood agar and MacConkey agar
cultures this misdiagnosis is undoubtedly still being made, partly because of
the poor production of the characteristic pigments pyocyanin and fluorescein
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in young cultures of mucoid P. aeruginosa, and further compounded by the poor
pigmentation associated with growth on these common diagnostic media. An
alternative explanation is that the rarity of mucoid P. aeruginosa was genuine.
Today, mucoid strains are almost solely isolated from the sputum produced in
chronic respiratojy infections in CP patients and indeed the presence of
mucoid P. aeruginosa has been suggested as a diagnostic feature of the disease
in older, previously undiagnosed patients (ref. 1+5)* In 19ii8, when Henriksen
(ref. 1+1+) described the isolation of a single mucoid strain, the life
expectancy of a CP patient was measured in months, today many patients survive
into adulthood. The increased isolation of mucoid P. aeruginosa reported by
Elston and Hoffman in 1967 (ref. 1+6) most probably resulted from the signifi¬
cant improvement in management and antibiotic therapy leading to a longer
survival and a greater reservoir for potential isolation of these strains.
Elston and Hoffman (ref. 1+6) noted that capsulation of mucoid P. aeruginosa
was not a constant finding, that when seen by the India ink technique (ref. 1+7)
capsules were irregular, indistinct and shown by only some of the individual
cells in a culture. Ve have observed that the presence or absence of a
discrete capsule for some strains is dependent on the level of Ca"1-1" ions in
the growth medium. As is the case with A. vinelandii (ref. 1+8), growth of
the alginate-producing P. aeruginosa l+92a (ref. 1+9) in low levels of calcium
resulted in release of the exopolysaccharide from the cells. On centrifugation,
this remained in the supernatant fraction and the cells appeared non-capsulate.
However, growth in medium containing 1 mM Ca++ resulted in the formation of
discrete capsules which remained attached to the cells even after washing.
This finding may have some relevance to the clinical situation as the bronchial
secretions of CF patients contain elevated levels of calcium.
The pioneering work of Doggett and colleagues (refs. 1+0, £0, $1) in the
1960's which first revealed the association of mucoid P. aeruginosa and CP
was accompanied by studies on the composition and properties of the exopoly¬
saccharide which by the end of the decade had been identified as an acetylated
heteropolymer of mannuronic and guluronic acids (refs. 13~15> 52) resembling
algal alginate and similar, to the polymer found in A. vinelandii (ref. 16).
Prom the earliest studies on P. aeruginosa, classic non-mucoid strains
belonging to Phillips colonial types 1 to 1+ (ref. 1+1) have been known to
produce viscid, slimy broth cultures particularly when incubation is prolonged
and in medium with a high carbon content. Indeed, slime production is so
characteristic of the species that its synthesis in medium containing U%
potassium gluconate has been long used as a diagnostic feature (refs. 1+1, 53)-
Unfortunately, in recent years, the teims mucoid material and slime have been
used indiscriminately and synonymously and considerable ambiguity can be found
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in the literature (ref. 51+) • This confusion is further compounded by a lack
of uniformity in the results of analyses carried out on slime extracted from
non-mucoid P. aeruginosa (Table 1).
TABLE 1









mannose, UNA, RNA, protein 55
mannose, glucose, rhamnose, galactose, 56, 57
glucosamine, galactosamine, glucuronic >
acid, DNA, RNA
mannose, glucose, rhamnose, glucosamine, 58
glucuronic acid, hyaluronic acid, UNA,
RNA, protein
mannose, glucose, fucose, galactose, 59
ribose, rhamnose, glucosamine,
galactosamine
A review of the literature indicates that whilst pseudomonas slime
undoubtedly exists and plays a part as a virulence determinant (refs. 57, 60),
the exact composition of this loosely-defined material is extremely variable
and dependent upon the strain, the cultural conditions and the method of
analysis. For the purpose of this chapter the term slime is restricted to the
viscid material consisting of UNA, protein and various polysaccharides which
is produced characteristically by all strains of P. aeruginosa. The term
mucoid is restricted to those strains producing the characteristic colonial
type 5 of Phillips within 2l+ h on agar media and producing an acetylated
alginate-like heteropolymer of mannuronic and guluronic acids.
The isolation of mucoid P. aeruginosa in vivo and in vitro
The association of mucoid strains of P. aeruginosa with chronic pulmonary
infection in CF patients is well recognised (refs. 1+0", 50, 61 —63)- Evidence
for their emergence in vivo was first provided by Boggett et al. (ref. 50)
who observed that in individual CF patients, initial colonisation is by non-
mucoid JE\_aeruginosa but, during the course of infection, mucoid isolates
gradually emerge and eventually come to predominate. In addition, when the
two forms are found in the same specimen, they belong to the same serotype
(ref. 63) and pyocin type (ref. 61+).
In contrast to their emergence in vivo, when cultured in vitro, mucoid
strains of P. aeruginosa tend to revert to the non-mucoid form. Zierdt
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and Schmidt (ref. 65) reported that serial transfer on solid medium gave rise
to the rapid loss of the mucoid character.
The first report of in vitro isolation of mucoid variants was that of
Martin (ref. 66) who, during the course of phage typing, noted rings of slimy,
mucoid growth around areas of phage lysis, while the background lawn remained
non-mucoid. Subculture from these slimy areas resulted in pure cultures of
mucoid colonies which looked and behaved like clinical isolates.
These mucoid variants had the same phage type and serotype as the non-
mucoid parent and thus were sensitive to the phage responsible for their
emergence. From this, Martin concluded that the mucoid variants had not been
selected from the non-mucoid population, but rather the presence of phage in
the lytip cycle was necessary for the continued expression of the mucoid
character. The term "pseudolysogeny" was used to describe this phenomenon.
Martin postulated that phage could also be responsible for the emergence of
mucoid strains in vivo, the source of which would be other strains of
P. aeruginosa, but no evidence for such mixed infections was presented.
An investigation of the influence of various substances on the stability of
mucoid P. aeruginosa in vitro (ref. 67) revealed that clinical and phage-
derived strains maintain their mucoid colonial form when serially subcultured
on desoxycholate citrate agar, or in sodium deoxycholate broth. However, the
genetic basis for the emergence of the mucoid characteristic remained obscure.
In 1978 we published an alternative method for isolating mucoid variants
in vitro without the use of phage (ref. 68). This method was based on the
observation that mucoid strains are slightly more resistant to some antibiotics
than the related non-mucoid forms (ref. 69). The selective agent of choice
is carbenicillin and the isolation procedure involves the following steps:
(Fig. 8).
n
1. Approximately 10 cells from an 18 h nutrient broth culture of
P. aeruginosa are spread on to the surface of nutrient agar plates containing
carbenicillin at a concentration of 1.5 times the MIC of the strain.
2. After 18 h incubation at 37°C, the resistant colonies are replica
plated from the antibiotic containing medium to PIA plates containing no
antibiotic.
3. After 18 h incubation at 37°C, the mucoid variants can be recognised as
distinctive, watery colonies against a background of non-mucoid growth (Fig. 9).
The frequency of isolation of mucoid variants from P. aeruginosa strain PAO
7
using this procedure is approximately 1 in 10' cells and this can be increased
ij.0-fold following mutagenesis with ethyl methanesulphonate (EMS). These
mucoid variants do not require the continued presence of the antibiotic for
mucoid colonial growth and infra-red spectroscopy of the exopolysaccharide has
indicated an acetylated polymer of mannuronic and guluronic acids.
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Pig. 8. Technique for the isolation of mucoid variants of P. aeruginosa
in vitro by selection for resistance to carbenicillin (ref. 68).
Carbenicillin is not the only antibiotic which can be used to select such
k V
mucoid variants - other penicillins and aminoglycosides were also used
successfully at a concentration of 1.5 times the MIC for the non-mucoid strain.
The ability to isolate mucoid derivatives of well characterised strains
and maintain them in vitro has led to progress in the physiological and
genetic studies of alginate synthesis in mucoid P. aeruginosa. In addition,
a modified version of the selection procedure has been used to isolate alginate-
producing variants of P. putida, P. fluorescens and P. mendocina, in which
species alginate biosynthesis had not previously been reported (ref. 70).












Pig. 9* Isolation of mucoid, mutants in vitro following oarbenioillin semi-
selection. PlA plate showing two mucoid colonies (indicated by arrows) amongst
a background of non-mucoid growth.
Biosynthesis of alginate by mucoid P. aeruginosa
Early studies (refs. 13, 15) which identified alginate from mucoid
P. aeruginosa employed clinical isolates cultured on Oxoid sensitivity test
agar for 2b h at 37°C. The first investigation in which the effect of growth
conditions on pseudomonas alginate biosynthesis was examined was that of Evans
and Linker (ref. 52). These authors grew three mucoid clinical isolates of
P. aeruginosa on various agar media and incubated at 12°C, 25°C or 37°C.,
Determination of maximal exopolysaccharide production was subjective, i.e. by
visual estimation of the ratio of transparent material to the amount of opaque
cellular material of a colony and the amount of bacterial exopolysaccharide
observed by the India ink technique (ref. b7)-
For each strain, a lower incubation temperature resulted in more exopoly¬
saccharide per cell, regardless of growth medium. Exopolysaccharide production
was enhanced by growth on MacConkey plates containing sodium chloride or
glycerol. Large batches of exopolysaccharide for analysis were obtained by
seeding the organisms on to MacConkey agar supplemented with j/o glycerol and
incubating at 25°C for four days.
Analysis of the material obtained in this way revealed that different strains
varied widely according to the mannuronic/guluronic acid ratio of the exopoly¬
saccharide. However, organisms isolated from the same patient at different
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times appeared to produce similar polymers. All the polymers were acetylated
and the acetyl content was proportional to the mannuronic acid content.
Molecular weights of all the pseudomonas alginates were higher than those of
the algal alginates tested.
A later investigation of the biosynthesis of alginate in batch culture
(ref. 71) ty a mucoid P. aeruginosa, isolated from a CF patient, showed that
in a glucose-yeast extract medium, exopolysaooharide was produced throughout
the growth phase and ceased simultaneously with growth as a result of glucose
exhaustion. In continuous culture, under nitrogen limited conditions, both
cell and exopolysaocharide concentrations were largely independent of dilution
rate. Polysaccharide was produced under all nutrient limitations tested
including carbon limitation.
An early observation made in our own laboratory in studies of mucoid,
alginate-producing mutants isolated in vitro from strain PA0381 (ref. 72) was
that certain mutants appeared to produce exopolysaocharide on both minimal
and complex media, e.g. PA0579, whilst other mutants, e.g. PA0568 failed to
produce exopolysaccharide on minimal medium (ref. 73). On this basis, mucoid
strains can be classified into groups 1 and 2 where PA0579 represents group 1
and PA0568, group 2. Fig. 10 shows the colonial appearance of PAO£68 and PA0579
after 2b h incubation at 37°C on PIA and minimal agar..
Fig. 10. Two mucoid mutants PA0568 and PA0579 after 2b h incubation at 37 C
on PIA (left plate) and minimal agar (right plate). The group 1 mutant PA0579
on the left of each plate produces alginate on both media, whereas the group 2
mutant PAO£68 on the right of each plate appears non-mucoid on the minimal agar.
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We have also observed that mucoid P. aeruginosa isolated from the sputa of
patients with CF can also be classified into these two groups, and in many
patients, both forms are isolated simultaneously from the same specimen
(ref. 7U).
Piggott (ref. 75) studied alginate biosynthesis in a number of mucoid mutants
derived from PAO38I, including PA0568 and PAO$79- In batch culture, in yeast-
extract medium with gluconate, polymer production in the majority of strains
was not growth associated. In addition, the conditions for optimal alginate
production varied markedly between strains. Some strains produced alginate
equally well at 30°C and 37°C, whereas others produced best at 37°C. When the
composition of the polymers from these strains (collected after I4.8 h growth in
yeast extract medium with 2% gluconate) was analysed, all samples had a high
mannuronic acid content ranging from 75% to 95%. The degree of acetylation
and viscosity also varied significantly and a linear relationship was observed
between % acetylation and viscosity over the range 2.3-8.696 acetate content.
In every aspect of alginate biosynthesis studied, the mutants varied con¬
siderably although all were derived from the same parent.
Piggott etal. reported enzyme analyses on PAO381 and four of the mucoid
mutants (ref. 76). The results obtained for three enzymes, phosphomannose
isomerase, GBP-mamnose pyrophosphorylase and GBP-mamose dehydrogenase involved
in the alginate biosynthetic pathway are shown in Table 2.
TABLE 2
Enzyme levels in P. aeruginosa PA0381 and four mucoid derivatives. Results are
expressed in umoles product formed mg protein-"' min-"' (ref. 76).
PA0381 PA0579 PA0578 PA0568 PA0585
22 380 360 280 U1
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The lew levels of activity of the GBP-mannose metabolising enzymes in
PA0568 were increased by the addition of 0.5 wM fluoride indicating the
probable presence of a nucleotide hydrolysing enzyme. Attempts to isolate an
epimerase from these strains were unsuccessful.
Similar enzyme analyses of four non-mucoid revertants of PA0579 revealed no
detectable GBP-mannose pyrophosphorylase or GBP-mannose dehydrogenase while
phosphomannose isomerase levels remained elevated.
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GENETICS OP BACTERIAL ALGINATE BIOSYNTHESIS
Genetics of P. aeruginosa and A. vinelandii
Genetic analysis of any organism is dependent on (a) the ability to obtain
and recognise stable genetic variation both natural and induced, and (b) a
system of gene transfer and recombination.
Por many years, bacterial genetics was synonymous with Escherichia coli
genetics following the pioneering work of Lederberg and Tatum (refs. 77-79)•
Interest in the genetics of organisms other than E. coli is more recent. The
genus Pseudomonas attracted the attention of geneticists because of its bio¬
chemical diversity and significance as an opportunist pathogen. Gene transfer
by means of conjugation was first described in P. aeruginosa in 1996 (ref. 80),
transducing phages were also isolated and characterised (ref. 81) and genetic
mapping studies ensued. Most of these studies have used two strains PAO and PAT
originally described by Eolloway (ref. 82). Strain PAO was isolated from a
patient in Australia in 195k- Strain PAT was originally isolated in South
Africa in 1950 and carried the sex factor now known as FP2. Several extensive
reviews reporting the progress in genetic analysis of P. aeruginosa have been
published (refs. 83-87).
Por over 20 years, mapping of the PAO chromosome was hampered by the in¬
ability to demonstrate genetic circularity. Unlike P, the original E. coli
sex factor, which can mobilise the chromosome from many different sites, PP2
apparently had a single origin of transfer, so that accurate mapping of markers
by plate and interrupted mating techniques was only possible for the 0' to 1+0'
region (ref. 87).
In strain PAT, however, several R plasmids were found that exhibited
chromosome mobilising ability (Cma) (ref. 88). Mapping data obtained using
the plasmids PP2, R91-5 (inc. P-10) and R68 (inc. P-1) together with trans-
ductional analysis, allowed a genetically circular linkage map to be constructed
for this strain (refs. 89, 90). The isolation of plasmid R68.U5, a variant
of R68 with efficient Cma for strain PAO (refs. 91, 92, for review see ref. 93)
proved a major step forward in PAO genetics, as it was shown to mobilise the
chromosome from multiple origins. Subsequently, a genetically circular map of
the PAO chromosome was constructed (ref. 9k, Pig- 11)• Indeed, because of its
broad host range, R68.k5 has been a useful tool in the genetic analysis of
various other bacterial species including Rhizobium leguminosarum (ref. 95),
R. meliloti (ref. 96), R. trifolii (ref. 97) and Rhodopseudomonas spharoides
(ref. 98).
Genetic studies of A. vinelandii have had an even more chequered development.
Several workers have reported the isolation of auxotrophs, (refs. 99-101),
antibiotic resistant mutants (ref. 100) and mutants unable to fix nitrogen



































Pig. 11. Chromosome map of P. aeruginosa PAO (ref. 9U)- Markers whose location
is indicated by a bar joined to the map were located by interrupted matings
using PP2 donors. Round brackets indicate that markers are cotransducible with
one or more of the phages F116, F116L, G101 and E79. Marker abbreviations are
as follows:- Anabolic markers: arg, arginine; car, carbamoylphosphate
synthase; cys, cysteine; his, histidine; ilv, isoleucine valine; leu, •
leucine; lys, lysine; met, methionine; phe, phenylalanine; pro, proline;
pur, purine; pyr, pyrimidine; ser, serine; thr, threonine; trp, tryptophan.
Cafabolic markers: ami, amidase; cat, catechol; cm, carnosine; hut,
histidine; mtu, mannitol; puu, purine; tyu, tyrosine. • Resistance markers:
agl, aminoglycoside; nal, naladixic acid; rif, rifampicin; str, streptomycin.
Other markers: aer, aeruginocin production; pho, alkaline phosphatase;
tol. aeruginocin tolerant.
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difficult to isolate, e.g. those blocked in B-hydroxybutyrate metabolism
(ref. 101;). The reasons for this are not completely understood, but genetic
instability of the mutant DNA is thought to be responsible rather than a
problem with mutagenesis per se (ref. 105). It has been estimated that a
mid log phase A. vinelandii cell contains enough UNA to account for approxi¬
mately I4O chromosomes (of the size found in E. coli) (ref. 101+). Hence, many
of the genes may exist in multiple copies. Whether this finding accounts for
the problems in obtaining stable mutants remains to be seen.
Gene transfer in A. vinelandii can take place by transformation (refs. 101,
106, 107) but mapping data has been limited. Page and Sadoff (ref. 101)
found that three auxotrophic loci were all linked to a locus conferring rif-
ampicin resistance, and Bishop and Brill (ref. 103) showed that the genes
involved in nitrogen fixation (nif) did not fall into one cluster, unlike the
nif genes in K. pneumoniae which are closely linked.
In a recent report (ref. 108), RPi;, an IncP-1 E plasmid probably identical
to R68 (ref. 109) was transferred into A. vinelandii strain BW and was stably
maintained. Resistances to ampicillin, tetracycline and kanamycin were all
expressed in this background and the plasmid ^transferred at high frequency
between different strains of A. vinelandii. RPl; could also mobilise the multi¬
copy plasmid RSF1010 into A. vinelandii UW and the plasmid could replicate
autonomously. This provides the potential for further genetic analysis of
A. vinelandii including cloning studies.
Genetic studies on alginate biosynthesis and regulation
Studies on the genetic aspects of alginate biosynthesis in mucoid P. aeruginoss
began in 1975> and have been mainly concerned with the regulation of the bio-
synthetic pathway rather than the pathway itself. No studies have been reported
on the genetics of the analogous system in A. vinelandii although non-capsulated
mutants have been reported in the context of encystment (ref. j6) and trans¬
formation (ref. 101).
Markowitz et al. (ref. 110) attempted to link alginate production with
plasmid content in clinical isolates of mucoid P. aeruginosa. They sought
evidence of plasmid DNA in cleared lysates from 18 mucoid strains and their
isogenic non-mucoid revertants, but were unsuccessful. In addition, the
spontaneous loss of the mucoid character was not significantly increased by
plasmid curing regimens, e.g. treatment with ethidium bromide, further indi¬
cating the lack of plasmid involvement.
Work in our laboratory (refs. 67, 68, 73> Ihi 111—111+)• aimed to test the
hypothesis that all wild type P. aeruginosa have the necessary genetic infor¬
mation for alginate synthesis and that this is normally repressed. Hence,
mucoid P. aeruginosa would arise following a spontaneous mutation in one of an
unknown number of regulator genes. An alternative hypothesis is that wild type
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P. aeruginosa have a defective enzyme in the alginate biosynthetic pathway and
mucoid strains have a normal one. However, enzyme analysis of a non-mucoid
P. aeruginosa (PA0381) described in a previous section (Table 2), suggested
that the alginate synthesising enzymes are present, but the specific activities
are very low. Thus we have attempted to determine the number and location of
genes responsible for the repression of alginate synthesis, prior to identi¬
fying the structural genes coding for the relevant enzymes, and determining
the nature of the regulatory system(s).
Our approach was based on the elegant studies of Markovitz and his col¬
leagues on mucoid E. coli (reviewed in ref. 11$). Wild type E. coli K12 does
not appear mucoid when grown at 37°C, however at 30°C, the strain produces an
exopolysaccharide composed of glucose, galactose, fucose and glucuronic acid.
This polysaccharide is known as colanic acid. Mutant strains of E. coli K12
can be isolated which are mucoid at 37°C, hence the wild type strain contains
all the genetic information necessary for colanic acid synthesis, but this is
not expressed under these conditions.
Studies on the genetics and regulation of colanic acid synthesis in E. coli
K12 began in 1,962. This organism was a particularly good candidate for such
an analysis because of the wealth of genetic information already available.
Early mapping studies revealed that mutations in at least two chromosomal sites
yielded mucoid strains. One of these mutations in capR (ion) was shown to be
cotransducible with the proC locus using bacteriophage P1, and the second
mutation, capS mapped near a trp locus. A third mutation, capT which resulted
in colanic acid production on EMB-glucose medium (capR and capS strains are
non-mucoid on this medium) at 37°C was also identified. It was possible to
confirm the regulatory role of these loci by performing partial diploid studies.
Using the F'13 plasmid (a derivative of P carrying the capR+ allele) it was
demonstrated that capR+ is dominant over capR and hence capR+ was thought to
specify a cytoplasmic repressor protein which acts on the genes for colanic
acid synthesis.
A working model for the system, controlling colanic acid synthesis was
proposed, i.e. there are several targets on the E. coli chromosome, capR, capS,
and capT whose function is to directly or indirectly switch on or off the
enzymes involved in colanic acid synthesis. The aim was then to determine
whether the control is at the level of transcription or translation and to
determine d;he nature of the regulatoiy products.
As well as switching on colanic acid synthesis', the capR mutation has a
number of pleiotropic effects. CapR strains are UV sensitive, resistant to
low levels of tetracycline, chloramphenicol and puronycin and do not allow
phages X and P1 to replicate in the plasmid mode. These properties are not the
direct result of colanic acid synthesis, but reflect the diverse role of the
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capR gene product. CapS and capT mutants do not share these properties.
Recently, (ref. 116) the capR+ gene has been cloned and its product identified
as a 9I4K protein, thought to he under autoregulatory control.
Obviously, our brief outline of the genetic studies on mucoid E. coli has
been a greatly simplified version and is not meant to give a detailed account
of the regulation of colanic acid synthesis. However, the rationale for these
studies in E. coli provided the basis for our approach to the genetics of
alginate synthesis in P. aeruginosa, although, at the time of our initial
studies, the background genetic information available for P. aeruginosa was
far less comprehensive than for E. coli.
The development of the semi-selection technique for isolation of alginate-
producing (muc) mutants of P. aeruginosa, already described (Fig. 8), allowed
us to put muc mutations into various genetic backgrounds. Table 3 describes
the strains relevant to our genetic studies.
TABLE 3
PAO strains used in genetic studies on alginate production
Strain
*
Genotype Origin and/or Reference
^A0381 leu-38, str-2. FP2 ref. 72
PA0568 leu-38. str-2. muc-2, FP2 Group 2 mucoid mutant
(ref. 73)
of PA0381
PA0578 leu-38, str-2. muc-22. FP2 Group 2 mucoid mutant
(ref. 73)
of £O CO
PA0579 leu-38, str-2, muc-23. FP2 Group 1 mucoid mutant
(ref. 73)
of T—CO0£
PAO$85 leu-38, str-2, muc-371 FP2 Group 1 mucoid mutant
(our laboratory)
of PA0381
PA0951+ met-9011. ami E200, oru-292 Obtained from II. Haas
PA0961: ami-151. hut-C107, pru-3$i+ Obtained from D. Haas
PA010U2 pur-67, thr-9001, cys-39» pro-6g ref. 9U
PA02021 cys-560g, his-5075, argA171,
pro-67, nal-25, muc-36, FP~
Group 2 mucoid mutant
(ref. 73)-v
of PA02022
PA02022 cys-g60g, his-5075, argA171,
pro-67, nal-25, FP~
ref. 73
The genotype symbols used are the same as.for Fig. 11. The following pairs of
markers are closely linked:- ilv-202 and ilvD, leu-38 and leu-8, str-2 and
strA, thr-9001 and thr-h8, pro-67, pro-65 and proB, nal-25 and nalA. Markers
not appearing on the chromosome map are pur, proline utilisation, oru, ornithine
utilisation, muc, alginate synthesis.
PAO38I was chosen as the initial genetic background for the mapping of muc
loci, as it is a single autotroph (leu-38), carrying the sex factor FP2 and thus
could act as donor in mating experiments.
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It should he emphasised at this point that unlike auxotrophic or catabolic
markers, muc cannot he selected for in matings or transductions. The small
increase in carhenicillin resistance associated with muc is not sufficient to
provide a specific selection of recombinants from the large number of recipient
bacteria. Hence, the mapping of muc loci is dependent on the demonstration of
linkage to known selectable markers.
We postulated that the muc mutation in PA0579 (muc-23) would be located
somewhere on the PAO chromosome, so the strain was used as a donor in plate
matings (ref. 117) with various multiply marked recipient strains (non-mucoid,
muc+), selecting for a range of auxotrophic markers in different regions of
the chromosome (non-circular at this stage). A significant early result from
these matings was that the recombination frequencies for all markers were
10 to 50 fold lower than those obtained using the isogenic non-mucoid donor.
However, when a mucoid strain, e.g. PA02021, was used as recipient in a plate
mating with PAO38I, the numbers of recombinants were not similarly reduced.
Later studies involving mucoid donors in plate matings mediated by R68.1;5
suggested that donorability is not impaired to the same extent using this sex
factor. Markowitz et al. (ref. 110) have reported that, in broth matings,
alginate synthesis by either the donor or recipient had little or no effect
on the transfer of certain R plasmids. The mechanism involved in the inhibition
of FP2-mediated chromosome transfer by alginate synthesis has yet to be deter¬
mined.
When PA0579 was crossed with the muc+ recipient PA02022, approximately 30%
of the recombinants obtained on selection for cys-360^+ and his-5075+ were
mucoid. These mucoid recombinants were easily distinguished from the non-mucoid
variety on the actual mating plates (minimal agar supplemented with the ap¬
propriate amino acids), thus showing the same, group 1, characteristics as
PA0579. When a similar cross was performed using the group 2 mucoid donor,
PA0578, similar linkage of muc-22 to cys-E>60g and his-5075 was observed.
However, the recombinants had to be transferred to PIA for scoring of muc.
This confirmed that the difference between group 1 and group 2 mucoid strains
is a result of the mutation leading to alginate production rather than a
secondary change modifying the phenotype.
The cross between PAO38I and the mucoid recipient PA02021 (muc-36) likewise
indicated linkage of the muc"1" allele to cys-$60g and his-5075. Table shows
the results of recombinant analysis.
These results indicated a chromosomal location for muc-38 at a point distal
to cys-5605 and his-5075 with respect to the origin of transfer. This was
confirmed by interrupted matings (ref. 118) in which cys+ recombinants obtained
at each interruption time were scored for co-inheritance of muc+, as well as




cys + pro +
cys + arg +
Time (min.)
Fig. 12. Interrupted mating between PAO38I and the mucoid recipient PA02021
(muc-36) (a) Time of entry kinetics of pro-67 (O), cys-5605> (• )> his-?075
(. □ ), and argA171 (■ ) (t>) Percentage coinheritance with cys-5>605+ of the




Recombinant analysis following plate matings between the donors PA0578 and
PA0579 and recipient strain PA0101+2
% Co-inheritance of unselected marker
Donor Selected Marker muc pro"1" cys+ pur*
PA0578 (muc-22) pro-65* 1 - 1+ <1
cys-59"1" 3b 33 - 6
pur-70"1" 10 2 5 -
PA0579 (muc-23) pro-65* 8 - 1+ <1
2ZS-39* 38 35 - 10
pur-70* 2 2 k -
muc-22 muc-23
pur-70 * cys-59 * - pro-65
Pig. 13• Approximate locations of muc-22 and muc-23 based on plate mating data.
It has been possible, however, to proceed further with the mapping of muc-22
using transductional analysis, due to the work of Soldati and Haas (manuscript
in preparation) who had isolated and mapped several catabolic loci in the
region between pur-70 and cys-59 (Pig. 1l+). Oru-292 and pru-35k are involved
in the utilisation of ornithine and proline respectively and show 6C»/o linkage
in R68.i4.5-mediated crosses.
pur-70 oru-292 jdtu-35U cys-59
Pig. 1l|. Selectable markers in the region pur-70 to cys-59•
It is extremely difficult to obtain high titres of transducing phage grown
in the usual way on mucoid strains, presumably because the phage receptors on
the bacterial surface are blocked or the phage immobilised in the viscid
environment surrounding the cells. Thus, before muc-22 could be mapped by
transduction, it was necessary to isolate a non-mucoid derivative of PA0578
which had arisen due to a second, unlinked mutation switching off alginate
production. Such "suppressed" revertants are still able to transfer the
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muc allele in matings, giving rise to mucoid recombinants on selection for
the appropriate markers. These kinds of strains are relatively common
amongst non-mucoid revertamts and their nature will be discussed later.
Phage F116L was grown on a revertant of PA0578 and used to transduce
PA095U and PAO96I+ selecting for oru+ or pru"1"; transductants were then scored
for the co-inheritance of muc-22. 20% cotransduction was obtained between
pru-351i and muc-22, while no mucoid transductants were observed on selection
for oru+. Similarly, 1+9% cotransduction was obtained between pru-33>U and
muc-2 (PAO$68).
Pour mucoid mutants (all group 2) of PAO96I+ were isolated and these were
transduced with F116L grown on PA01, selecting for pru+. In each case, 30-50%
of the transductants were muc+ (i.e. non-mucoid) indicating a similar location
for these muc mutations. Two of these strains were used as recipients in
three factor crosses to determine the marker order for oru, pru and muc.
R68.1+5 was transferred into PA095U and this strain was crossed with the two
mucoid derivatives of PAO96I+, selecting for pru+. Recombinants were then
scored for co-inheritance of oru and muc+. The results indicated that both
muc mutations in these strains were to the right of pru-35^- (Fig. 15).
-
oru pru muc
Pig. 15- Marker order determined from 3-ftactor crosses.
On the basis of results obtained so far, we can conclude that at least two
regions on the PAO chromosome are involved in the repression of alginate
synthesis. Mutations in either of these loci (or clusters of loci) result in
derepression of the enzymes in the alginate biosynthetic pathway.
The nature of the repression of alginate synthesis in wild type (non-mucoid)
strains has still to be determined. Partial diploid studies using R68.1+5 in
a recA background (ref. 119). or involving P. putida (ref. 120) have been
reported, and now that at least one muc locus is known to be closely linked
to a selectable marker (pru~35U), it should be possible to determine whether
a cytoplasmic repressor, analogous to the capR gene product, is coded for by
this muc locus. Cloning studies in P. aeruginosa have also been reported
recently (ref. 121), thus further adding to the techniques available for the
genetic analysis of this organism.
Indirect evidence for the protein nature of the capR+ cytoplasmic repressor
in E. coli was obtained by growing wild type strains on amino acid analogues,
e.g. para-fluorophenylalanine (PPA) (ref. 122). When grown on certain
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concentrations of FPA at 37°C, wild type E. coli K12 produced colanic acid,
presumably because the analogue was incorporated into the capR*1" (or capT )
gene product, resulting in a biologically inactive repressor.
Attempts to find levels of FPA derepressing alginate production in wild
type P. aeruginosa have so far proved unsuccessful (ref. 75> Govan and Fyfe
unpublished data).
A different approach to the genetic analysis of alginate production in
P. aeruginosa has been described by Ohman and Chakrabarty (ref. 123). They
attempted to develop a genetic system in a clinical mucoid isolate and map the
loci (alg) responsible for the instability of alginate production in this strain.
Using a fluctuation test we have shown that instability in PA0568 can be
explained on the basis of spontaneous mutations back to the non-mucoid form
(ref. 113)- A variety of mutations capable of "switching off" alginate pro¬
duction would be expected, including mutations in the structural genes coding
for the biosynthetic enzymes leading to polymannuronic acid, so the approach
taken by Ohman and Chakrabarty combined with enzyme analyses would prove
valuable in the identification of genes involved in this system.
Ohman and Chakrabarty identified three classes of alg mutants based on
colonial appearance and the results of genetic crosses between alg donors
and recipients, some of which produced alg"1" recombinants. They concluded that
the alg loci responsible for each of the three classes of non-mucoid mutants
were located in a cluster. Unfortunately, no comparison was made between the
markers employed in this system and those appearing on the PAO chromosome map
(Pig. 11). Also, no attempt was made to determine the nature of the genes
being studied. Hence, it is difficult to relate this work to our studies using
PAO.
The possibility that PAO mucoid strains might be genetically distinct from
mucoid P. aeruginosa isolated in vivo has been dispelled to a large extent by
our finding that a muc locus in the clinical strain 1^92c (ref. 1*9) has been
mapped in a R68.1;5-mediated inter-strain cross (with PA010l^2) and is located
between cys-59 pur-70 (Fyfe and Govan, unpublished data).
*• V
THE SIGNIFICANCE OF BACTERIAL ALGINATE
A taxonomic relationship between Azotobacter and Pseudomonas?
In any consideration of the biosynthesis, regulation and function of bacterial
alginate it is difficult to avoid the intriguing and obvious question as to
why this unusual polymer, normally associated with marine algae, is uniquely
produced in the case of procaryotes by members of two such diverse genera as
Azotobacter and Pseudomonas. It is interesting to speculate on the origin,
evolution and maintenance of the genes responsible for alginate biosynthesis
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and regulation, the "biological function of the polymer and even a possible
taxonomic relationship between the soil-inhabiting, nitrogen fixing
A. vinelandii and the opportunist pathogen P. aeruginosa.
Although comparisons of the genera Pseudomonas and Azotobacter are not
commonly found in research publications several studies have recently revealed
close relationships between species of these two genera, on the basis of various
characteristics. Durham et al. (ref. 121+) compared the three enzymes that
initiate metabolism of protocatechuate in Azotobacter and Pseudomonas and
revealed a close immunological relatedness of isofunctional proteins. Further¬
more, they found that in both Azotobacter and Pseudomonas species of the
"fluorescent" and "cepacia" groups, 8-ketoadipate induces all the enzymes of
the protocatechuate pathway (except protocatechuate oxygenase), a regulatory
property which sets these organisms apart from other bacteria. The authors
concluded that a closely related set of genes may code for the protocatechuate
pathway in Azotobacter and Pseudomonas.
While studying the antigenicity of various outer membrane molecules in
P. aeruginosa. Hancock et al. (ref. 125) using a monoclonal antibody, demon¬
strated that a single antigenic site on the major outer membrane lipoprotein,
H2, is shared by various strains of P. aeruginosa,- P. fluorescens, P. putida
and a strain of A. vinelandii. Further evidence for evolutionary conservation
of genetic information was provided by De Vos (ref. 126) who has demonstrated
significant rHNA homology between A. vinelandii and a variety of fluorescent
pseudomonads.
The biological function of bacterial alginate
We have already discussed evidence for a structural function for bacterial
alginate in the metabolically dormant microcysts of A, vinelandii. This does
not explain, however, the abundant production of extracellular alginate in
metabolically active vegetative cells of this species. It is even more dif¬
ficult to explain the evolutionary retention of alginate biosynthesis and
regulation in P. aeruginosa, P. putida, P. fluorescens and P. mendocina. It
would seem likely that in vegetative cells alginate has no single function but
rather that the polymerias with other exopolysaccharides (ref. 127), may
contribute a range of properties whose specific roles might depend upon the
environment. Evidence suggests that, in A. vinelandii, alginate does not
serve as an overflow metabolite (ref. 22) but rather that it may act as a
protective barrier against heavy metal toxicity (ref. 128), as a diffusion
barrier to oxygen (ref. 5), as an ion-exchange system (ref. 129) with enhanced
selectivity for Ca"1-1", particularly when alginate is in the gelled state
(refs. 38, 130) or provide the bacterium with a hydrophilic, negatively charged
coating which provides protection against attack and adverse environmental
conditions (refs. 22, 127). Reference has already been made to the possible
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utilisation of alginate as a nutrient source in the germination of Azotobacter
cysts (ref. 39). Although an alginate lyase can be detected in cultures of
A. vinelandii, the biological significance of this enzyme is uncertain.
Couperwhite and McCallum (ref. 131) suggested that alginate could serve as
a storage polymer although further confirmation for this role has not been
found (ref. 22).
In the case of P. aeruginosa, Piggott found no evidence for the production
of alginate lyases by mucoid or non-mucoid strains (ref. 75) although alginases
have been detected in P. putida and P. maltophilia (ref. 132). No natural,
ecological niche for alginate-producing pseudomonads, with the exception of
the CP lung, is known. This suggests that in the majority of habitats alginate
biosynthesis provides no advantage to the organism. However, in the unusually
compromised environment of the CP lung, alginate must confer some advantage.
Evidence is now available which suggests a multifactorial role for pseudomonas
alginate in CP and provides a classic example of the ability and versatility
of P. aeruginosa to act as an opportunist pathogen.
It is interesting to note that although P. cepacia can also be isolated
from some CP patients, alginate-producing strains of this species have not
been reported. This is in agreement with our observation that alginate-
producing P. cepacia could not be isolated in vitro (ref. 70) and suggests
that alginate biosynthesis is not a characteristic of this species or, if
repressed, is controlled by a mechanism fundamentally different from that found
in P. aeruginosa.
The adaptibility of P. aeruginosa and the significance of alginate bio¬
synthesis in this species can be more fully appreciated by a knowledge of
the pathological features found in CP patients. CP is an inherited, autosomal
recessive disease characterised by symptoms which include high sweat electro¬
lyte levels, pancreatic insufficiency and in the respiratoiy tract, raised
levels of Ca++ and Mg"1^ in bronchial secretions which in turn are abnormally
viscid due to the presence of highly sulphated glycoproteins (refs. 133» 13U)-
These abnormally viscid bronchial secretions depress the normal non-specific
immune defences of the lung in particular the rapid removal of bacteria and
foreign matter via the ciliated epithelium of the upper respiratoiy tract.
As we have already discussed in an earlier section of this chapter, during
the course of chronic respiratory infection in CP patients, alginate-producing
mutants of P. aeruginosa gradually emerge in the majority of patients. The
emergence and eventual predominance of alginate-producing pseudomonas correlates
with a poor prognosis (ref. 135i 136) suggesting that in CP patients the
alginate acts as a virulence determinant. Doggett and Harrison (ref. 51)
detected pseudomonas alginate in the sputum of CP patients confirming in vivo
synthesis of the polymer. Various studies have suggested mechanisms by which
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alginate contributes to the virulence of P. aeruginosa in the respiratory tract,
e.g. in bacterial adhesion to the surface of ciliated tracheal epithelium
(ref. 137)» resistance to attack by host phagocytes (refs. 138—lij.0), resistance
to pulmonary surfactant (ref. 67) and to antibiotics (refs. 68, 69) and in
reduced pulmonary clearance of P. aeruginosa (ref. 7i+). T° these roles as an
adhesin and protective agent it is arguable to add the potential for patho¬
logical damage residing in the physical properties of alginate. Aqueous
solutions of pseudomonas alginate are extremely viscid and gel rapidly in the
presence of physiological levels of Ca'*-1" (ref. 71+)• It is not difficult to
imagine the detrimental effect of the polymer's rheological properties in a
lung already characterised by sticky bronchial secretions and stasis, and to
appreciate, albeit reluctantly, this particular form of bacterial adaptation
in a species whose versatility is already well recognised.
FtFTOBE STUDIES
Many questions remain to be answered concerning the biosynthesis and regu¬
lation of alginate in A. vinelandii and P. aeruginosa. Physiological studies
have been few and the results obtained dependent to some extent on the strains
used. The relationship between cell wall biosynthesis and alginate production
has not been fully investigated. In A. vinelandii strain 9068, the rate of
alginate synthesis is relatively independent of specific growth rate, suggesting
that in these bacteria, competition for precursors between alginate synthesis
and cell wall synthesis does not have a great influence on the rate of alginate
synthesis (ref. 22). In P. aeruginosa, however, strains which do not produce
detectable alginate during log phase, have a higher specific growth rate than
those strains exhibiting growth association of alginate synthesis.
No studies have been reported on the genetics of alginate biosynthesis and
regulation in A. vinelandii and progress in this area is dependent on further
development of the genetic system in this organism.
In P. aeruginosa, the techniques are now available for a detailed analysis
of the alginate biosynthetic pathway, along with the added component of its
repression in wild type strains. We know that at least two genes involved in
the repression of the alginate biosynthetic enzymes are located on the
P. aeruginosa chromosome in the region near the major PP2 origin, however, the
nature of the gene products has yet to be determined. Partial diploid analysis
should reveal whether the muc loci, so far identified, code for repressor
proteins or some other regulatory product. Cloning studies will be required
if these gene products are to be fully identified.
Yet another question to be answered involves the genetic significance of
the different mucoid phenotypes in P. aeruginosa, i.e. groups 1 and 2. In
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E. coli, capT mucoid mutants synthesise colanio acid when grown on EMB-glucose
agar at 37°C, whereas capR and capS mutants do not. In addition, capR and
capS mutants are distinguishable on the basis of other characteristics, e.g.
UV sensitivity. Our initial mapping results using PA0578 and PA0579 suggested
that strains with mutations at one of the two different sites, (represented by
muc-22 and muc-23, Pig. 13) could be distinguished on the basis of alginate
synthesis on minimal agar. However, further work has shown that several group 1
mutations are closely linked to pru-35>U (unpublished data). The medium com¬
ponent responsible for differential alginate synthesis on minimal agar has not
been fully determined. However, we have some evidence that Mg"1^ concentration
may play a role, as increased Mg-1-1" concentration leads to increased alginate
synthesis in some group 2 mutants. Ho enzyme analyses have been performed on
group 2 strains grown in minimal medium, so it is not known at which stage
alginate synthesis is blocked.
Apart from increased resistance to various antibiotics and surfactants,
indicating cell membrane changes, none of the other pleiotrophic effects
detected in capR mutants of E. coli, e.g. TJV sensitivity, have been observed
in mucoid P. aeruginosa.
Determination of the role of acetylation in the alginate biosynthetic path¬
way will require the isolation of mutants whose alginate lacks acetyl groups.
It will be interesting to see if such alginates have a high guluronic acid
content, thus providing evidence for the role of acetylation, postulated by
Davidson et al. (ref. 27), to protect certain mannuronic acid residues from
epimerisation.
Finally, what of the potential of bacterial alginate as an alternative to
the present marine algal product. Clearly bacterial alginates exhibit all the
physical properties necessary for the commercial applications of the polymer.
The problems may lie in the production of the bacterial polymer on a large
scale.
A. vinelandii has been examined in this context and the results reviewed
elsewhere (ref. 20). Production of alginate on a large scale by this organism
could turn out to be fairly costly as the efficiency of conversion of the
carbon source to alginate is low, especially under conditions where respiration
rate is high. Genetic manipulation of the organism may overcome this problem.
Amongst the alginate-producing pseudomonads, mucoid P. aeruginosa are
strain dependent in respect of the conditions leading to maximal alginate yield.
Some strains synthesise alginate during the growth phase, and at first sight
would appear good candidates for alginate production in a continuous culture
system. However, these strains are extremely unstable and revert back to the
non-mucoid state due to the growth advantage of non-mucoid revertants (ref. 113).
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Strains which synthesise alginate only in late log phase and stationary
phase tend to be more stable, but perhaps more suitable for batch production.
Although advantages in the use of mucoid P. aeruginosa for production of
alginate include the relative efficiency of alginate synthesis in terms of |
carbon conversion, and the possibilities of genetic manipulation, the problems ||
of this organism's potential as an opportunist pathogen must be a major hazard.
Alginate producing mutants of P. putida, P. fluorescens and in particular
P. mendocina would perhaps be more acceptable, because of these species'
relatively infrequent association with infections.
However, physiological studies are required to determine the optimal con¬
ditions for alginate synthesis by these species, and any similarity to the
genetics and regulation in P. aeruginosa is open to speculation.
It is probable that future studies of bacterial alginate will continue to
emphasise the diverse and occasionally conflicting research aims of modern
microbiologists. Biochemists and industrial microbiologists will undoubtedly
seek to improve the yield, viscosity and gelling potential of alginate as a
commercially valuable polymer, especially if supply of the raw source of marine
alginate becomes scarce or commercially uneconomic. In contrast, recognising
mucoid P. aeruginosa as an important pathogen in the lungs of CP patients,
medical microbiologists are already actively seeking means to interfere with
alginate production in vivo in order to aid antibiotic therapy and reduce the
organism's virulence.
Irrespective of the reasons for studying bacterial alginate, each field of
microbiology will certainly benefit from a greater knowledge and understanding
of the synthesis, regulation and function of bacterial alginate, both in vitro
and in vivo.
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